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Abstract 
 
Complete genomes of many organisms have been recorded using high throughput nucleic 
acid sequencing; however the intricate functions of the gene products, namely proteins, 
remain largely undiscovered.  As the most prominent technology for polypeptide 
sequence determination and quantification, tandem mass spectrometry is used extensively 
to address questions regarding the behaviours of proteins in the biological context.  The 
capacity of mass spectrometers to measure covalent modifications of amino acids is also 
of great value in the investigation of biological processes since specific reactive sites 
within proteins modulate their activity.  Integration of liquid chromatography into mass 
spectrometry platforms has greatly improved their sensitivity and throughput and is of 
particular benefit in the analysis of highly complex polypeptide mixtures.  Studies of the 
behaviours of individual intracellular proteins in bacterial, plant and metazoan systems 
employing liquid chromatography-mass spectrometry are described herein.  Amino acid 
phosphorylation, a type of covalent modification which can switch a protein between 
inactive and active states, was investigated in detail in each system.  The phosphorylation 
of individual amino acid residues and resulting alterations in function were determined in 
GraR and VraR, two antibiotic resistance factors of the human pathogen Staphylococcus 
aureus.  Such information improves understanding of bacterial antibiotic resistance.  
Three phosphosites of starch branching enzyme IIb which appear to regulate starch 
biosynthesis in Zea mays (corn) as well as kinases for which these sites are putative 
substrates were identified.  The definition of such molecular drivers of starch formation 
could inform the generation of novel cereal varieties capable of making novel starch 
 
 
iii 
 
types.  Regulation of the highly conserved multifunctional protein Beta-catenin by p38 
mitogen activated protein kinase was explored.  Gene products with affinity for Beta-
catenin, including several not previously known to interact, were identified from Rattus 
norvegicus (rat) smooth muscle cells.  Since Beta-catenin is integral to animal growth and 
repair, mapping its interaction network has broad implications for the advancement of 
medicine.  The specificity of peptide ion mass and peptide fragment ion mass relative to 
instrumental mass accuracy and the consequence for tandem-mass spectrometry-based 
quantification are explored mathematically in a separate chapter.  In silico comparison of 
peptide ion/product ion mass pairs calculated from the human proteome revealed a range 
of mass redundancy from high to low simulated mass accuracy.  Product ions from a 
single peptide sequence were found to differ in their tendencies toward mass redundancy 
however no correlation between size and sequence specificity was apparent, 
demonstrating accuracy limitations in quantitative tandem mass spectrometry of peptides.  
This dissertation illustrates research into protein function conducted on three types of 
mass spectrometers and demonstrates some effects of liquid chromatographic and mass 
spectrometric performance on proteomic studies. 
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Chapter 1 
Theoretical and practical aspects of polypeptide analysis by high 
performance liquid chromatography-mass spectrometry 
 
1.1 Introduction 
Proteins are a diverse group of biopolymers whose primary structures are linear amino 
acid chains connected by amide bonds.  Since polypeptides are integral to biology, 
myriad biological phenomena can be explored through their characterization.  Proteins 
can be distinguished by their physiochemical parameters.  Reactivity, isoelectric point 
and optical properties are generally imprecise protein identifiers due to the functional and 
structural redundancies of these diverse macromolecules.  Each protein has a unique 
primary structure, or sequence, which reflects the genetic sequence encoding it as well as 
transcription and translation.  Covalent post-translational modifications introduce 
additional levels of differentiation.  Primary structures are definitive protein identifiers. 
The first widely accepted technique for the determination of primary polypeptide 
structure, commonly known as Edman degradation, involved sequential derivatization of 
the amino-terminal amino acid followed by selective acid-catalyzed cleavage and 
identification of the free, modified residue (1). Though automation improved throughput, 
Edman degradation required the analyte in relatively large amounts and at high purity (2).  
The utility of the technique is also restricted by interference from amino acid 
modifications and inherent reaction efficiency limits.  These shortcomings necessitated a 
more sensitive and less restrictive protein sequencing technique. 
The sensitivity of automated Edman sequencers was matched by early mass 
spectrometers equipped with polypeptide-compatible ionization sources (3).  Though 
polypeptides are not volatile, techniques by which they could be transitioned from the 
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solid or liquid phase into the gas phase permitted their analysis by mass spectrometry 
(MS).  Fast atom bombardment (FAB) and plasma desorption (PD) were the first 
techniques used to ionize native polypeptides for MS but both had practical problems 
such as low ion yields (3).  Electrospray ionization (ESI) and matrix assisted laser 
desorption-ionization (MALDI) simplified the ionization of labile, non-volatile molecules 
such as proteins, increasing the applicability of MS to polypeptide analysis (4-6).  
Tandem mass spectrometry (MS/MS) provided a rapid alternative to time-consuming 
sequential labelling and cleavage of single amino acids in Edman degradation (7).  With 
MS/MS, sequence information could be derived from the mass spectra of both intact 
polypeptide ions and fragments produced by their gas-phase dissociation.  
Complementary MS and MS/MS data for a peptide could be acquired in seconds or less.  
Furthermore, unlike Edman sequencing, MS analysis was unhindered by modification of 
N-terminal amino groups.  Thioredoxin from Chromatium vinosum was the first protein 
to be completely sequenced by a combination of MS and MS/MS (8).  With continual 
improvement in mass resolution, sensitivity, versatility and throughput, MS ultimately 
eclipsed Edman degradation as the primary technology for protein sequencing. 
Though it has demonstrable advantages over other polypeptide sequencing approaches, 
MS requires specific sample conditions.  Every ionization source is limited by the 
maximum number of molecules that it can simultaneously ionize.  In mixtures, different 
compounds compete for ionization, reducing the signal of any single species.  The 
capacity of a mass spectrometer to sample ions is limited by physical constraints such as 
the orifice diameter in ESI instruments.  Every mass analyzer operates over a mass-to-
charge (m/z) range, beyond which it cannot effectively transmit ions.  Ion detectors and 
mass analyzers also have limits of sensitivity and speed.  All mass spectrometers 
therefore operate within specific ranges of analyte concentration, analyte size and sample 
complexity. 
Top-down proteomics, the investigation and identification of intact proteins by MS, 
presents technical and bioinformatics challenges which have yet to be overcome (9).  Gas 
phase-fragmentation and spectral interpretation are complicated by the structural 
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heterogeneity and size of protein analytes.  Many mass spectrometers can resolve and 
detect ions up to a few thousand Thompsons (Th), however proteins range in mass from 
tens to hundreds of kiloDaltons (kDa).  Consequently, it is impractical to sequence a 
protein from its molecular ion.  Bottom-up proteomics, the assignment of primary protein 
structure based on sequencing of peptides, is more commonly employed than the top-
down approach.  Proteins of interest must be digested into peptides prior to MS in 
bottom-up proteomics workflows.  Purified endoproteinases are typically used for protein 
digestion, yielding peptides whose sequences depend on the enzyme’s specific cleavage 
sites (10).  Digestion increases sample complexity, producing many small peptides from a 
single protein, but confers useful sequence characteristics to each peptide in the form of 
the protease-specific terminal amino acids.  The exclusive specificity of trypsin for 
cleavage at the C-termini of arginine and lysine residues makes this enzyme particularly 
useful for bottom-up experiments as the basic side chains of these amino acids readily 
accept protons from acidic matrices to confer a positive charge to the peptide(11).  The 
broad distribution of lysine and arginine residues throughout most proteomes and the high 
catalytic efficiency of trypsin also contribute to the popularity of this protease so that 
MS/MS of tryptic digests has become the standard for protein sequencing.  It should be 
noted that a proline residue immediately C-terminal to Arg or Lys blocks the action of 
trypsin and that this is accounted for in automated spectral interpretation.  Consecutive 
arginine or lysine residues diminish tryptic activity, creating peptides with so called 
ragged ends (10). 
To be efficiently characterized by MS, peptides in a mixture such as a protease digest 
must be separated prior to reaching the detector.  Separation prior to ionization reduces 
matrix effects on ionization and decreases the separatory burden on the mass analyzer.  A 
perfect separation would rapidly and completely isolate each analyte while removing non-
proteinacious components of the biological matrix, but no technique satisfies this ideal.  
Similarities in the physiochemical properties of polypeptides as well as other 
biomolecules impede their partitioning and this has remained a technical challenge in the 
field of proteomics from its inception.  Many techniques are available for protein and 
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peptide separations.  Sample complexity, the number of proteins to be identified, desired 
sequence coverage of each protein and MS performance characteristics are all 
considerations in the optimization of a sample preparation procedure.  
High performance liquid chromatography (HPLC) provides efficient separation under 
conditions in which polypeptides are stable and consequently can be applied to proteins 
or peptides.  Though gas chromatography delivers comparable resolution and speed, it is 
incompatible with polypeptides, which are non-volatile.  Sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) is convenient for the isolation of small 
numbers of polypeptides in the kDa mass range but cannot be directly coupled to MS (12, 
13).  In contrast, HPLC is capable of resolving hundreds or thousands of species, can be 
adapted to the separation of small or large molecules and is compatible with MS. 
Provided the mobile phase promotes ionization, an HPLC pump can be directly coupled 
to a mass spectrometer via ESI so that compounds spatially focussed on the analytical 
column are measured as they elute.  This instrument configuration, known as on-line LC-
MS or LC-ESI-MS, has the capacity to capture extensive sequence information from a 
single analysis.  With continuous separation and analysis, complex mixtures of 
biomolecules can be rapidly characterized in an automated fashion. The automated 
process, known as data-dependent acquisition or shotgun sequencing (used 
interchangeably with bottom-up proteomics), begins with the acquisition of a mass 
spectrum of the LC eluate to establish the m/z values of peptides eluting at any given 
time.  The peptide ions are then isolated based on their m/z values, fragmented and mass 
spectra of the resulting product ions are acquired.  The cycle is then repeated for the 
duration of the LC run.  Ongoing technological advances in LC-ESI-MS have 
dramatically increased throughput and data quality so that tens of thousands of peptides 
can be routinely sequenced from a single sample in minutes or several hours. 
Currently, ESI-equipped mass spectrometers surpass the throughput of those with 
MALDI interfaces for several reasons.  MALDI-MS requires off-line sample 
fractionation and real-time user input to generate high sequence coverage from complex 
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peptide mixtures, whereas ESI allows continuous automated sampling of a 
chromatographic eluate.  Since MALDI produces mostly singly charged molecular ions, 
compounds of high molecular weight ionized in this manner tend to exceed upper 
instrumental m/z limits (6).  In contrast, ESI generates singly and multiply charged 
molecular ions with the degree of ionization depending in part on analyte structure (4).  
For instance, longer peptides have more ionisable moieties than shorter peptides and 
therefore tend to obtain higher charge states by ESI.  Intramolecular electrostatic 
repulsion between charged sites such as protonated His, Lys or Arg side chains decreases 
with increasing peptide length so that larger peptides can accommodate more charges.  
The tendency of peptides to reach charge states proportional to their length and unique 
chemistries by ESI compresses their m/z range to match the characteristics of many 
conventional mass spectrometers. 
The following sections of this chapter describe fundamental concepts in liquid 
chromatography, ESI and MS particularly with respect to their application in polypeptide 
analysis. 
Fundamental principles of chromatography 
All chromatographic systems consist of a stationary phase, a mobile phase and some 
support within which both are contained.  As their names suggest, the mobile phase 
moves through the fixed stationary phase.  In essence, chromatography involves a series 
of liquid-liquid or liquid-solid extractions in which one of the solvents is continuously 
moved along with any solutes it contains.  Analytes are partitioned between the stationary 
and mobile phases depending on intermolecular interactions between all three, so that 
every compound has a velocity unique to each chromatographic system. 
The column has convenient fluid dynamic properties for a chromatographic system and is 
used extensively for gas (GC) and liquid chromatography (LC), in which the mobile 
phases are gas and liquid respectively.  The typical LC column is filled with densely 
packed stationary phase in order to maximize surface area and therefore solute 
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adsorption. A Gaussian spatial distribution of solute within the column produces 
symmetrical peaks when eluate concentration is plotted over separation time.   
Given the mobile phase flow rate, the dimensions of the stationary phase and the 
dimensions and retention time (tR) of a peak, the separatory efficiency of the 
chromatographic column can be determined.  Considering chromatographic separation as 
a series of extractions, it follows that resolving power is proportional to the number of 
these events.  Each extraction is termed a theoretical plate and the height (H) and number 
(N) of theoretical plates are common metrics of column performance.  The value of N 
depends on the method by which peak width is measured.  For Gaussian peaks the 
following are equivalent: 
 
 
 
Where tR is the time at which the species elutes relative to the beginning of the separation, 
σ is the standard deviation of tR, W is the baseline peak width and Wh is the peak width at 
half height (14).  Asymmetry, fronting and tailing are common features of 
chromatographic peaks causing their shapes to deviate from Gaussian distributions 
(Figure 1.1).  The terms tailing and fronting describe analyte elution beyond the slopes of 
the front and rear of the peak respectively.  Where noise obscures analyte-dependent 
signal around the base of a peak, its limits cannot be unambiguously measured.  In such 
cases, N cannot be accurately determined from the baseline peak width and Wh or σ are 
more appropriate.  The height of each theoretical plate is described in relation to column 
length (L) and to standard deviation (σ) of the Gaussian analyte elution profile, which 
corresponds to peak width. 
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Since H is expressed in units of length, σ must be expressed in relation to mobile phase 
velocity and the column dimensions with the use of a conversion factor.  Resolution 
increases with column length as longer columns accommodate more stationary phase but 
decreases with column diameter due to increased lateral diffusion.  Long, narrow columns 
produce high backpressure and therefore require high performance mobile phase pumps. 
For evaluating the properties of a stationary phase-mobile phase pair, it is convenient to 
consider the chromatographic separation a single extraction, as terms used to describe 
extraction efficiency apply to chromatography.  The mass distribution ratio Dm, describes 
the relative amount of a solute in each phase according to the relationship: 
 
The relationship is valid in terms of the absolute amount or concentration of a solute and 
reflects the equilibrium established between interactions of the solute with the stationary 
and mobile phases.  The corresponding equilibrium constant is termed the partition 
constant K, where: 
 
and Cstationary phase and Cmobile phase are the molarities in each respective phase (14).  For any 
given analyte, K increases with increasing retention time.  In practice, the value of K is 
manipulated to minimize separation time and maximize chromatographic performance by 
adjusting column temperature and phase composition. 
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Chromatographic resolution  
The degree to which any two analytes are separated by a chromatographic system is 
expressed as the system’s chromatographic resolution, Rs .  Assuming Gaussian peak 
shapes: 
 
where tR1 and tR2 are the retention times of the two analytes and wb1 and wb2 are the 
corresponding baseline peak widths (15).  Resolution is proportional to peak separation 
and inversely proportional to peak width.  The minimum resolution at which two peaks 
are resolved, or do not overlap at their baselines, is 1.  It is convenient to estimate the area 
of a Gaussian peak by the extrapolation of straight lines from tR along the boundaries of 
either side (Figure 1.1).  This simple and commonly employed integration technique most 
accurately describes the areas of triangular peaks but omits some area, particularly around 
the base, when applied to other peak shapes.  The minimum resolution at which two 
Gaussian peaks are resolved using such integration must be extended from 1 to at least 
1.5.  Deviation of GC and LC peak shapes from the ideal Gaussian distribution increases 
the minimum resolution required for complete separation and necessitates more complex 
peak limit modeling.  For these reasons, the peak integration technique employed must be 
considered along with the reported chromatographic resolution of two analytes. 
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Figure 1.1: Two fully resolved chromatographic peaks with infinite signal-to-noise (s/n). 
(A) A non-ideal, broad peak with tailing, the area of which is inaccurately described by 
both normal distribution and triangular distribution.  (B) An ideal chromatographic peak 
having normal distribution.  ti ; the time at which the peak begins, tf ; the time at which 
the peak ends, tR ; the retention time of the peak.  Dashed lines indicate the limits of a 
triangle by which the peak area is approximated.  The actual peak area includes all signal 
underneath the peak between ti and tf. 
Peak broadening is caused by analyte diffusion in both stationary and mobile phases. The 
surfaces of the packing material and the inner column wall create turbulent flow, further 
broadening analyte distribution.  Both diffusion and turbulence are affected by the mobile 
phase flow rate so that peak widths are highest at extremes of high and low flow.  Broad 
peaks of low maximum intensity also result when localized saturation of the stationary 
phase increases analyte diffusion as a result of column overloading.   These factors 
restrict chromatographic separations to ranges of analyte concentrations, resolution and 
speed (16). 
Because analytes are concentrated on the column, sensitivity in GC-MS and LC-MS 
experiments depends on the quality of chromatographic separation.  Though the two 
peaks shown in Figure 1.1 have comparable areas, peak A would not be detected if the 
sensitivity of the detection system decreased by 40%.  Quantitative MS based on 
measurement of chromatographic peak area is most accurate where peak areas are 
uniform with high s/n.  Optimal separation upstream of the ion source therefore provides 
optimal MS performance.  Current state-of-the art HPLC systems produce optimal 
baseline peak widths on the order of several seconds over separations of several minutes 
to hours.  
Polypeptide separation can be achieved using a number of stationary phases, including 
those with ion-exchange, size exclusion, ligand affinity, polar and non-polar properties.  
Packing materials commonly used for polypeptide HPLC consist of porous spheres 
several micrometers in diameter which have high surface area-to-volume ratios, are stable 
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under pressures of tens of KiloPascals (KPa), and can be functionalized with a variety of 
compounds.  
Reversed phase chromatography 
Reversed phase (RP) liquid chromatography, in which the stationary phase is 
hydrophobic, affects efficient peptide separation under ESI-compatible conditions and has 
been widely adopted for LC-MS sequencing.  Aromatic and aliphatic hydrocarbons both 
bind peptides and octadecane (C18) is the most widely used in proteomics.   The 
performance of RP packing materials depends on analyte size, for instance long aliphatic 
hydrocarbons tend to retain proteins so that C18 resin provides good peptide separation 
but poor protein elution. 
Polypeptides adsorbed on RP can be separated by binary gradients over which the organic 
solvent content of the mobile phase is varied.  Acetonitrile and methanol are volatile, 
water-miscible solvents capable of solvating hydrophobic compounds and are therefore 
common binary mobile phase modifiers. In general, gradients of increasing organic 
content elute peptides in order of increasing hydrophobicity and size, with the majority of 
peptides eluting in less than 40% acetonitrile.  Since their molecular masses are lower 
than those of peptides, water and small organic molecules do not overlap peptide mass 
spectra.  This simplifies data interpretation and the automated selection of precursor ions 
for MS/MS. 
Ion-pairing agents boost LC separation as well as ionization. Formic acid, acetic acid and 
trifluoroacetic acid (TFA) are used for the generation of protonated peptides while 
ammonium formate, ammonium acetate and ammonium bicarbonate are used for peptide 
anion production (17).  Each has advantages and disadvantages, for instance TFA has 
been shown to improve LC separation while diminishing ESI signal intensity and stability 
relative to formic acid and acetic acid (18, 19).  Formic acid was the modifier used in the 
studies described here due to its overall LC-MS performance and low toxicity relative to 
TFA. 
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Ion exchange chromatography 
Ion exchange chromatography exploits the association between solvated analyte ions and 
ions fixed in the stationary phase.  Peptides are retained on ion exchange resins because 
their amines are readily protonated and their carboxyl groups are readily deprotonated.  
Many types of ion exchange chromatography are used for polypeptide separation. Weak 
anion exchange (WAX) stationary phases such as those based on diethylaminoethanol 
(DEAE) are commonly used in intact protein purification.  Strong cation exchange (SCX) 
is well suited to peptides since at low pH, peptides are stable, cationic and interact with 
deprotonated strong acids.  Sulfonic acids make versatile SCX stationary phases due to 
their low pKa values.  With gradients of increasing ionic strength, peptides are eluted 
from SCX resins according to their charge states as they are displaced from the anionic 
sites by other cations present in the mobile phase.  The technique suffers from low 
resolution because the distribution of peptide charge states tends to be narrow. 
Though RP provides superior peptide separation than ion exchange, the two are 
complementary, providing higher sequence coverage when used in series than separately 
(20).  The high salt content of ion exchange mobile phase impedes gas phase analyte 
ionization so desalting is required prior to MS.  This can be accomplished by 
fractionating the SCX eluate and desalting the fractions separately or by using on-line RP 
as in the multidimensional protein identification technology (MudPIT) workflow (21).  
Biological specimens such as blood serum contain more polypeptides than can be 
separated by reversed phase chromatography alone so two-dimensional LC is often used 
to expand sequence coverage from samples of such complexity. 
Metal ion and metal oxide affinity chromatography 
Protein phosphorylation is a prominent post-translational modification but the physical 
properties and low abundance of phosphoaminoacids often necessitate specialized sample 
preparations for their observation. Phosphate bonds with serine, threonine and tyrosine 
side chains are relatively stable, tolerating drying, SDS-PAGE and a wide pH range 
without dissociation and can therefore be purified (22).  Interactions between phosphates 
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and metal cations are exploited in immobilized metal affinity chromatography (IMAC), in 
which the stationary phase contains chelated metal ions such as Fe(III) (23).  While 
histidine-containing sequences can be purified using nickel and copper columns, the 
affinity of phosphopeptides for metal ions differs, with trivalent gallium reported to 
provide the lowest binding of non-phosphorylated peptides (24).  Metal oxide affinity 
chromatography (MOAC), in which the stationary phase contains stable metal oxides 
such as ZiO2 and TiO2, is a more selective variant of IMAC though both techniques tend 
to retain peptides containing aspartate and glutamate (25, 26).  One approach to 
improving phosphopeptide specificity is the derivatization of carboxyl groups (27).  
Inclusion of aliphatic hydroxy acids in the MOAC mobile phase was also reported to 
enhance selectivity for phosphopeptides by decreasing interactions between acidic 
peptides and the stationary phase without interfering with LC-MS analysis (28). 
Nanoflow HPLC 
Sensitivity, which can be measured as the lower limit of detection of a mass spectrometer 
for a given analyte, is critical to the characterization of compounds present in low 
abundance or whose concentration is low relative to matrix components.  Nanoflow LC is 
defined by mobile phase flow rates in the hundreds of nanoliters per minute range and by 
column bores in the range of tens to hundreds of micrometers, which impart higher 
sensitivity compared to conventional microliter per minute HPLC.  The sensitivity 
improvement is due to confinement of analytes in smaller mobile and stationary phase 
volumes, a concentrating effect.  To restrict post-column analyte diffusion and provide 
stable electrospray, nanoflow LC systems are coupled to ESI emitters several 
micrometers in internal diameter.  Nano-electrospray ionization enhances sensitivity 
further because droplet desolvation and ionization increase inversely with emitter bore.  
The passage of ions from source to mass spectrometer is several orders of magnitude 
more efficient in nano-ESI compared to ESI (29, 30).  Limited sample loading capacity is 
an inherent disadvantage of nanoflow HPLC so the technique is best for analytes present 
in low concentration ranges or where high sample volumes are unavailable. 
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The manipulation of sub-microliter fluid volumes requires automation and in nanoflow 
HPLC, the trap column serves as an interface between microliter and sub-microliter scale 
liquid handling systems.  Trap columns are many times shorter and wider than the 
analytical columns with which they are paired, a geometry which accommodates both 
microliter per minute flow from a sample loading pump and low flow from the pump 
supplying the separatory gradient.  The trap and analytical column packing material are 
matched so they respond in the same way to the mobile phase.  A switching valve 
separates the two elements. In sample loading mode, the valve brings a sample syringe or 
a fixed volume loop connected to a loading pump in line with the trap.  Polypeptides are 
passed over the trap in solution and bind to it, while other soluble material is carried away 
with an excess of solvent.  The valve position is then changed, bringing the trap in line 
with the downstream column and the polypeptides are eluted from both with mobile 
phase.  Trap unloading can be accomplished either by reversing the flow or by keeping its 
direction constant, the latter allowing the trap to act as a particulate filter.  The geometry 
of the trap and its size relative to the analytical column and the analytical gradient are 
important to system performance.  Excessive trap volume can lead to delayed retention 
times, peak broadening, low sensitivity and column overloading.  Considering that a 
typical nanoflow column with an internal diameter of 75 µm and a length of 150 mm has 
a volume of 0.66 µl and is operated at flow rates from 200 to 300 nl per minute, a trap 1 
mm long 1 mm in diameter would more than double the volume of the chromatographic 
bed and would take from 2.6 to 3.9 minutes to flush with mobile phase.  An RP trap can 
be used for sample desalting during loading; however excessive mobile phase volumes 
diffuse or wash out the analyte, decreasing sensitivity.  Desalting the sample in advance 
of trapping is advisable in light of anecdotal evidence of excessive salt formation around 
the ESI orifice during analysis of SCX fractions. 
Operating principles of mass spectrometers 
All mass spectrometers contain one or more ion source, mass analyzer and ion detector.  
Ion sources transition neutral analytes to the gas phase while imparting them with charge. 
Mass analyzers separate ions on the basis of their m/z.  Detectors convert ion related 
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events, such as the discharge of an ion onto a metalized surface, into electronic signals for 
further processing into interpretable forms.  Mass spectrometry technologies of relevance 
to modern protein analysis are discussed in the following sections. 
Electrospray ionization 
During ESI, charged droplets are continuously generated from the end of a liquid filled 
capillary and accelerated toward the orifice of a mass spectrometer by an electrostatic 
potential.  As they travel, the unstable droplets collapse into successively smaller 
particles, ultimately releasing ions.  The process transpires in milliseconds to 
microseconds depending on initial droplet size (31).  In contrast to the similar 
atmospheric pressure chemical ionization process, electrospray is known as a soft 
ionization technique because it preserves the integrity of labile species such as peptides.  
A few key aspects of the ESI mechanism are described here. 
An electric field between the electrospray needle and the orifice draws the eluting liquid 
into a point or several points from which droplets are ejected.  The liquid surface from 
which droplets are ejected has a conical shape known as a Taylor cone.  It follows that the 
charge of the orifice must be opposite that of the droplets and that the emitter must have 
no net ionic charge.  Accumulation of counterions within the emitter would counteract the 
ESI voltage, reducing ion transmission.  A steady state is maintained at the emitter 
because counterions of those ejected confined to the tip by the electric field undergo 
reduction or oxidation.  The Taylor cone can be sustained indefinitely if the flow rate of 
liquid from the capillary is matched to the ESI voltage and if the redox chemistry of the 
solution allows the balancing of charge.  
In order to be effectively transferred to the mass analyzer, ions exiting the Taylor cone 
must be desolvated.  Once droplets leave the emitter, they are concentrated by solvent 
evaporation.  Ions within the shrinking volume arrange themselves at its surface by 
mutual repulsion.  Where charge repulsion overcomes the cohesive forces holding a 
droplet together, it ruptures and ejects smaller charged droplets in what is known as 
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Coulombic explosion.  A droplet collapses due to this effect at its Rayleigh limit.  The 
relationship between charge and stability is approximated by the equation: 
 
Where Qdroplet is the droplet charge, ε0 is electrical permittivity, γ is the surface tension 
and R is the droplet radius (32).  Since the radius term is cubed, desolvation contributes 
disproportionately to this relationship.  Volatile solvents and conditions promoting 
evaporation provide strong ion current, for instance ion yields are significantly improved 
by heating (33) and passing dry gas over the source.  Though the Rayleigh model is 
relatively simple, there is much empirical evidence of Coulombic explosion occurring 
near or at the Raleigh limit (34).  The electric field of an ESI source may destabilize the 
droplet below the Rayleigh limit by drawing charges to the side closest to the orifice, so 
electrospray voltage affects ionization (35). 
Though Coulombic explosion is known to be repeated by droplets of decreasing size 
during ESI, the progression from solvated ions to molecular ions is incompletely 
described.  Two theories regarding the final stage of the process have been proposed. 
These are the ion evaporation model and the charged residue model.   In the ion 
evaporation model, multiple ions contained in a single droplet separate from its surface as 
desolvated species (36).  In the charged residue model, Coulombic explosion leads to the 
formation of droplets containing single analyte molecules, from which all solvent 
evaporates (37). There is evidence that both occur and that the route by which an analyte 
ion enters the gas phase depends on its size. 
Electrospray ionization produces a dense ion beam, however transit from atmospheric 
pressure to the vacuum of the mass spectrometer causes particles passing through the 
orifice to separate by adiabatic expansion.  If the pressure difference between the faces of 
the orifice is 2.05 or higher, a condition met by virtually all atmospheric pressure 
ionization sources, the gas forms a supersonic free jet (38).  Expansion continues until the 
gas reaches ambient pressure by which point its temperature has decreased to a fraction of 
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its initial value, so the separation and stability of the ions increase with lower front end 
pressure. Within the free jet the gas achieves supersonic speeds, while collisions along its 
boundary restrict the gas speed to subsonic range.  Here the fluid on the high pressure 
face of the orifice defines the speed of sound.  Jet dimensions but not jet shape change in 
relation to orifice diameter.  Three problems in mass spectrometry result from free jet 
expansion; radial ion movement results in ion loss, cold species form gas-phase clusters 
and cold ions do not readily fragment in MS/MS.  All of these issues can be mitigated in 
the front end.  
Energy to break apart adducts and promote intramolecular dissociation can be supplied by 
heating the source or inducing gas-phase collisions.  Various front end design features are 
used to focus the diffuse ion beam in order to decrease ion loss.  Skimmers are conical 
collimators placed between the orifice and the high vacuum region which deflect a large 
proportion of neutral species while accommodating the ion beam and controlling the 
shape of the free jet.  A skimmer positioned close to the orifice restricts expansion and 
keeps those neutral species at the axis of the jet moving at supersonic speeds, where they 
concentrate ions by collision (39).  A non-linear electric field between the orifice and the 
skimmer also directs ion trajectories.  The field strength is highest at the point of the 
skimmer and decreases with distance from the orifice.  Discharge of ions near the 
skimmer tip is counteracted by the dense stream of supersonic neutrals formed here, 
which sweep them past the high field region.  Farther away from the orifice, the neutral 
density decreases and ions are steered mainly by the electric field.  The influence of the 
applied potential on an ion’s trajectory depends on its m/z.  In one model, transmission of 
singly charged ions with masses between 105 and 609 Da beyond the entrance of the 
skimmer was twice that of myoglobin with a charge of 9 (m/z 1883), but total ion loss 
along the entire skimmer wall was comparable for all ions(40).  The remaining gas-phase 
ions are further drawn toward the mass analyzer by an electrostatic potential between the 
skimmer and an element immediately downstream of it, such as a mass analyzer. 
Aside from decreasing gas load on front end vacuum pumps and collimating the ion 
beam, a skimmer can be used to control ion temperature and therefore ion chemistry.  
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High orifice-skimmer field regions accelerate the ions through the slower neutrals, 
causing heating sufficient for declustering or even in-source fragmentation (41).  Orifice-
skimmer potential can be adjusted to suit an application, for example high voltage is used 
to dissociate clusters where strong intermolecular attraction diminishes the strength of the 
molecular ion signal while low voltage is used to stabilize labile species (42, 43).  Front 
end ion optic voltages are often referred to as declustering potentials for these reasons. 
One inherent limitation of a skimmer is that it omits a portion of the ion beam from the 
mass analyzer.  Sensitivity gains resulted from replacement of a skimmer with other 
elements such as a quadrupole in the AB Sciex QJet
TM
 and a stacked ring ion guide in the 
Thermo S-lens
TM
(44).  These systems allow the free jet to expand completely and supply 
electric fields which confine the ions at sufficient distance from the elements to minimize 
discharge. It is important to note that the source is not the only area limiting instrument 
sensitivity.  Every mass analyzer has a fixed volume which restricts the number of ions it 
can simultaneously contain before Coulombic repulsion drives them out of containment 
and detectors have lower limits of response dependent on electronic noise. 
Mass analyzers 
Once they reach the low pressure region of the mass spectrometer, ions can be guided by 
mass analyzers and ultimately detected.  The structure of the instrument beyond the 
source depends on many factors.  Scan speed, sensitivity, resolution, mass accuracy, 
dynamic range, stability and cost all vary with mass analyzer design.  Mass spectrometers 
used extensively for polypeptide analysis incorporate mass analyzers in many different 
configurations, each with advantages and drawbacks.  The forms employed in the 
following chapters are discussed below. 
Quadrupoles 
The versatility and simplicity of quadrupoles account for their widespread use.  A 
quadrupole consists of four parallel rods with identical dimensions forming the four 
corners of a theoretical square and separated by a vacuum.    Given round rods, the ideal 
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distance between opposing corners of the square is 1.148 of the rod diameter so that the 
electrostatic field they generate is hyperbolic along the axis of the rod set (45).  Opposite 
rods in the quadrupole are electrically connected.  Though the field created by elliptical 
rods is better for ion transmission, cylindrical rods are also suitable.  Other multipoles, 
such as hexapoles and octapoles are also used in mass spectrometers.  These differ from 
quadrupoles in the field shapes they generate and only permit transmission of broad m/z 
ranges. 
The Mathieu equation, shown below, describes ion confinement in a quadrupole as a 
function of radio-frequency alternating current (RF) and direct current (DC) voltages 
applied to the rod set (45). 
 
Where: 
 
Here u is the position along the cross-sectional quadrupole plane, U is DC voltage, V is 
RF voltage from zero to peak, r is the distance between electrode surfaces, Ω is the RF 
frequency in radians per second, ξ is equal to one half the product of time and RF 
frequency and m is ion mass. The au term describes the DC voltage space and the qu term 
describes the RF voltage space so that finite combinations of values for these terms give 
solutions corresponding to stable ion trajectories.  Conversely, certain RF voltage and DC 
voltage combinations will cause an ion to discharge on a rod or pass between rods 
perpendicular to the ion path of the mass analyzer. 
Combined DC voltage and RF voltage are applied to the four rods with a 180 degree 
phase shift between adjacent rods.  The resulting field creates mass discrimination by 
confining ions with specific m/z values to the space between the rods along the geometric 
center of the quadrupole rod set.  At a given DC voltage (amplitude) and RF voltage 
 
 
19 
 
(amplitude), only a narrow m/z range is transmitted.  In other words, the ions are pulled 
and repelled by alternating rod pairs to an extent that they are either held between them or 
are lost.  To scan a mass range, DC voltage and RF voltage are simultaneously ramped.  
Quadrupoles are driven by a resonant inductor/capacitor circuit at constant RF frequency.  
Increasing RF frequency tends to decrease mass range with concomitant improvements in 
resolution and sensitivity, while requiring higher RF voltage (46).  Ions transit the axis of 
the rod set through a combination of their initial kinetic energy and acceleration due to 
any potential gradient applied between elements located at opposing ends of the 
quadrupole. 
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Figure 1.2:  Mathieu stability diagrams for two theoretical ions in a quadrupole.  Actual 
m/z values of each ion, the maxima of each stability region, are denoted as m/z1 and m/z2 
respectively.  A linear RF voltage/DC voltage gradient (m/z scan line) starting from the 
origin is shown as a diagonal arrow.  Limits of observed m/z ranges for each ion are 
defined by the points at which the RF voltage/DC voltage gradient line transects each 
stability region.  R1: Theoretical resolution 1, R2: theoretical resolution 2. Average m/z 
values for each of the ions, assuming both are observed at R1, are indicated by asterisks.  
Peak geometries shown are approximations. 
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Linear RF voltage/DC voltage scans produce spectra in which resolution decreases with 
increasing m/z (46).  Figure 1.2 shows the stability diagram for two theoretical ions in 
relation to RF and DC voltages at constant RF frequency.  Ramping RF voltage/DC 
voltage linearly from the origin produces high resolution (R1) in the low m/z region and 
low resolution (R2) at higher m/z.  The two peaks shown in Figure 1.2 will only have 
equivalent resolution (R1) if the DC voltage is increased proportionally to RF voltage or if 
the intercept of the straight scan line is decreased and the slope is increased, however a 
linear scan calibrated for constant resolution at two m/z values may have discontinuous 
resolution for others (47). 
Due to their asymmetrical stabilizing behaviour, quadrupoles are inherently biased toward 
lower apparent m/z values.  The linear voltage gradient allows disproportionate 
transmission of the lower m/z portion of each stability region, resulting in shifts of the 
peak maxima within the resulting mass spectrum toward the average transmitted m/z 
value (47).  Signal processing after ion detection is required to correct for effects of this 
fundamental limitation of quadrupoles on m/z accuracy.  Furthermore, the shapes of the 
stability regions imply that for a quadrupole, sensitivity can only be improved at the cost 
of resolution, by effectively lowering the slope of the RF voltage/DC voltage gradient and 
broadening the transmitted m/z range. 
Time-of-flight analyzers 
High mass resolution is necessary for studies of isobaric mixtures not separated before the 
ion source or studies requiring the determination of the isotopic distributions of large 
(tens of kDa) highly charged ions for which mass separation is compressed by the charge.  
The distinction of ions of the same nominal m/z value exceeding 300 Thomson (Th) and 
differing in mass by 0.01 Th requires resolution greater than 30,000 full peak width at 
half maximum peak height (FWHM), a condition met by three types of mass analyzers.  
To date, the Fourier transform ion cyclotron resonance (FT-ICR) mass analyzer is 
unsurpassed in resolution with scan times comparable to other instruments.  Second in 
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mass resolution is the orbital trap (orbitrap) followed by the time-of-flight (TOF) analyzer 
(48).  TOFs provide high resolution based on the familiar Newtonian equation: 
ek = ½ mv
2
 
which relates the kinetic energy (ek) of a particle to its mass (m) and velocity (v).  The 
time-of-flight system consists of a field-free region under vacuum with analyte-
accelerating electronics at its entrance and a detector at the terminus of the ion path.  
Analytes are initially accelerated at constant DC voltage and travel in the field-free region 
(time-of-flight tube) at velocities inversely proportional to the square roots of their m/z 
values.  The TOF scan cycle is unique in that it is discontinuous, with each discrete ion 
packet being accelerated, separated and detected in succession (49).  The time required 
for a scan depends on the drift time corresponding to the upper mass limit.  For this 
reason, TOFs require a pulsing supply of ions such as a MALDI source or a linear ion 
trap, which accumulates and periodically releases ions produced by a continuous source.   
In TOF-MS, mass resolution (m/Δm) and time resolution (Δt) are related according to the 
following equation: 
m/Δm     = t/2Δt 
Time resolution can be considered time domain FWHM.  It follows that the mass 
resolution of such systems depends on the length of the ion path, with separation of 
different m/z values increasing over distance.  Resolution is also affected by the three-
dimensional distribution and velocity distribution of the analyte ion population so many 
instruments incorporate ion optics for shaping the ion beam.  Ions enter the TOF with a 
range of initial velocities.  High acceleration voltage compensates for the velocity 
distribution at this stage, decreasing the range of flight times of a population of ions 
having the same m/z.  Analyte spatial distribution is particularly important along the axis 
in which the ions are accelerated.  For hybrid Q-TOF instruments in which the TOF 
entrance is coupled to a quadrupole, the two are typically oriented orthogonally so that 
ions spread along the length of the quadrupole are accelerated from the same plane in the 
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TOF drift axis.  Some TOF analyzers include one or more ion mirrors which generate 
electrostatic fields to reverse ion trajectories.  Placing an ion mirror, known as a 
reflectron, opposite the accelerator in the drift tube increases flight time and therefore 
TOF resolution without increasing instrument size.  Such a design produces parabolic ion 
trajectories so the detector is mounted at the same end of the flight tube as the accelerator.  
The distance ions penetrate the ion mirror increases with their kinetic energy and this will 
decrease resolution if not compensated by an electrostatic field gradient (49).  Ion mirrors 
therefore increase resolution both by extending drift time and beam focusing.  The static 
electric field gradient of the reflectron can be given linear, quadratic or curved slopes to 
optimize focusing (50). 
Orbitraps 
Many detectors employed in mass spectrometry are electron multipliers similar to those 
used in spectroscopy, for instance quadrupole instruments use channel electron 
multipliers and Qq-TOF instruments use multichannel plates, which are arrays of 
miniature electron multipliers.  Upon contact with ions, these detectors release many 
more electrons and the resulting current is measured as signal.  The orbitrap is both a 
mass analyzer and a detector which uses induced image current rather than ion discharge 
to generate a signal.   The orbitrap consists of two electrodes separated by a vacuum.  The 
outer electrode is a tube segmented at its center into two halves, which surrounds the 
inner rod shaped electrode. Both have parabolic cross sections. An electrostatic field is 
applied to the trap to maintain analytes in stable trajectories with rotational and axial 
components.  Axial rotation frequency, that is the rate of oscillation along the length of 
the trap, is independent of ion energy and position but proportional to (m/z)
-1/2
.  Ionic 
charge induces current on the outer electrode which is converted to m/z by means of 
Fourier transform (48).  Since their recent commercialization, Orbitraps capable of high 
resolution, high sensitivity and wide dynamic range have been widely adopted in 
proteomics (51).  Orbitraps commonly provide resolution in excess of 100,000 FWHM, 
significantly higher than the 30,000 FWHM range capability of Qq-TOFs; however their 
resolution is proportional to scan time so that a scan at maximum resolution can require 
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several seconds to produce.  This has the potential to impact sequence coverage or 
quantification so resolution and scan speed should be balanced in consideration of the 
specific application. 
1.2 Tandem mass spectrometry of peptides 
Sequencing from MS/MS data takes advantage of the patterns in which polypeptide ions 
fragment.  With respect to dissociation, the amides of the peptide backbone are for the 
most part comparable in their reactivity and are more reactive than amino acid side 
chains.  For these reasons, backbone fragmentation dominates, forming various products 
containing parts of the original sequence from which the order of amino acids can be 
ascertained.  Peptide ion fragmentation has been extensively studied from intramolecular 
to proteomic scales, in part to establish rules for spectral interpretation.  While the amino 
acid sequence of a peptide impacts how it fragments, relative abundances of product ions 
in MS/MS spectra cannot be entirely predicted.  Established gas-phase peptide bond 
dissociation mechanisms define favoured and disfavoured products.  The chemistry and 
universal trends of peptide cation fragmentation facilitating spectral decryption are 
discussed below. 
Gas phase protonated ions can be dissociated via reduction (gain of electrons), collision 
with neutral species or infrared irradiation.  Collision-activated dissociation (CAD), also 
known as collision-induced dissociation (CID), is the most commonly used technique for 
peptide MS/MS and involves passing the analyte through inert gas.  Collisions between 
analyte ions and gas molecules supply the energy required for bond disruption.  A 
collision cell includes a mass analyzer, a collision gas supply and a barrier to isolate the 
gas.  Amide carbon-nitrogen bonds of the peptide backbone are the most susceptible to 
disruption by CAD.  The resulting amino terminus-containing fragment ions and carboxyl 
terminus-containing fragment ions are termed b-ions and y-ions respectively according to 
the nomenclature developed by Roepstorff, Fohlmann and Biemann (Figure 1.3) (52). 
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Figure 1.3: Possible gas phase fragments of a theoretical tripeptide labelled according to 
the conventional Roepstorff-Fohlmann-Biemann nomenclature.  The bonds broken in the 
formation of each product are indicated by dashed lines. Arrows indicate the name of 
each product ion and its elemental composition, not including the charge-imparting 
species.  The structures of the product ions are not reflected.  I: an iminium ion consisting 
of the overlapping structures of the y2 and a2 ions.  The b1 ion is crossed out to indicate 
that it does not occur in tandem mass spectra of peptides.  
The CAD of protonated peptides is charge directed, requiring protonation of the amide 
undergoing dissociation.  In low-energy peptide ions, protons mainly reside on the side 
chains of the most basic amino acid residues and to some extent on the amino-terminal 
amine.  Collision supplies energy to destabilize the ion, mobilizing charges along the 
peptide backbone.  When the proton localizes at an amide, it can direct carbon-nitrogen 
bond dissociation through the formation of an intermediate with a protonated five-
membered ring.  Either the amide nitrogen or oxygen atom can accept protons and 
cleavage mechanisms requiring protonation at either atom have been proposed.  The 
carbonyl oxygen is more basic than the nitrogen and the carbon atom of a protonated 
carbonyl is susceptible to nucleophilic attack by the carbonyl carbon N-terminal to it (53).  
The resulting ring may undergo 1,1-elimination in which one product retains the proton 
from the ring (54).  Though the amide nitrogen has lower proton affinity, the proposed 
intermediate following nitrogen protonation has a significantly lower energy barrier to 
dissociation.  Here the intermediate is an oxazolone formed through nucleophilic attack 
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on the carbonyl carbon adjacent to the protonated nitrogen by the nearest N-terminal 
oxygen.  In the theoretical transition state between the oxazolone and its fragments the 
proton is shared between nitrogen atoms of the residues where cleavage takes place, 
whereas in the transition state of the protonated-oxygen directed fragmentation the proton 
is confined to the ring  (55).   The tendency of the charge to reside on the product having 
higher proton affinity has been presented as evidence for the nitrogen protonation-
directed fragmentation model, in which the proton is more equally shared by the 
transition state fragments.  Conversely the rarity of dissociation at C-terminal amides of 
proline residues is given as support for the oxygen protonation-directed model (53).  
Proton transfer from amide oxygen to the amide nitrogen has a low energy barrier in the 
context of CAD experiments so the movement of a proton from amino acid side chain to 
amide oxygen to nitrogen is feasible under typical CAD conditions. 
Single collision conditions are invaluable for CAD-based thermodynamic studies but 
result in limited fragmentation.   Numerous collisions are generally required to maximize 
product ion signal and diversity.  Multiple collision conditions are invariably used in 
proteomics experiments.  Comparable spectra can be obtained over a range of collision 
cell pressure and kinetic energy.  This is fortunate considering that collision conditions 
vary with instrument design and that acquisition settings are not standardized.  Where 
optimal collision conditions are unknown, precursors are often accelerated through the 
collision cell using a voltage ramp to vary their collision energy, which tends to produce 
more product ions. 
The more basic an amino acid, the more collision energy is required to mobilize a proton 
associated with it.  The side chain of arginine has the highest gas phase basicity of any 
amino acid, followed by lysine and histidine (56).  Consequently, singly charged tryptic 
peptides with C-terminal arginine residues require more energy to fragment than those 
with C-terminal lysine residues while multiply protonated species require less collision 
energy to induce dissociation than their singly charged counterparts. 
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A y-ion has the equivalent structure of an intact peptide ion and fragments primarily at the 
amide C-N bond during CAD (55).  The lowest energy b-ion structure includes a 
protonated oxazolone ring at the cleavage site, formed from the C-terminal amino acid 
and the amino acid N-terminal to it (57).  The absence of b1 ions from the tandem mass 
spectra of peptides is evidence that interaction of adjacent carbonyl groups is required for 
the unimolecular reaction to occur.   Subjecting b-ions and y-ions to CAD causes them to 
fragment similarly to peptide ions.  A b-ion can undergo further backbone cleavage to 
form a smaller b-ion or the oxazolone can lose carbon monoxide to form an a-ion. 
In addition to backbone cleavage, internal fragmentation occurs, particularly at aromatic 
amino acids, proline, histidine, leucine and isoleucine.  The resulting iminium ions are 
single amino acid hybrids of y-ions and a-ions (Figure 1.3) (58).  Iminium ions are 
conventionally denoted by the single letter abbreviation of the amino acid from which 
they are derived.  Iminium ion information is often omitted by MS/MS scan windows 
biased toward the collection of ions with higher masses. The only iminium ion with a 
mass greater than the lysine y1 ion at 147 Th is that of tryptophan at 159 Th, so that the W 
ion is often present in proteomic data. 
Fragment ionization depends on the retention of charge from the precursor on a product, 
thus fragments with high proton affinity such as y-ions from tryptic peptides are the most 
abundant.  The competition of fragmentation products for protonation is illustrated by the 
increasing intensity of b-ions relative to the corresponding y-ions in a series of peptides of 
increasing N-terminal proton affinity (59).  Multiply protonated peptides yield singly and 
multiply charged products upon dissociation.  Precursor charge state can influence 
sequence coverage.  Increasing the number of charges on a peptide increases proton 
mobility and therefore the accessibility of a proton to amino acids of decreasing basicity. 
Of the biologically occurring amino acids, proline alone has a secondary amine at its 
amino terminus which forms a five-membered ring with the side chain.  The high basicity 
of the secondary amine and to some extent ring strain destabilize the proline amide.  
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Consequently, C-N bond dissociation at proline amides is energetically favoured and the 
corresponding product ions tend to be highly abundant (60, 61, 62). 
Cleavage of aspartic acid and glutamic acid C-terminal amide C-N bonds is favoured 
where proton mobility is restricted by the side chain of arginine or by chemical 
modification (63, 64).  This is particularly evident in MALDI MS/MS data, in which 
tryptic peptides are singly charged.  With the single proton associating with the C-
terminal arginine, y-ions ending at residues C-terminal to acidic amino acids form 
prominent peaks.  The proline effect and aspartic acid effect can be considered 
synergistic.  Where proline is C-terminal to aspartate or glutamate, cleavage between the 
two is enhanced (65).  The proline effect is also enhanced by N-terminal histidine in the 
presence of mobile protons (53). 
Reduction activated dissociation 
Electron transfer dissociation (ETD) and electron capture dissociation (ECD) are related 
techniques with two advantages over CAD.  First, they tend to produce more evenly 
distributed product ion spectra because radical driven bond dissociation is less dependent 
on primary sequence. Second, they selectively cleave the peptide backbone, leaving labile 
modifications such as phosphates intact.  Fragmentation between alpha carbons and 
amide carbons produces a-ions and x-ions analogous to the b/y-ion series while the c/z-
ion series results from dissociation of alpha carbon and amide nitrogen atoms (Figure 
1.2).  These alternative fragmentation products are absent from CAD MS/MS spectra with 
the exception of occasional a-ions.  In contrast, ETD and ECD mainly produce c-ions and 
z-ions from relatively unstable protonated peptide ion radicals (66, 67).  Complementary 
b/y-ions and a/x-ions also result from electron transfer (68). 
Both ECD and ETD cause bond dissociation by the addition of an unpaired electron to the 
analyte, the former employing an electron beam and the later an electron donating reagent 
ion.  ECD is only efficient in FT-ICR instruments, the most expensive type of mass 
spectrometer.  Conversely, more economical quadrupole ion traps can be equipped with 
ETD.  CAD spectra are information rich so ETD is not necessary for sequencing 
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unmodified peptides; however the technique has demonstrable advantages for the 
characterization of peptide modification. For example, reporting of amino acid oxidation 
by ETD is charge state independent but is inaccurate at some charge states with CAD 
since peptides with the same sequence but oxidized at different sites produce ambiguous 
CAD MS/MS spectra (69). 
Charge reduction can be a problematic consequence of electron transfer.  Singly 
protonated hypervalent radicals have no net charge and therefore cannot be detected, 
while doubly protonated radicals exhibit low fragmentation efficiencies without 
supplemental collisional activation (70).  These techniques are therefore best suited to 
analytes with three or more positive charges. 
Polypeptide quantification 
Compound identification and quantification are the parallel motives of analytical 
chemistry.  Some biological inquiries can be satisfied using polypeptide identification 
alone, while others require knowledge of the influence of an independent variable on the 
concentrations of specific analytes.  For instance, human immunodeficiency virus 
infection testing is based on the presence or absence of viral antigens while the levels of 
Prostate-specific Antigen and Cancer Antigen 125 in blood are diagnostic of prostate 
cancer and ovarian cancer respectively.  Because LC-MS is versatile and sensitive, the 
platform is widely used in protein quantification.  The amount of a compound in a sample 
can be inferred from LC-MS data by several methods but all operate on the assumption 
that an analyte-specific signal is proportional to its concentration. Every quantitative 
experiment follows one of two sample preparation paradigms, label-free quantification in 
which native species are measured or labelled quantification in which isotopic tagging is 
performed prior to analysis and the relative abundances of heavy and light species are 
measured.  Heavy isotopes can be incorporated directly into a protein sample in vivo as in 
the case of stable isotope labelling by amino acids in cell culture (SILAC), or by 
derivatization of intact proteins or digests thereof (71-73).  Alternately the sample can be 
spiked with synthetic heavy isotope labelled standards.  Label-free quantification is 
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inexpensive but error prone.  Assuming the species being quantified have consistent 
response factors, isotope labelling gives excellent precision and accuracy.  Also, if the 
concentration of the standard is known, the absolute amount of the analyte can be 
ascertained. 
Many LC-MS operating modes can supply quantitative information.  The most general 
approach to quantification is spectral counting, a technique based on data-dependent 
acquisition which relates the number of spectra assigned to a protein to its concentration, 
(74).  While broadly applicable, the accuracy of spectral counting is constrained by the 
variable ionization efficiency among peptides, ion suppression, trypsin cleavage site 
distribution, and precursor ion sampling bias.  Protein homology also leads to error in 
spectral counting measurements, since peptides which could be derived from any of 
several different proteins must be excluded from the count or assigned to a specific 
protein somewhat arbitrarily.  Like other techniques, the response factor as a function of 
spectral counts, varies from protein to protein (75).  
Targeted analysis increases sensitivity by increasing the amount of acquisition time 
dedicated to detecting ions of interest.  Most targeted strategies make use of ion 
chromatograms.  In selected ion monitoring (SIM), the mass spectrometer is programmed 
to collect data for masses corresponding to known peptides and areas of chromatographic 
peaks associated with each precursor ion are subsequently integrated.  Isobaric 
interference and retention time shifts are common in quantification regimes based on 
precursor ion m/z (76).  Incorporating fragmentation into the assay increases its 
specificity where precursor mass and retention time are questionable identifiers.  This is 
the basis of selected reaction monitoring (SRM), also called multiple reaction monitoring 
(MRM).  In the SRM scan cycle, the mass spectrometer is programmed to select a 
precursor ion of specific m/z, fragment it, then select a limited number of its product ions, 
detecting them in series (77).  A single precursor ion/product ion pair is known as a 
transition and transitions are defined in advance of the SRM experiment to target species 
of known identity.  SRM can be multiplexed for the quantification of hundreds of 
analytes on sensitive and rapid scanning triple quadrupoles with large ranges of linear 
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dynamic response.  These instrument features translate to high throughput and linearity 
over a wide analyte concentration range.  The simultaneous appearance of signals for 
multiple transitions, which can be overlaid to form a single chromatographic peak, is the 
basis of specificity in SRM. 
Until recently, acquisition schemes were divided into those providing reliable 
quantification and those sampling the highest number of peptides in a sample, attributes 
which have been merged with the advent of workflows such as SWATH MS (78).  These 
operate on the concept that multiple precursor ions and their products can be 
simultaneously manipulated within the same mass analyzer and the resulting chimera 
spectra deconvoluted.  SWATH MS divides the entire precursor ion mass range into 
overlapping isolation windows tens of Th units wide, subjects the analytes in each 
window to CID then collects the resulting product ion spectra.  The merged data is 
searched for peptide sequences then mined for quantitative data from recognized analytes.  
By replacing mass selection with powerful post-acquisition data processing, the process 
greatly reduces scan time limitations.  High resolution is obligatory for spectral 
deconvolution, so SWATH MS was developed for Qq-TOF instruments.  SWATH MS is 
better suited to the exploration of unknowns than the quantification of specific molecules 
since it is less sensitive than SRM (79). 
1.3 Interpretation of MS/MS data 
Machine learning based product ion prediction 
Large scale MS/MS datasets have been mined for fragmentation trends since they became 
available, however features of product ion spectra remain unpredictable (80).  In one 
example, a training set of MS/MS ion trap spectra from 319,578 unique peptides was used 
to develop sequence-driven peak ranking models for peptides with charge states of 1 to 3.  
The models were incorporated into an algorithm for predicting relative fragment ion 
intensity (81). Table 1.1 demonstrates the correlation between results from this program 
and experimentally derived MS/MS product ions identified by a sequence database 
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search.  The majority of observed fragments were predicted to be among the most intense; 
however the predicted order of intensity was inaccurate.  For instance, four of the six 
major products of AEFVEVTK were ranked in the top six while only eight of all forty 
observed ions matched their predicted rank.  The difference was most pronounced where 
neutral losses were prominent, as with YNGVFQECCQAEDK.  It is worth noting that the 
instruments on which the training data and the data shown here were acquired had 
comparable resolution and mass range and therefore comparable quality.  The 
performance of this algorithm points to the strengths and weaknesses of a predictive 
approach to spectral interpretation or SRM transition design.  Spectrum derived 
fragmentation models revealed aggregate sequence effects but their failure to correctly 
rank product ions illustrates the importance of sequence-naive peak scoring systems in 
spectral interpretation.  In fact, combined peak ranking and sequence database searching 
significantly increased the number of spectra identified with high confidence (82). 
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Protein/Peptide Sequence
Precursor 
m/z (Th)
Precursor 
charge state
Product ion m/z 
(Th)
Observed 
product ions
Predicted 
Intensity 
Rank
Bos taurus  Serum Albumin 
K.AEFVEVTK .L 462.13 2+ 722.41 y6 1
575.34 y5 3
476.27 y4 4
347.23 y3 7
173.09 a2 NA
201.09 b2 2
K.HLVDEPQNLIK.Q 653.95 2+ 956.50 y8 2
841.48 y7 6
251.15 b2 4
712.44 y6 3
332.18 a6+2 NA
465.25 b4 7
R.KVPQVSTPTLVEVSR.S 820.97 2+ 706.89 y13+2 <25
900.51 y8 1
1088.59 y10 2
756.43 y14+2 <25
1150.68 b11 11
K.YNGVFQECCQAEDK.G 874.49 2+ 1314.51 y10 1
910.34 y7 4
1039.38 y8 2
1150.41 y*9 <25
462.22 y4 6
1167.44 y9 3
893.31 y*7 <25
1470.60 y12 8
750.31 y6 5
K.CCAADDKEACFAVEGPK.L 643.66 3+ 741.28 b*13+2 <25
804.3 or 804.4 b*7 or y15+2 <25
776.27 a*7 NA
747.40 y7 8
768.85 y14+2 <25
Saccharomyces cerevisiae Alcohol Dehydrogenase
K.SISIVGSYVGNR.A 626.47 2+ 752.37 y7 1
851.44 y8 2
1051.55 y10 7
445.25 y4 6
608.32 y5 5
695.35 y6 9
K.VVGLSTLPEIYEK.M 724.45 2+ 778.40 y6 1
1079.56 y9 2
1249.67 y11 8
439.22 y3 7
891.48 y7 4
341.3 or 341.2 a4 or y5+2 NA
992.53 y8 5
 
Table 1.1: A comparison of observed and predicted product ion intensity.  Tryptic and 
semi-tryptic peptides from B. Taurus-derived serum albumin and S. cerevisiae-derived 
alcohol dehydrogenase were separated by nanoflow HPLC on a 17 cm long, 75 
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micrometer diameter C18 column then fragmented by CAD on an AB Sciex 
QTRAP4000
TM
 triple quadrupole linear ion trap.  The product ions from each peptide ion 
are listed from highest to lowest observed peak height.  All product ions were identified 
by Mascot with a fragment mass tolerance of ± 0.6 Da.  Relative intensities of up to 25 
product ions from each peptide were estimated using the Pepnovo Predict Fragmentation 
algorithm (81).  The precursor ion charges defined in the prediction input were those 
observed in the experimental data set.  Product ions considered by the algorithm included 
b-ions, y-ions with and without water and ammonia loss. All cysteine residues were 
considered carbamidomethylated.  Ions for which the predicted and observed relative 
intensity were in agreement are shown in bold.  Tryptic cleavage sites are denoted with 
periods. Water or ammonia loss is denoted by an asterisk. 
Automated sequence assignment from MS/MS data 
Modern instruments require milliseconds or seconds to acquire a mass spectrum, thus the 
rate at which sequence information is collected far exceeds the time required for manual 
peptide identification.  The quantity and variable quality of peptide MS/MS data 
necessitates bioinformatics solutions to spectral interpretation.  Automated algorithms are 
used to differentiate the spectra of peptides from those of non-peptides, to match ion m/z 
values to amino acid masses, to match identified peptides to the proteins from which they 
are derived and to measure the statistical significance of sequence assignments.  Many 
programs providing these functions are available.  Each has strengths and weaknesses so 
that searching a single dataset using different programs can yield different sequence 
information (83). 
The so-called heuristic algorithms, including SEQUEST (Thermo) and X!Tandem, count 
the number of ions common to experimental and theoretical tandem mass spectra while 
probabilistic algorithms like Mascot (Matrix Science) consider the likelihood that a set of 
ions is randomly matched to a peptide accounting for factors such as sequence overlap.  
Both types of programs rely on extensive protein libraries created primarily by in silico 
translation of genomic data to produce theoretical tandem mass spectra.  Sequence can 
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also be assigned by matching experimental spectra to reference spectra or by de novo 
sequencing, in which experimental data are compared to theoretical product ions 
generated using known amino acid masses and fragmentation rules  (84, 85).  De novo 
sequencing overcomes the main disadvantage to the other two methods, namely that those 
polypeptides absent from the database cannot be recognized.  Spectral library searching 
outperforms sequence library searching in the number of peptides correctly assigned, 
though the latter remains the dominant technique.  The superior results of spectral 
libraries have been attributed to the incorporation of accurate product ion intensity and 
unpredictable product ions into the search (86). 
In general, sequencing algorithms compare the masses of precursor ions and their product 
ions to some reference then score each match.  Several qualities of the raw data are 
critical to the speed and accuracy of this process.  Where the charge state of an ion is 
unknown, its mass is ambiguous. The accurate assignment of charge state therefore 
reduces the number of possible identities of any ion, decreasing the complexity of the 
search and improving the confidence of the result.  The isotopic distribution of a 
population of otherwise identical ions is reflected in their isotopic envelope, within which 
the peaks are one Dalton apart in mass and differ in abundance in a pattern coinciding 
with their molecular formula.  Charge is therefore determined by the difference in m/z of 
peaks in the isotopic envelope.  One reason high resolution is advantageous for protein 
sequencing is that charge state can be unambiguously determined from isotopic 
envelopes.  Some degree of error in mass measurement is inevitable.  Search algorithms 
account for this error with the use of tolerances, mass ranges over which experimental 
and theoretical masses are considered equivalent.  The differences between actual and 
theoretical masses serve as metrics for confidence in the match.  It follows that mass 
accuracy determines search complexity as well as the degree to which experimental and 
theoretical masses match.  Highly accurate data can be treated with lower mass 
tolerances, reducing the number of matching theoretical ions and increasing the 
confidence of each match.  Finally, confidence in an identification increases with the 
number of fragments matching the hypothetical sequence so the number of product ions 
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at high s/n is important.  The fraction of all ions in a mass spectrum matching the 
hypothetical sequence is another indicator of accuracy so that confidence is affected by 
noise.  Fragmentation conditions, instrument sensitivity and mass selectivity determine 
these variables.  Excessive collision energy degrades product ion signal while wide 
precursor transmission range increases noise by allowing multiple species into the mass 
analyzer, creating chimera spectra (87). 
Regardless of the method by which the product ion spectrum is matched to a peptide 
sequence, identification requires determination of the precursor ion mass.  Mass may be 
estimated where the precursor ion scan lacks baseline resolution of the isotopic envelope.  
Fragment ions of fully tryptic peptides are mostly singly charged, so observation of their 
isotopic envelopes is less important. 
All search algorithms modify MS/MS spectra to facilitate their manipulation.  Filtering 
out peaks below an s/n threshold may take place at this stage to reduce the size of the 
dataset. The simplest approach to processing is to maintain all mass spectral information, 
for what is known as uninterpreted searching, which is used by algorithms such as Mascot 
(88).  Uninterpreted searching permits the identification of low intensity product ions and 
allows probability-based scoring of the peptide identification at the cost of increased 
computational burden. 
The search space, the total number of solutions to a query, can be reduced by cursory 
peptide sequence tag searches to generate from a whole proteomic database a smaller set 
of hypothetical identities.  A peptide sequence tag consists of several product ions in an 
MS/MS spectrum representing a short continuous series of residues.  Since a tag is 
specific to the peptide ion from which it originated and will appear a limited number of 
times within a database, confining possible spectral identities to those containing the tag 
sequence is an effective means of simplifying the search (89).  The use of tags also 
circumvents error caused by amino acid modifications.  In contrast, searches for candidate 
sequences based on precursor mass, such as those performed by SEQUEST, must either 
accommodate all possible modifications or exclude modified peptides (90). The database 
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search engines ProteinPilot (AB Sciex) and Spectrum Mill (Agilent) are examples of 
programs employing peptide sequence tags (89, 91).  These two software packages 
demonstrate the versatility of the tag approach since ProteinPilot uses uninterpreted data 
while Spectrum Mill uses both uninterpreted and processed data. 
Figure 1.4A demonstrates that MS/MS spectra can contain numerous ions to which no 
portion of a peptide sequence can be assigned, including many low intensity ions 
distributed over the entire m/z range.  Peaks at 183.12, 312.16, 536.80, 908.40 Th do not 
match the predicted ion series despite their relatively high intensity compared to the 
known b-and y-ions.  These may be noise or peptide fragments undefined by the 
fragmentation model used in the algorithm.  The Mascot algorithm groups peaks into 
fragmentation series then determines the probability that all ions in a series simultaneous 
occurrence is random. Only groups of fragments exceeding this confidence contribute to 
the peptide score (Figure 1.3C).  This excludes the majority of spectral noise from 
consideration. The inset of figure 1.4B shows the distribution of mass accuracy over the 
mass range for the identified product ions.  Restricting the product ion mass tolerance to 
+0.05 Da in this case would result in the rejection of seven fragments, the most abundant 
y9 ion included.  Expanding the mass tolerance beyond +1.3 Da would add incorrect 
identifications without affecting the number of true identifications, thus mass tolerance 
should be set to the practically achievable limits of the mass spectrometer to maximize 
reliable sequence coverage.  Spectral noise can randomly match the masses of known 
product ions, leading to false positive identifications.  This problem is most pronounced 
when peaks of low signal intensity are included in the search. 
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11 1098.57 549.79 1126.56 563.79 V 246.18 123.59 229.15 115.08 2
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Figure 1.4: Mascot search result identifying the fully tryptic peptide LSEPAELTDAVK 
from a tryptic digest of purified endogenous human prostate-specific antigen (PSA).  The 
MS/MS spectrum was obtained from 100 fmol of a PSA digest during an LC-MS 
experiment.  The protein was identified by the algorithm from the single spectrum shown 
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above.  Mascot search parameters were as follows.  Peptide mass tolerance: +1.2 Da, 
Fragment mass tolerance: +0.6 Da, Enzyme: Trypsin, Protein database: SwissProt 
October 2010 (521,016 sequences; 183,900,292 residues).  Mascot statistics for the 
sequence assignment from this spectrum were as follows.  Expect: 3.3e-05, Ions Score: 
71, Fragment ion matches: 14/88, calculated peptide mass: 1271.6609 Da.  Peptide mass 
deviation: -0.0354 Da. A: The original MS/MS spectrum. Inset of A: The precursor ion 
isotopic envelope showing the monoisotopic and first heavy isotopic peaks having a mass 
difference of 0.56 Th.  B: The MS/MS spectrum shown in the Mascot result. As shown in 
the figure, a 4 Th window centered on the precursor ion m/z is omitted from the search.  
B inset: the mass error of each identified product ion in Daltons. C: The Mascot generated 
table of theoretical product ions showing the ions used in scoring.  Ions shown in bold 
numbering match theoretical product ion masses but cannot be distinguished from 
random peaks.  Ions considered to be derived from the identified peptide sequence are 
shown in large bold numbering. Ions included in the scoring are shown in large italicized 
bold numbering. 
Sequence assignments from MS/MS spectra vary considerably in their reliability.  
Statistical evaluations of search results aid in their interpretation.  Numerous tests fulfil 
this requirement.  One of the most popular is false discovery rate estimation, which 
entails finding the distribution of scores for a mixed set of true and false positive results 
as well as the distribution of scores for a set of false positive results then determining the 
overlap of these score populations to establish limits of confidence.  False positive sets 
are generated by searching the data against a randomized or reversed version of the same 
protein library used to find true positives under the assumption that this will result 
exclusively in incorrect assignments.  The mean score of the true positive distribution is 
higher than the mean of the distribution generated from the decoy library search so only 
true positives exceed a certain threshold value (92). Cutoff scores based on perceived 
false positive to true positive ratios can be used as filter criteria to balance sensitivity with 
specificity, which are defined in the following equations (83). 
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Here a true positive is a correct sequence assignment with a score above the cutoff, a true 
negative is an incorrect assignment with a score below the cutoff, a false positive is an 
incorrect assignment exceeding the cutoff and a false negative is a correct assignment 
beneath the cutoff.  A cutoff score at 99% confidence corresponds to the value at which 
one in one hundred sequence assignments is false and is clearly superior in specificity 
than a cutoff of 95%, however the latter may be more sensitive, giving more true 
positives.  Increase in content sometimes makes relaxing cutoff stringency desirable. 
There is no universal randomization method for decoy database creation, and the 
estimated false discovery rate may vary with the method used (93).  One alternative is to 
search random MS/MS spectra against a proteomic library.  Compared to reversed 
database searching, this was shown to improve protein identification by differentiating the 
peptide-to-protein ratios of authentic and false positive sequence assignments (94).  One 
metric of accuracy that avoids false discovery rate estimation altogether is the expectation 
value, the probability that a given score would occur by chance based on the size of the 
search space and the score distribution of all hypothetical sequences matching a given 
spectrum.  Since it is independent of the means by which a score is calculated, the 
expectation value can be applied to results from any spectral matching function (95).  
Mascot and X!Tandem both calculate expectation values but in different ways.  For each 
spectrum, X!Tandem plots the number of hypotheses per score and extrapolates to the 
value of the presumed true positive to find its frequency, while Mascot directly relates the 
number of hypotheses per score to a user defined confidence interval then reports the 
difference between the highest score and that corresponding to the limit of the confidence 
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interval (83, 96). Interestingly, the two programs differ in their sensitivity to search space 
(97). 
Search algorithms are integral to proteomics workflows and each has its own nuances. 
The direct comparison of datasets from different groups is complicated by the use of 
different of spectral interpretation software under different settings.  The lack of a 
universal standard can in part be explained by the variety of solutions to polypeptide 
inference.  Fortunately the most widely accepted algorithms tend to give complementary 
rather than contradictory outputs. 
1.4 Special considerations in polypeptide analysis 
Proteins are large, reactive molecules naturally forming in intricate heterogeneous 
mixtures and as such many obstacles to their analysis continue to confound elucidation.  
These technical issues remain the focus of much study while biological discoveries 
continue to be made from LC-MS data in spite of them.  Some details of proteomic 
analysis of are discussed below. 
Influence of the sample matrix on LC-MS 
Diverse sample composition can profoundly affect the success of polypeptide LC-MS.  
Analytes and contaminants interact during analysis to alter separation and sensitivity in 
both chromatography and mass spectrometry.  HPLC systems are susceptible to shifts in 
retention time and peak shape caused by column overloading.  Stationary phase fouling 
by non-polypeptides, exemplified by the detrimental effect of plasma lipids on blood 
analysis, is another common problem degrading overall performance (98). 
Interference also occurs at the ESI source, resulting in ion suppression or ion 
enhancement known as the matrix effect (99).  This decreases dynamic range and 
sensitivity for certain compounds as manifested in the detrimental effect of increased 
sample loading amount on the number of peptide identifications from a single sample 
(100).  Two sources of the matrix effect have been identified; competition between 
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sample components for charged species such as protons and disruption of droplet 
formation or collapse (101).  Detergents and non-volatile salts suppress ESI by competing 
with analytes for ionization and forming deposits on ion optics. MALDI is also impaired 
by detergents so the problem may not be circumvented by changing sources (102).   
Peptides compete for ionization in a sequence and concentration dependent manner.  Over 
the course of an LC-MS run, the effect is most pronounced where coelution is highest, 
usually at high organic solvent concentration (103-105).  Even heavy isotope labelled 
internal standards, which control for variation in ionization efficiency, cause matrix 
effects at high concentrations (106).  The problem varies among highly similar matrices 
such as plasma or urine from different individuals (107, 108).  
The elimination of all non-proteinacious components of a sample prior to LC-MS is 
highly desirable.  Dialysis and reversed phase extraction both remove water soluble 
inorganic compounds with minimal polypeptide loss.  The removal of detergents is more 
problematic because of their limited solubility and high affinity for reversed phase 
materials.  Solid phase extraction and liquid phase extraction techniques for the reduction 
of detergent content exist but are not entirely effective (109-113).  Proteins of no 
relevance to an investigation can cause severe matrix effects, for instance the high 
abundance proteins of blood hamper detection of less concentrated biomarkers.  Being 
composed of the same amino acids, analytes of interest and proteinacious contaminants 
are not easily isolated.  Selective removal of either the analyte or abundant matrix 
proteins is possible by affinity purification.  It should be noted that the elimination of 
abundant species from a complex proteome leaves behind a great deal of the matrix which 
may still hinder LC-MS.  Figure 1.5 shows the protein distribution of human blood serum 
before and after removal of the most concentrated proteins.  Untreated sera run in lanes 
two and three have wide bands characteristic of the most abundant species while the 
treated serum in lane four does not; however most bands are common to all three lanes.  
A Bradford protein assay standardized against bovine gamma globulin indicated the 
protein content of the treated serum to be approximately 20% that of the untreated serum. 
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Figure 1.5: Human serum resolved on a 10% acrylamide SDS-PAGE gel stained with 
silver. 1: 15 ul of 7 to 125 kDa molecular weight marker from New England Biolabs, 2: 
100 nl of normal male type AB serum (Sigma Aldrich), 3: 100 nl of serum from an 
endometrial cancer patient, 4: 1 ul of serum from the same sample as shown in lane 3 
after two passages through a ProteoPrep
TM
 immunodepletion spin column (Sigma 
Aldrich).  The immunodepletion column was designed to remove twenty abundant plasma 
proteins including albumin, Immunoglobulins, transferrin, fibrinogen, compliment 
components and apolipoproteins. 
A sample can continue to influence the LC-MS system long after it has been injected onto 
the column and analyzed.  Elution of analytes from one sample during subsequent 
chromatographic runs is called carryover.  This can be a significant source of error in 
proteomics experiments, complicating cross-sample comparison.  An empirical limit of 
acceptable carryover for contemporary reversed phase HPLC platforms is an analyte 
signal intensity ratio of 1:100 between a blank and the sample run preceding it.  Large 
and hydrophobic peptides tend to persist, eluting over numerous runs with signal 
intensities near their initial values.  It follows that extensive washing with acetonitrile or 
water cannot eliminate the issue.  The order in which samples are analyzed is important in 
label free quantitation in light of these facts.  Contamination is minimized with the use of 
trifluoroethanol or isopropanol, although the latter must be flushed from the system to 
restore chromatographic performance (114).   
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Variability in enzymatic digestion efficiency 
Most bottom up proteomic studies employ more or less the same trypsin digestion 
protocol with the implicit assumption that it has substrate and matrix independent high 
efficiency.  Several studies have shown this general approach to sample handling to be 
suboptimal.  Even pure proteins vary in their susceptibility to trypsin at different cleavage 
sites under different conditions to an extent that sensitivity of quantification differs with 
the peptide measured (115).  In plasma, some proteins resist degradation regardless of the 
detergent, denaturing agent and treatment time used (116).  Such findings suggest treating 
one sample with several proteolytic conditions would be beneficial to sequence coverage.  
One surprising development of trypsin research is the emergence of protocols requiring 
high organic solvent concentration.  Since trypsin is a mammalian protein, it seems 
counterintuitive that it would retain its function at acetonitrile or methanol contents as 
high as 80% (v/v) however such conditions have been shown to dramatically enhance its 
rate of catalysis (117-119).  Microwave heating is another innovation shown to increase 
digestion speed, though conventional incubation in water baths or ovens at 37
o
C is still 
widely used (120).  Regardless of the experimental system it is important to recognize the 
uncertainty in proteolysis introduced by enzymatic cleavage. 
Amino acid modifications 
Proteins undergo an assortment of chemical modifications in vivo and in vitro, mostly at 
amino acid side chains.  Such alterations range in complexity from the addition of single 
atoms to macromolecules.  Biological amino acid modifications within a protein are 
referred to as post-translational modifications (PTMs).  Modification can obstruct protein 
sequencing and quantification by altering the mass and physical properties of amino acids 
on which they occur.  Modified forms of a peptide reduce or eliminate the MS signal of 
the unmodified version, which is especially problematic in peptide quantification.  The 
inclusion of PTM-associated hypothetical mass shifts in spectral interpretation models 
increases computational burden and the number of spurious sequence matches.  In 
practice, only a few common modifications are considered in automated searching in 
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order to maximize true positive identifications while minimizing false positives, though 
such a data interpretation paradigm concedes partial sequence coverage of modified 
proteins.  The biological relevance of certain modifications may be obscured by their 
occurrence both in vivo and as artefacts of sample handling, so strict controls are essential 
to the study of modified peptides.  Several protein modifications and their impact on LC-
MS and proteomics in general are discussed below. 
Glycosylation 
The majority of polypeptides are believed to be functionalized with monosaccharides or 
polysaccharides in what is recognized as the most diverse and common type of post-
translational modification (121).  The prevalence of protein glycosylation attests to its 
metabolic importance and a host of biological systems have been shown to depend on this 
post-translational modification.  Glycosylation is both a source of considerable biological 
information and a hindrance to protein sequencing.  Covalently bound sugars interfere 
with automated spectral interpretation by altering polypeptide mass and fragmentation 
chemistry.  Glycopeptides readily ionize by ESI but current sequencing algorithms cannot 
discern their highly complex and variable glycan moieties.  Appreciation of carbohydrate-
protein bonding therefore aids the design of proteomics experiments and interpretation of 
their results. 
Polysaccharides are ethers resulting from condensation reactions of monosaccharide 
hydroxyl groups forming what are commonly referred to as glycosidic bonds.  Since they 
are polyols, monosaccharides can polymerize at multiple positions to form extensively 
branched glycans.  While leucine and isoleucine are the only structurally isomeric amino 
acids, many monosaccharides are structural isomers.  As a result, glycans of markedly 
different sizes and shapes are isobaric.  A glucose residue has a mass of 180 Da, while 
glycans can reach masses of several thousands of Daltons, so the mass range added to a 
peptide by glycosylation is wide.   Characterization of specific glycoproteins has revealed 
that polysaccharide moiety structure reflects glycan synthesis and transport machinery, 
host-pathogen interactions, genetic variation and disease state so a single amino acid 
 
 
45 
 
residue within a protein has the potential to be linked to a multitude of glycans (121, 122).  
For these reasons, glycosylation complicates protein analysis. 
Glycosylation occurs at the side chain nitrogen of asparagine residues as well as the side 
chain oxygen of serine or threonine residues giving N-linked and O-linked glycosylation 
respectively.  Where the amino acid sequence of a glycoprotein is sought, glycans can be 
removed by several means. Beta-elimination with bases such as sodium hydroxide or 
ammonium hydroxide is a simple, MS-compatible method of removing O-linked glycans 
(123).  For the removal of N-linked glycans, a class of enzymes known as 
endoglycosidases can be used (124).   The bacterial protein peptide N-glycosidase F 
(PNGase F) specifically removes N-linked glycans under conditions commonly used for 
proteolytic digestion, converting asparagine residues to aspartate in the process.  
Deglycosylation has a direct influence on peptide identification. For example, an 18% 
improvement in sequence coverage of influenza virus antigens was reported when 
PNGase F treatment was incorporated in the sample preparation (125).  It is worth noting 
that glycopeptides can be characterized using the same instrumentation normally applied 
to peptide analysis (126, 127).  In principle, glycopeptide and peptide identification could 
be integrated to enrich the structural detail of proteomic datasets while simplifying 
sample preparation. 
Phosphorylation 
Protein phosphorylation is a reversible signalling mechanism in eukaryotes and 
prokaryotes.  Two classes of enzymes control phosphorylation, kinases which transfer 
phosphates from adenosine triphosphate (ATP) to protein substrates and phosphatases 
which remove protein-bound phosphates.  In addition, protein phosphorylation by small 
molecules such as acetyl phosphate occurs in bacteria (128). 
Around one third of the vertebrate proteome is thought to undergo this post translational 
modification (129).  In vertebrate proteins, serine is the most commonly phosphorylated 
amino acid, followed by threonine then tyrosine, with the respective ratio of 
phosphorylation being approximately 1800 to 200 to 1 (26).  The side chain hydroxyl 
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groups of serine, threonine and tyrosine are bound to phosphate as relatively stable 
phosphoesters. In bacteria, aspartate and glutamate residues constitute the main phosphate 
acceptors, forming labile phosphoanhydrides(130).  Higher organisms are also known to 
produce phosphoanhydrides.  Prothymosin alpha, a highly conserved mediator of immune 
function in eukaryotes, is also phosphorylated at numerous glutamic acid residues (131).  
Side chain nitrogen atoms of arginine, lysine and histidine form a third group of 
phosphoamino acids, the phosphoramidates, which occur in both prokaryotes and 
eukaryotes (132). 
Phosphosites tend to be modified at substoichiometric levels so the recognition of 
phosphopeptides has little impact on sequence coverage in most proteomic contexts.  The 
roles of phosphate transfer in metabolism are explored in the related field of 
phosphoproteomics.  Phosphoproteomics workflows typically involve purification of 
phosphopeptides from proteolytic digests before LC-MS.  Both the isolation and 
identification of phosphopeptides present barriers distinct from those encountered in 
proteomics.  Phosphopeptides behave differently from peptides having identical 
sequences in both LC and MS. Phosphates are acidic, reducing phosphopeptide ionization 
efficiency and charge in positive ion mode (133-135). The phosphate group is labile in 
the gas phase, especially under CAD conditions, and reveals little structural detail after 
detachment from the phosphopeptide (133).  In addition, gas phase phosphate mobility 
leads to intramolecular relocation in those species having multiple serine, threonine or 
tyrosine residues (136).  These phenomena impede phosphosite assignment.  Routines for 
phosphopeptide MS are diverse and include neutral loss scanning to monitor phosphate 
dissociation as well as MS/MS in both negative and positive ion mode.  Phosphoserine 
and phosphothreonine derivatization producing less labile functional groups can be used 
to improve detection (137).  
Though their physical properties make for difficult MS analysis, phosphopeptides are 
well resolved by reversed phase HPLC, having equivalent peak widths but longer 
retention times on reversed phase over acetonitrile gradients compared to non-
phosphorylated peptides with the same sequence(138).  In light of the susceptibility of 
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phosphopeptides to ion suppression, a problem exacerbated by the presence of other 
analytes, LC is warranted in phosphoproteomics.  
Deamidation 
Deamidation is the spontaneous rearrangement of the asparagine and aspartic acid side 
chains through reactive succinimide intermediates following the loss of NH2
-
 and OH
-
 
respectively (139).  The succinimide ring opens upon addition of a hydroxyl group, 
resulting in mass shift of 1 Da for asparagine or no mass shift for aspartate.  Glutamine 
and glutamate react analogously, with only the former gaining 1 Da through deamidation 
(140).  The process is much more rapid for aspartate than asparagine (139).  The reaction 
occurs under physiological conditions and is reversed in vivo by the enzyme L-isoaspartyl 
O-methyltransferase, an important reaction in the preservation of protein function since 
deamidation has been shown to promote protein degradation (141).  Deamidation also 
takes place during sample preparation and sequence dependence has been described, with 
glycine residues apparently promoting the modification during trypsin digestion when C-
terminal to asparagine (142).  The proposed mechanism of deamidation involves 
nucleophilic attack by the amide nitrogen in the peptide bond C-terminal to the affected 
residue on the Asn or Asp side chain carbonyl carbon (143). 
Peptides containing deamidated asparagine and glutamine residues have longer retention 
times than their unmodified equivalents on C18 columns with water/acetonitrile mobile 
phase (144).  Partitioning of the MS signal for a given peptide into unmodified and 
deamidated forms is potentially detrimental to quantification and sensitivity.  Mass shifts 
associated with this PTM are commonly considered in MS/MS sequence identification.  
This effect can be mitigated by performing digestion under mildly acidic conditions 
(145). 
Oxidation 
Both biological and abiotic influences affect the oxidation of proteins.   The sulfur atoms 
of cysteine and methionine are readily oxidized.  The tryptophan side chain undergoes a 
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number of oxidation reactions.  Addition of one or two oxygen atoms produce 
hydroxytryptophan and dihydroxytryptophan respectively.  Extensive side chain 
modification yields kynurenine and several derivatives thereof, all of which have masses 
exceeding that of tryptophan.  While tryptophan derivatives are biologically regulated and 
active, all of the above tryptophan modifications have been shown to result from SDS-
PAGE separation by MS/MS of tryptic digests (146).   
Disulfide bonding 
Disulfide bonding between the side chains of two oxidized cysteine residues presents a 
challenge to bottom up sequencing, covalently linking distant regions of a protein or two 
separate proteins.  Digestion of sulphur bridged polypeptides yields non-linear peptides 
with masses and product ions representative of both contributing regions, which present 
challenges to identification.  Treatment with reducing agents such as dithiothreitol (DTT) 
followed by alkylation controls cysteine reactivity, eliminating disulfide bonds and 
preventing subsequent oxidation of the sulfur atoms.  Reduction and alkylation are 
practically stoichiometric and widely used in the field of proteomics.  Derivatization is 
essential because sulfhydryl groups spontaneously bond.  The technique is not effective 
for methionine derivatization.   
Alkylation 
Excess of cysteine derivatization agents can cause alkylation of the N-terminal amine as 
observed with iodoacetamide (147).  This modification is minimized by limiting 
alkylation agent concentration.  In vivo, methyltransferases mediate the alkylation of 
arginine and lysine residues, particularly in proteins controlling gene expression (148).  
As many as two or three methyl groups may be added to arginine and lysine respectively. 
Ubiquitylation 
The covalent attachment of two proteins is not restricted to disulfide bonding in vivo.  In 
eukaryotes, the primary function of members of the ubiquitin protein family is to regulate 
other proteins in an enzyme catalyzed process known as ubiquitylation.  Such reversible 
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PTMs maintain homeostasis by marking the modified protein for degradation, altering its 
activity or its subcellular location (149).  Ubiquitylation is known to occur mainly at 
lysine side chains and to a lesser extent cysteine and amino-terminal residues. Ubiquitin 
itself harbours seven lysine residues by which it forms homopolymers, the size of which 
affect the fate of its substrates (150).  A diverse group of ubiquitin homologues such as 
the small ubiquitin-like modifier (SUMO) perform similar roles through analogous 
mechanisms. 
The consequences of ubiquitylation in proteomics experiments include lost sequence 
coverage due to missed cleavages and unanticipated mass shifts.  Trypsin cleavage at 
lysine is blocked by ubiquitylation in some cases.  When fully cleaved, ubiquitin and 
ubiquitin-like proteins leave di-glycine with a mass of 114 Da on the modified residue.  
Assigning ubiquitylation sites based on the di-glycine modification is challenging since it 
does not change the fragmentation pattern of the peptide and is isobaric with 2-
acetamidoacetamide, an artefact of iodoacetamide alkylation (151, 152). 
1.5 Conclusion 
The emergence of proteomics over the past several decades has resulted from the creation 
of complementary analytical technologies centered on mass spectrometry.  Demand for 
knowledge of polypeptide elemental composition has been met to such a degree that 
instrument accessibility, rather than quality, has become the major limiting factor in 
scientific advancement in proteomic applications.  The current generation of LC-MS 
platforms could inform research into protein expression, localization, interaction and 
post-translational modification for decades to come but improvements in all 
characteristics of LC-MS performance are ongoing.  Bottom-up proteomics stands to 
benefit especially from advancements in sensitivity, separation and data processing.  MS 
sensitivity and LC separation are complementary in that the negative impact of sample 
complexity on the detection of any analyte is reduced as both performance characteristics 
are increased.  Current high quality LC separation incompletely resolves all peptides from 
a typical proteomic sample and MS scan speeds which could make up for the shortfall are 
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orders of magnitude higher than those currently available (153).  The separate acquisition 
of MS/MS data for all peptides in a single LC run will require either a leap in scan speed 
and sensitivity or chromatographic resolution.  SWATH MS has demonstrated the 
potential to collect data from all peptides in a sample without the need for improvements 
in instrumentation and represents a step toward a unified analysis mode with combined 
high-throughput identification and quantification.  Analytics are crucial here, since the 
relationship between precursor ions and product ions is obscured by the presence of other 
analyte ions.  Even with only a fraction of the observable proteome accessible in a single 
run, LC-MS/MS experiments generate vast amounts of raw data which must be organized 
into a meaningful form.  From sequence assignment to the recognition of post-
translational modifications to quantification, fast and transparent data processing is vital 
to mass spectral interpretation and its simplification may encourage the wider use of LC-
MS based proteomics in biology. 
1.6 Statement of Purpose 
There are countless uses for LC-MS/MS in the study of protein biochemistry and 
proteomics.  A diverse collection of inquiries centered on LC-MS/MS technology is 
described in the following chapters, with subjects ranging from specific metabolic events 
in prokaryotes, plants and animals to theoretical limits of sequence specificity in MS-
based proteomics.  The main purpose of this dissertation was to solve problems unique to 
each biological investigation using various LC-MS/MS platforms.  A separate theoretical 
study comparing mass accuracy in MS and MS/MS to MRM transition redundancy was 
undertaken with the objective of better defining the relationship between proteomics 
sample heterogeneity and the accuracy of MS/MS-based experiments in terms of peptide 
sequence. 
The scientific results central to this dissertation consist of sequence information derived 
from data-dependent acquisition and structural information derived from targeted 
MS/MS.  Attributes of the MS/MS datasets on which their interpretation, and the 
credibility thereof, are based are discussed in order to relate mass spectrometer 
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performance to data quality.  Similarly, LC performance is related to reproducibility and 
reliability of peptide characterization through illustrations of extracted ion 
chromatograms and discussions of their properties.  Though LC-MS/MS systems may 
sometimes be regarded as “black boxes” by those who employ them, the data they 
generate should be assessed on a technical basis in the interest of accurate scientific 
reporting.  Examples of such assessments are presented in the following chapters to show 
how the qualities of mass spectra influence the confidence of each biological finding. 
In the projects described in chapters 2, 3 and 4, LC-MS/MS was used to evaluate the 
potential of specific amino acids within specific proteins to be phosphorylated.  Direct 
observation of specific amino acid residues with and without phosphates bound to them 
was achieved with MS/MS, whereas the presence of the phosphate could only be inferred 
using complementary biochemical techniques.  Novel phosphosites identified were shown 
by other analytical techniques to be relevant to specific protein functions.  Chapter 4 
details the finding that an assumed phosphosite was not phosphorylated by a particular 
kinase in a demonstration that LC-MS/MS can be used to disprove as well as prove a 
hypothetical modification.  Aside from phosphosite determination, MS/MS-based 
polypeptide sequencing was employed to address questions relating to each of the 
proteins under study, as summarized below. 
Chapter 2 describes a study of two transcription factors of the human pathogen 
Staphylococcus aureus whose activities are known to impart resistance to antimicrobial 
agents.  The novel demonstration of phosphorylation at specific residues within both 
proteins was central to the characterization of their functions in response to antibiotic 
stress.  Chapter 3 is focused on the identification of three phosphosites within an enzyme 
integral to starch biosynthesis in Zea mays and of several kinases responsible for 
modifying these residues.  Direct observation of the phosphorylated residues and the 
assignment of putative kinases provided a basis for further investigation into the 
biochemistry of the substrate protein and the protein complex to which it belongs.  
Chapter 4 describes the discovery of novel interacting proteins for an intracellular 
signalling protein within a mammalian cell line through a combination of immunoaffinity 
 
 
52 
 
chromatography and LC-MS/MS.  Additionally, while a novel kinase-mediated 
modulation of the signalling protein’s activity was illuminated by in vitro techniques; LC-
MS/MS analysis indicated the effect of the kinase was indirect, prompting exploration of 
an alternative regulatory mechanism.  Chapter 5 differs from the others in that it is 
broadly focused on limitations of tandem mass spectrometry for polypeptide analysis and 
details a study which employed computation rather than LC-MS/MS in the generation of 
exploratory data. 
LC-MS/MS was an integral component of each research program discussed here, 
exposing protein-protein interactions and mechanisms of protein regulation.  
Corroborative data obtained by other techniques is presented to support conclusions 
drawn from mass spectra.  The selected topics covered here reflect the current 
understanding of the mass spectrometry of polypeptides. 
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Chapter 2 
Phosphorylation-mediated activation of Staphylococcus aureus 
antibiotic resistance response regulators 
 
2.1 Introduction 
Antibiotic tolerant pathogens such as methicillin-resistant Staphylococcus aureus present 
a threat to public health, causing hundreds of thousands of potentially life-threatening 
infections annually (1).  To survive antibiotic challenge, a pathogen must sense the stress 
then coordinate a suitable response.  Two-component systems (TCSs), which consist of 
paired sensor and response regulator (RR) proteins, confer resistance to several classes of 
antimicrobial agents by mobilizing activities such as drug efflux and cell wall synthesis 
(2, 3).  The sensor protein of a TCS functions as a transmembrane receptor, a kinase and a 
phosphatase while the RR is typically a transcription factor with an entirely cytosolic 
distribution.  Following recognition of the external stimulus, signal transduction begins 
with sensor autophosphorylation at a histidine residue.  The receptor then activates the 
RR by phosphorylating it at an aspartate residue.  The signal is negatively regulated by 
phosphatase activity of the receptor on the RR or by RR autophosphatase activity or by 
other phosphatases (4).  Seventeen TCSs have been identified in the ubiquitous Gram-
positive bacterium S. aureus, of which ApsSR/GraSR, BceSR, BraSR, and VraSR are 
associated with antibiotic resistance (5-7). 
Several distinct properties of TCSs influence the means by which their behaviour can be 
studied.  Both components are homodimers in their active states and the activating 
phosphate is transferred from ATP by one sensor monomer to its pair, then to the RR. 
Stimulus is thought to elicit a low degree of sensor autophosphorylation so the degree of 
sensor protein phosphorylation is unrepresentative of pathway activation (4).  RRs 
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possess potent autophosphatase activity toward their activating aspartate residues, causing 
rapid turnover of the PTM (8).  Furthermore, the aspartate phosphoanhydride group is 
unstable and readily dissociates under mild conditions in the absence of a phosphatase.  
Phosphoaspartate degradation occurs rapidly under acidic, basic and neutral conditions 
(9).  Phosphoanhydride fragility and low concentration of TCS phosphoproteins present 
challenges to detection, however phosphoaspartate may be studied indirectly using a more 
stable phosphate surrogate or by derivatization. The highly electronegative tetrahedral 
bonding phosphate analogue beryllofluoride (BeF3
-
) forms more stable active RRs in vitro 
(10, 11).  Phosphoaspartate can be reduced with sodium borohydride (NaBH4) to the 
amino acid homoserine (Hse), though the E.coli protein CheY is the only RR that has 
been studied using the technique (12, 13).  Aspartate-57 within the conserved RR 
activation sequence was shown to be the CheY phosphosite by a combination of 
reduction, proteolytic digestion, RP-HPLC fractionation and MS/MS.   
Phosphoesterification is an emerging mechanism of TCS regulation which is amenable to 
study using established phosphoproteomics techniques.  Like eukaryotes, bacteria possess 
serine/threonine kinases. CheY has been shown to be activated by phosphorylation at 
Serine-56, suggesting that more RRs may be similarly controlled (14). 
Herein is reported a study of two S. aureus antibiotic resistance-mediating RRs, VraR and 
GraR, by LC-MS/MS in which their activating phosphorylations were observed.  The 
locations and states of VraR and GraR phosphosites can only be inferred using 
biochemical methods and this is an impediment to the elucidation of their behaviour.  LC-
MS/MS can supply proof of the phosphorylation state of any residue in a protein and was 
therefore used here to determine serine-threonine kinase 1 (Stk1) directed phosphosites 
on GraR and the acetyl phosphate directed phosphosite of VraR.  Acetyl phosphate 
modified VraR at aspartarte-55 (D55) while the endogenous Stk1 modified GraR at 
threonine residues 128, 130 and 149.  The PTM increased the RRs affinities toward their 
respective promoters while site directed mutagenesis of the phosphosites inhibited 
functions normally under GraR control. In addition to confirming that VraR is activated 
by D55 phosphorylation, GraR was shown to be under the control of an entirely different 
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class of kinase/phosphatase pair than is typical of TCSs.  This work contributed to the 
established model of TCS signalling and uncovered a novel means of response regulation 
in S. aureus.  In addition, a sample preparation technique was evaluated to assess its 
applicability to the measurement of in vivo VraR phosphorylation. 
VraSR 
The VraSR TCS confers resistance to cell wall synthesis-inhibiting compounds such as 
vancomycin, bacitracin and beta-lactams by inducing the expression of at least 46 genes, 
among them those of VraSR itself as well as several responsible for cell wall construction 
(3, 15). Like all TCS names, that of VraSR alludes to both components, the 
transmembrane sensor VraS and the RR VraR.   
Vancomycin resistance associated regulator (VraR), is a 209 amino acid protein with an 
N-terminal regulatory domain and a C-terminal DNA-binding domain, both of which are 
conserved among the RRs of a number of prokaryotes.  Though never previously 
observed, D55 was assumed to be the VraR phosphate acceptor based on sequence 
alignment with other RRs.  While the wild-type protein was phosphorylated by phospho-
VraS within minutes, mutation of residue 55 to asparagine negated this effect. VraR was 
also shown to undergo phosphorylation at a single site between residues 1 and 133, albeit 
more slowly, by acetyl phosphate.  Small organophosphates are known to modify 
regulatory aspartate residues of other RRs though the significance of such reactions in 
vivo remains to be established (16).  VraS rapidly dephosphorylates phospho-VraR, 
reflecting negative regulation by the intrinsic phosphatase activity of the sensor.  Both 
acetyl phosphate-phosphorylated VraR and phospho-VraS-phosphorylated VraR were 
affected by VraS.  In the case of phospho-VraS-phosphorylated VraR, complete 
dephosphorylation was rapid, occurring in less than five minutes (17). 
The phosphorylation of VraR results in structural changes implicated in its activation.  
Binding of BeF3
-
 resulted in conformational remodelling which enabled VraR 
homodimerization as assessed by crystallography (17, 18). Phosphate-dependent 
conformational changes of VraR have also been observed by circular dichroism and 
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hydrogen-deuterium exchange MS (17, 19).  DNA binding by VraR was shown to 
increase substantially upon phosphorylation using regions upstream of the VraSR 
promoter as substrates (17, 20).  VraR dimerization and binding to the VraSR promoter 
appear to be concentration dependent, so its upregulation following VraS stimulation can 
be presumed to result in increased VraR activity, possibly with decreased dependence on 
direct PTM-dependent activation (17).  One study found the cytosolic concentration of 
VraR increased more than three fold in vancomycin-challenged S. aureus compared to 
untreated controls, a change higher than all but one of the ten VraSR-controlled genes 
found to be upregulated by this stimulus (21).  The above studies describe a rapid 
antibiotic-triggered signalling cascade in which VraS stimulates genetic expression within 
minutes and VraR concentration quickly reaches levels which may be sufficient for 
phosphate-independent promoter binding.  The capacity of VraS to reverse VraR 
activation suggests the response to cell wall damage is under both post-translational and 
transcriptional control. 
GraSR 
The TCS GraSR, also called apsSR, acts in two ways to confer resistance to cationic 
antimicrobial compounds causing cell wall damage.  The negative charge of the bacterial 
cell wall is decreased by covalent attachment of amino acids to the teichoic acids and to 
phosphatidylglycerol which protrude from the cell surface, in turn protecting S. aureus 
from cationic antibiotics.  In addition, the membrane transporter VraFG pumps cationic 
drugs out of the cell.  The genes responsible for both of these functions are under the 
control of GraSR (22, 23).  GraSR differs from VraSR in that it does not regulate its own 
promoter and its expression is unaffected by the class of antibiotics to which it responds 
(24). 
Glycopeptide resistance associated regulator (GraR) is 224 amino acids long.  Like VraR, 
GraR contains a C-terminal DNA binding domain as well as an N-terminal regulatory 
domain in which Aspartate-51 is understood to be a phosphate acceptor.  In addition, 
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GraR contains 14 serine, 14 Threonine and 7 tyrosine residues, none of which are known 
phosphosites. GraR is apparently not phosphorylated by acetyl phosphate (25). 
Stk1 
The S. aureus genome contains one known serine/threonine kinase (Stk1) and one 
serine/threonine phosphatase (Stp1) which dephosphorylates it (26).  An extracellular 
sensory role for Stk1 is suggested by its transmembrane domain and three extracellular 
penicillin-binding protein serine/threonine kinase-associated (PASTA) domains, features 
common to STKs of other bacteria (26, 27).  Stk1 is a known beta-lactam antibiotic 
resistance factor and controls the expression VraFG and VraSR among many other genes, 
though its substrates have not been fully described (27, 28).  Notably, VraFG 
transcription is controlled by GraSR, suggesting that Stk1 influences GraSR activity (24).  
The possibility of such an interaction is reasonable given that serine/threonine kinases of 
other prokaryotes are known to regulate RRs (29). 
2.2 Methods and Materials 
Recombinant protein expression 
Full length Stk1, Stp1, GraR and VraR genes from S. aureus strain MU50 were ligated 
into the plasmids then transformed into E.coli BL21 DE.  Truncated GraR and GraR 
point-mutants were created using a Stratagene
TM
 site-directed mutagenesis kit.  The four 
mutants created were the effector domain construct GraR
C
 (GraR residues 123-224), the 
N-termial construct GraR
N
 (GraR residues 1-134), the point mutant GraR-Thr130Ala and 
the triple mutant GraR-Thr128Ala/Thr130Ala/Thr149Ala.  Plasmid pET26b was the 
expression vector for all genes with the exception of pET141/D-TOPO used for Stk1 
expression. Inclusion of the expected genes was confirmed by DNA sequencing of the 
expression vectors. Recombinant protein expression was induced by addition of 
isopropyl-beta-D-thiogalactopyranoside at concentrations between 0.5 and 1 mM in the 
growth medium.  After 16 to 18 hours Terrific Broth cultures were sedimented by 
centrifugation at 7459 g and lysed by sonication then centrifuged at 18138 g to pellet cell 
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debris.  The desired proteins were isolated from the lysate supernatant.  Recombinant 
Stk1 included an N-terminal six-histidine tag and was purified using a nickel-NTA 
column while the other proteins were purified using DEAE-Sepharose.  The molecular 
weights of the recovered gene products were verified using SDS-PAGE with Coomassie 
blue staining. 
Response regulator phosphorylation 
To evaluate its kinase activity on a number of proteins, 5 µM Stk1 was incubated with 
potential substrates in 25 mM Tris-HCl (pH 7.5), 1 mM dithiothreitol, and 10 mM MgCl2 
with ATP or [γ-32P]-ATP at room temperature for 30 minutes in the presence of ATP. 
Substrate concentrations used were as follows; 10 µM of GraR, 10 µM of the Bacillus 
subtilis GraR homolog BceR, 20 µM of VraR.  The interaction was arrested by heating in 
SDS-PAGE sample loading buffer. The kinase and GraR were separated by 
electrophoresis on 12.5% acrylamide gels then visualized with Coomassie blue stain.     
VraR was phosphorylated in 50 mM Tris-HCl, pH 7.0, 50 mM KCl and 20 mM MgCl2 
with 50 mM lithium potassium acetyl phosphate (Sigma-Aldrich, St. Louis, MO, USA) at 
37°C for 60 minutes. Acetyl phosphate treatment was followed by incubation on ice 
during which 1 ml volumes of 10% (w/v) ice-cold trichloroacetic acid (TCA) were added 
to precipitate the protein.  The samples were then brought to 30°C for 10 minutes then 
chilled and centrifuged at 10,000 g and 4°C for 20 minutes. The pellet was washed with 
200 µl of ice-cold 10 mM HCl and dried in a centrifugal concentrator at low heat. 
NaBH4 Reduction 
The TCA precipitates (approximately 100 µg total protein) were suspended in 100 µL of 
dimethyl sulfoxide (DMSO) containing 2.7 µmoles of NaBH4 at 30°C for 10 minutes, 
then the reaction was terminated by the addition of 1 ml of 0.44 M ice-cold perchloric 
acid  (HClO4)  on ice.  Protein was collected by centrifugation at 10,000 g and 4°C for 20 
minutes then washed with 200 µl of ice-cold 10 mM HCl prior to SDS-PAGE or 
proteolytic digestion. 
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Reduction of whole cell lysates 
Matrix effects on phosphoaspartate reduction and LC-MS performance were determined 
in two ways.  E.coli overexpressing VraR was lysed then treated with acetyl phosphate 
and subsequently with NaBH4 without prior HPLC purification of the recombinant 
protein.  Alternately, acetyl phosphate treated recombinant VraR was spiked into S. 
aureus RN4220 lysates in varying amounts and the lysate was then reduced for the 
evaluation of matrix effects on LC-MS/MS sensitivity.  Each sample contained 52 mg of 
lysate protein with 0, 0.1, 1, 10 or 100 µg of phospho-VraR in a total sample volume of 
500 µl, from which 10 µl portions were loaded onto SDS-PAGE.  Borohydride-treated 
samples were separated by SDS-PAGE on 15% acrylamide gels and bands matching the 
mass of VraR excised and digested with Glu-C for LC-MS/MS analysis. To test for 
endogenous phospho-VraR, 40 ml Terrific Soy Broth cultures of S.aureus MU50 were 
grown at 37
o
C to an OD600 of 0.6-0.7 then supplemented with 5 mg/ml oxacillin for one 
hour pelleted and lysed as described above.  The lysates were reduced then separated by 
SDS-PAGE or immunoprecipitation with a rabbit anti-VraR antibody immobilized on 
ImmunoCruz IP/WB Optima F matrix (SantaCruz Biotechnology Inc. Dallas, TX, USA).  
Immunoprecipitates were collected from the support with 0.5 M NH4OH. 
Electrophoretic mobility shift assay 
A segment of the S. aureus MU50 genome including the VraRG promoter region was 
amplified then collected and phosphorylated with [γ-32P]-ATP using recombinant T4 
polynucleotide kinase.  Recombinant GraR was incubated with 500 µM ATP in the 
presence or absence of Stk1 for 40 minutes at room temperature.  A five-fold excess of 
GraR to Stk1 was used.  Following treatment with ATP, the protein was diluted to 
concentrations between 3 and 18 µM and mixed with 4 ng of the radiolabelled DNA 
segment for 30 minutes at room temperature.  The mixtures were separated by native 
PAGE on 6% acrylamide gels and radioactivity visualized on a Typhoon Trio imager (GE 
Healthcare, Little Chalfont, UK). 
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LC-MS/MS 
Protein bands were excised from polyacrylamide gels then destained with acetonitrile.  
Whole cell lysates were digested without reduction or alkylation, since VraR contains no 
cysteine residues while GraR has one. The GraR samples were digested with trypsin 
(Promega, Madison, WI) while VraR samples were either digested with trypsin or Glu-C 
(Sigma-Aldrich) overnight at 37
o
C in 100 mM ammonium bicarbonate.  Each sample was 
confirmed to be pH 8 prior to addition of the enzyme.  In general, 0.2 to 0.5 µg of 
protease were used per gel band.  Tryptic peptide solutions were dried in a centrifugal 
concentrator, dissolved in 0.1% formic acid in water then desalted using C18 ZipTips 
(Millipore, Billerica, MA).  Eluates of the desalting columns were analyzed by HPLC-
MS/MS on a NanoLC-Ultra 2D HPLC system coupled to an AB Sciex 5600 quadrupole-
quadrupole-time-of-flight (Qq-TOF) mass spectrometer via a NanoSpray
TM
 III ion source 
(Concord, ON, Canada).  Samples were loaded via an autosampler onto a C18 trap 
column then separated by nanoflow HPLC on a C18 reversed phase analytical column (75 
µM I.D., 15 cm long, 3 µM particle size and 120 Å pore size) mounted in a cHiPLC-
nanoflex system.   The LC separation of GraR peptides was performed using a 45 minute 
binary mobile phase gradient from 5 to 35 % mobile phase B followed by a two minute 
wash at 80% mobile phase B then a 20 minute equilibration at 5% mobile phase B.  The 
compositions of mobile phases A and B were 0.1% formic acid in water and 0.1% formic 
acid in acetonitrile respectively.  Mass spectrometry was performed in positive ion mode.  
The data acquisition cycle consisted of a single MS scan followed by MS/MS scans of the 
ten most abundant analytes present in the MS.  VraR peptides were analyzed over a 30 
minute acetonitrile gradient by MRM on either an AS1-TempoLC-4000QTRAP with a 
NanoSpray
TM
 II ion source (AB Sciex) or on the Qq-TOF platform described above in 
MRM high resolution (MRMhr) mode.  The 4000QTRAP platform was equipped with a 
0.5 µm long 200 µm ID C18 trap (Michrom Bioresources, Auburn CA, USA) and an in-
house packed 12 cm long, 75 µm ID column containing 3 µm Reprosil-Pur C18-AQ  
particles with 120 Å pore size (Dr. Maisch, Ammerbuch-Entringen, Germany). 
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GraR peptides and phosphopeptides were identified from the MS/MS data using 
ProteinPilot software (AB Sciex).  The search conditions used for the sequence 
assignment were as follows: no cysteine modification, trypsin digestion, phosphorylation 
emphasis, biological modifications, amino acid substitutions, thorough ID and confidence 
threshold of 95% for protein detection.  Spectra were searched against the entire UniProt 
protein sequence library (downloaded on September 8, 2012) (30). 
2.3 Results 
The mass spectrometry of proteolytic peptides containing the VraR D55 phosphosite and 
GraR phosphosites T128, T130 and T149 is described below.  The dependencies of GraR 
threonine phosphorylation on Stk1 and VraR aspartate phosphorylation on acetyl 
phosphate were demonstrated with the use of negative controls. 
GraR phosphorylation by Stk1 
Coverage of the GraR sequence obtained by untargeted MS/MS exceeded 98% in all the 
samples analyzed.  Two singly phosphorylated tryptic peptides from GraR were identified 
with 99% confidence in the sample treated with Stk1 in the presence of ATP.  The 
sequences of the two phosphopeptides corresponded to amino acids 128 to 140 
(TLTWQDAVVDLSK) and 146 to 154 (GDDTIFLSK) of the full length protein.  No 
GraR phosphopeptides were identified from wild-type protein treated with ATP alone or 
from the triple mutant treated with Stk1 and ATP or from the untreated GraR control 
whereas two singly phosphorylated peptides were observed by LC-MS/MS with 99% 
confidence in replicate preparations of GraR incubated with Stk1 in the presence of ATP.  
The three threonine-to-alanine amino acid substitutions present in the triple mutant were 
identified with 99% or higher confidence in multiple MS/MS spectra obtained from the 
mutant sample. 
Peptide sequences and locations of the phosphosites shown in Figures 2.1 and 2.2 were 
assigned with 99% confidence by the ProteinPilot software in a search against the entire 
UniProt sequence library.  Multiple MS/MS spectra were identified with 99% confidence 
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as those of the phosphopeptides with unambiguous phosphosite assignment. The 
sequence library to which the MS/MS data were compared by the algorithm was the 
largest available, including the most complete proteomes of all species on record, yet the 
only phosphopeptides identified were those from the GraR protein of S. aureus. In this 
context, the likelihood that the algorithm randomly assigned these MS data to the 
molecular species predicted by other lines of experimental evidence is exceedingly low. 
Representative spectra of the two tryptic GraR phosphopeptides, the non-phosphorylated 
peptides with the same amino acid sequences and the corresponding mutant peptides are 
shown in Figures 2.1 and 2.2 and include product ion series representative of their 
complete amino acid sequences.  The tentative locations of the phosphoamino acids were 
assigned based on the presence of characteristic ions in the product ion series.  In order to 
confirm that the phosphates resided on the residues shown to be phosphorylated in wild 
type GraR, the triple mutant containing alanine at these sites was exposed to the kinase 
and ATP and analyzed in parallel with the wild-type protein.  Mutation of threonine 128, 
130 and 149 abrogated GraR phosphorylation which indicated that phosphorylation was 
dependent on the presence of threonine at these sites independently of the serine residues 
within both peptides.  No spectra obtained from any sample denoted phosphorylation at 
serine 139 or serine 153.  The absence of phosphorylation within the mutant peptide 
GDDAIFLSK suggests that threonine 149, not serine 153, is the phosphorylation site.   
There was no evidence for the phosphorylation of serine 139 in wild-type or triple mutant 
GraR, indicating the phosphate resided at a threonine residue.   
Phosphopeptides give characteristically low signal response in positive ion mode due to 
their acidity (31).  Thus the low intensity of the spectra in Figure 2.1B, 2.1C, 2.1D and 
2.2B are typical of such peptides. Accurate mass measurement of phosphopeptide product 
ions compensated for their low s/n to enable their identification and accounts for the high 
confidence sequence assignments (Table 2.1). Precursor and product ions were observed 
within hundredths or thousandths of a Dalton of their calculated m/z values. The high 
resolution Qq-TOF spectra also permitted low abundance product ion peaks to be 
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distinguished from electronic noise, since the former had width in the m/z domain while 
the latter had no measureable width.  
Mass spectra assigned to non-phosphorylated, singly phosphorylated, doubly 
phosphorylated and mutant versions of the sequence TLTWQDAVVDLSK were 
differentiated by their unique precursor ion m/z, chromatographic retention times and 
their distinctive fragmentation. The MS and MS/MS spectra corresponding to each 
phosphopeptide were exclusive to the kinase treated samples, indicating they formed only 
in the presence of Stk1 and ATP. 
In the case of the peptide TLTWQDAVVDLSK, phosphorylation occurred both at a 
single threonine residue (Figure 2.1B and D) and at both threonine residues (Figure 2.1C).  
Phosphorylation of T128 and T130 could not be distinguished by MS/MS since they were 
contained in a single peptide. Where a phosphopeptide contains multiple serine, threonine 
or tyrosine residues the phosphate may transfer from one of these amino acids to another 
within the mass spectrometer, due to unintentional ion activation, obscuring the initial 
location of the phosphate (32). Spectra were collected showing the wild-type peptide 
singly phosphorylated on either threonine so that the order of dual phosphorylation could 
not be determined, however phospho-T128 in the T130A mutant revealed this event to be 
independent of T130 (Figure 2.1D). Glutamine deamidation is a common and 
uncontrollable reaction in LC-MS experiments which causes an increase of peptide ion 
mass of 0.98 Da (33, 33).  Since the peptide TLTWQDAVVDLSK has two 
phosphorylation states and a glutamine residue, four modified variants with unique 
masses are present, reducing the MS signal of any one variant.  High mass accuracy, mass 
resolution and chromatographic resolution were therefore necessary to isolate and 
confidently identify GraR phosphopeptides.  
Loss of phosphate as a neutral species is a prominent and well documented feature of 
phosphopeptide CAD MS/MS.  Phosphate loss results in a mass shift of 18.015 Da 
relative to the unmodified ion because H2O is lost from the serine or threonine side chain 
along with the phosphate.  The s/n of the y11-H3PO4 peak in Figure 2.1B is 6.67:1 and 
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unlike the baseline noise, this peak had width characteristic of genuine ions.  These peak 
characteristics are sufficient for MS/MS sequencing algorithms to differentiate them from 
noise so that the phosphopeptide identity was automatically assigned based on the y11-
H3PO4 ion among others.  The doubly charged version of the y11-H3PO4 was also 
identified in this spectrum with s/n of 8:1. In the same spectrum the a3-H3PO4 and b3-
H3PO4 ions were identified with s/n of 8:1 and 6.7:1 respectively while b4-H3PO4, b8-
H3PO4 and doubly charged y13 were also present above s/n of 5:1.  Taken together, these 
product ions all support the assignment of the phosphosite to the second threonine from 
the N-termius of the peptide.  The measured masses of the y6 and y7 ions in Figure 2.2A 
and the y6-H3PO4 and y7-H3PO4 ions in Figure 2.2B differ by 18.0124 Daltons and 18.020 
respectively, indicating that water loss has occurred in both cases. Though non-
phosphorylated amino acids undergo some water loss during CID of peptides, the major 
fragments of non-phosphorlyated peptides are typically y- and b-ions. Similarly, non-
phosphorylated residues within phosphopeptides tend not to undergo water loss so that 
phosphopeptide fragments in which phosphosites are absent are mainly b- and y-types.  In 
data from Stk1/ATP-treated GraR, both the absence of non-phosphorylated y6 and y7 ions 
and the presence of y6-H3PO4 and y7-H3PO4 implicate T149 as the phosphosite. 
To increase instrument sensitivity for GraR phosphopeptides, MRMhr experiments were 
performed with the extracted mass width of each product ion maintained at 0.05 Th.  
Chromatograms of MRMhr transitions obtained from Stk1/ATP-treated GraR specific to 
doubly phosphorylated TLTWQDAVVDLSK, which have s/n between 1500:1 and 
3745:1 are shown in Figure 2.3. The peptide was shown to be doubly phosphorylated 
based on its precursor m/z of 454.9 Th, while y4, y5, y6 and y9 ions were consistent with a 
non-phosphorylated serine residue.   The iminium ion at m/z 159 Th was the most 
prominent fragmentation product of the doubly phosphorylated species, confirming the 
presence of tryptophan. 
Figure 2.1: Phosphorylation of GraR at T128 and T130.  Qq-TOF MS/MS spectra of 
tryptic GraR peptides containing the Stk1 phosphorylation sites and corresponding 
peptides from GraR point mutants in which threonine residues were replaced by alanine.  
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Sequence coverage is illustrated by labelling of fragment ions of each peptide according 
to Roepstorff–Fohlmann–Biemann nomenclature.  Phosphoamino acids are indicated by 
lower case letters.  Phosphate dissociation is indicated by the loss of phosphoric acid 
(H3PO4) from fragment ions which initially contained phosphorylated amino acid 
residues.  The MS/MS spectra of (A) the peptide 128-TLTWQDAVVDLSK-140 from 
untreated GraR, (B) the phosphopeptide 128-TLtWQDAVVDLSK-140 from GraR 
incubated with ATP in the presence of Stk1, (C) the doubly phosphorylated peptide 
tLtWQDAVVDLSK from wild-type GraR incubated with ATP in the presence of Stk1, 
(D) the phosphopeptide 128-tLAWQDAVVDLSK-140 from the GraR-Thr130Ala mutant 
incubated with ATP in the presence of Stk1 and (E) the peptide 128-
ALAWQDAVVDLSK-140 from the GraR triple mutant incubated with ATP in the 
presence of Stk1. 
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Attempts to observe endogenous phosphorylation were made using S.aureus RN6390 
transformed with the pMK4 vector wild type GraR.  All three phosphosites were evident, 
but only in their unmodified states, within two peptides by LC-MS/MS of a tryptic digest 
of the lysate.  A gel band excised at the expected position of GraR gave the same result.  
No GraR peptides or phosphopeptides appeared in LC-MS/MS data from a MOAC eluate 
of the same digest in which many other S. aureus phosphopeptides were identified.  Lack 
of MS evidence for in vivo PTM points to an inability in maintaining RR activation at a 
high level.  Similar challenges were encountered in the case of VraR D55, a phosphosite 
of known biological significance. 
Biochemical tests and Nuclear Magnetic Resonance Spectroscopy suggest Stk1 
phosphorylates GraR in vivo 
In agreement with LC-MS/MS, a kinase assay, a phosphatase assay, a DNA binding assay 
and 
1
H-NMR analysis of cell wall teichoic acid supported the hypothesis that Stk1 
phosphorylates GraR in vivo in response to antibiotic stress (25). 
Unlike BceR, heat-denatured GraR or VraR, GraR became radioactive after exposure to 
Stk1 and [γ-32P]-ATP, demonstrating the interaction was substrate specific.  Since in vitro 
phosphorylation assays combining substrate and kinase in relatively high concentrations 
are prone to false-positives, BceR and denatured GraR were important negative controls.  
Whereas VraR and GraR have low homology, BceR and GraR share 56% sequence 
identity including T128 and T130 (Figure 2.4).  That GraR only bound phosphate in its 
native state showed the PTM to depend on conformation rather than sequence alone.  
Stk1-induced GraR phosphorylation was restricted to the C-terminal DNA binding 
domain since GraR and GraR
C
 were radiolabelled by Stk1 while the GraR
N
 construct was 
not.  Despite high reagent concentrations used in the kinase assay, only an estimated 9% 
of total GraR was modified, an observation supported by the low abundance 
phosphopeptide signals relative to the corresponding peptide signals in MS.  The addition 
of Stp1 following Stk1 treatment abrogated the phospho-GraR signal, suggesting a 
mechanism for direct negative modulation of the RR in vivo. 
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An electrophoretic mobility shift assay was used to determine the effect of GraR 
phosphorylation on its function as a transcription factor.  Treatment with ATP and Stk1 
increased the affinity of GraR for the vraRG promoter from S. aureus strain MU50 by 
1.5-fold, despite the phosphorylation equilibrium favouring the unmodified protein.  This 
result implies a relationship between the transcription factor action of GraR and its Stk1-
depenendent phosphorylation state. 
The biological role of the phosphosites was further investigated using S. aureus GraR 
knockout mutant strain RN6390ΔgraR, which grows normally but is twice as susceptible 
to vancomycin as RN6390.  Alternate strains were produced by inserting the genes for 
wild-type GraR or the double mutant GraR-Thr130Ala/Thr149Ala or GraR-
Thr128Ala/Thr130Ala/Thr149Ala into RN6390ΔgraR.  Wall teichoic acids were isolated 
from cultures of each modified RN6390 strain then analyzed by 1D proton NMR on a 
Bruker AV III 700 MHz NMR spectrometer.  The effect of each GraR variant on wall 
teichoic acid composition was assessed by the intensity ratios of peaks corresponding to 
the N-acetyl group of N-acetyl-glucosamine (2.10 ppm) and D-alanine (1.63 ppm).  
RN6390ΔgraR had substantially lower wall teichoic acid D-alanine content than RN6390.  
wall teichoic acid from RN6390ΔgraR complimented with the wild-type GraR gene was 
indistinguishable from that of RN6390 though complimenting the same knockout with the 
GraR double mutant or triple mutant reduced D-alanine content by approximately half.  
That NMR showed the alanine content of wall teichoic acid to depend on a GraR isoform 
having intact Stk1 phosphosites is indicative of a phosphorylation-induced GraR 
activating effect.  The results presented above depict a serine/threonine kinase as a sensor 
complimentary to GraS.  Since two-component systems confer tolerance to antibiotics, 
this work suggests Stk1 or the threonine phosphorylation sites of GraR are potential 
therapeutic targets in the management of multidrug resistant S.aureus infection. 
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Figure 2.2: Phosphorylation of GraR at T149. Qq-TOF MS/MS spectra of (A) the tryptic 
peptide 146-GDDTIFLSK-154 from untreated GraR (B) the phosphopeptide 146-
GDDtIFLSK-154 from GraR incubated with ATP in the presence of Stk1, (C) 146-
GDDAIFLSK-154 from the GraR triple mutant incubated with ATP in the presence of 
Stk1. 
 
 
Table 2.1: Mass accuracies of ions observed in MS/MS spectra of tryptic GraR peptides 
harbouring the three Stk1 phosphorylation sites and the corresponding alanine point 
mutants.  Scans from which the listed masses were obtained are shown in the figure 
panels indicated. 
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Ion 
Observed 
monoisotopic m/z 
(Th) 
Error (Th) 
      TLTWQDAVVDLSK, 2+ Figure 2.1A 
 
M+2H2+ 738.3908 0.0003 
y1 147.1137 0.0009 
W 159.0920 0.0003 
b2 215.1390 <0.0001 
y2 234.1462 0.0014 
a3 228.1353 -0.0565 
b3 316.1869 0.0002 
y3 347.2306 0.0017 
y4 462.2572 0.0014 
b4-H2O 484.2552 -0.0002 
y5 561.3251 0.0008 
y102+ 580.8023 0.0014 
b5 630.3246 <0.0001 
y6 660.3937 0.0010 
M+2H-H2O
2+ 729.3871 0.0017 
y7 731.4308 0.0010 
b7 798.3788 0.0007 
y8 846.4583 0.0016 
b8-H2O 897.4438 -0.0027 
b8 915.4359 0.0212 
y9-NH3 957.4907 0.0017 
y9 974.5158 0.0005 
y10 1160.5967 0.0021 
y11 1261.6462 0.0039 
      TLtWQDAVVDLSK, 2+ Figure 2.1B 
 
M+2H2+ 778.3737 -0.0002 
a2 187.1497 0.0056 
y2 234.1386 -0.0062 
a3-H3PO4 270.1226 -0.0586 
b3-H3PO4 298.1762 0.0001 
y3 347.2287 -0.0002 
a4-H3PO4 456.2486 0.0119 
y4 462.2569 0.0011 
b4-H3PO4 484.2588 0.0034 
y5 561.3211 -0.0032 
a5-H3PO4 584.2653 0.0538 
y112+-H3PO4 622.3277 0.0082 
y6 660.3964 0.0037 
y7 731.4267 0.0031 
y8 846.4567 <0.0001 
b8-H3PO4 897.4581 0.0116 
y9-NH3 957.4901 -0.0013 
y9 974.5103 -0.0050 
y10 1160.6106 0.0160 
y11-H3PO4 1243.6186 0.0131 
      tLtWQDAVVDLSK, 3+ Figure 2.1C 
 
y1-NH3 130.0638 -0.0225 
y1 147.1150 0.0022 
W 159.0918 0.0001 
y2 234.1453 0.0005 
y3 347.2340 0.0051 
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y4-H3PO4 444.2952 0.0499 
y4-NH3 445.2989 0.0696 
y4 462.2564 0.0006 
y92+ 487.2493 -0.5120 
y5 561.3338 -0.0589 
y6 660.3725 -0.0202 
y7 731.4297 -0.0001 
y8 846.4626 -0.0059 
b7-H3PO4 958.4760 0.0193 
y9 974.5057 -0.0096 
      ALAWQDAVVDLSK, 2+ Figure 2.1D 
 
a2 157.1359 0.0024 
b2 185.1309 0.0024 
y2 234.1481 0.0033 
b3 256.1688 0.0032 
y3 347.2329 0.0040 
a4 414.2514 0.0014 
b4 442.2481 0.0032 
y4 462.2604 0.0046 
y5 561.3287 0.0044 
y102+ 580.8058 0.0049 
y6 660.3976 0.0049 
M+2H2+ 708.3832 0.0031 
y7 731.4336 0.0038 
y8 846.4621 0.0054 
y9-NH3 957.4949 0.0061 
y9 974.5219 0.0066 
y10 1160.6023 0.0077 
y11-H2O 1213.6212 <0.0001 
y11 1231.6395 0.0078 
      tLAWQDAVVDLSK, 2+ Figure 2.1E 
 a3-H3PO4 240.1758 0.0051 
b3-H3PO4 268.1670 0.0014 
y3 347.2315 0.0017 
y4 462.2570 0.0012 
y5 561.3269 0.0026 
b5-H3PO4 582.3133 0.0098 
M+2H-H3PO4
2+ 714.3801 <0.0001 
M+2H2+ 763.3769 0.0084 
y8 846.4580 0.0013 
y9-NH3 957.4791 -0.0097 
y9 974.5242 0.0089 
y10 1160.6018 0.0072 
y11 1231.6289 -0.0028 
      GDDTIFLSK, 2+ Figure 2.2A 
 
a2 145.0611 0.0003 
y1 147.1131 0.0003 
b2 173.0560 0.0003 
y2 234.1457 0.0009 
b3 288.0839 0.0013 
y3 347.2300 0.0012 
b4-H2O 371.1213 0.0016 
b4 389.1316 0.0013 
M+2H-H2O
2+ 489.2527 0.0021 
y4 494.2972 -0.0001 
M+2H2+ 498.2563 0.0008 
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y5 607.3818 0.0004 
y6 708.4297 0.0006 
y7-H2O 805.4465 0.0011 
y7 823.4566 0.0006 
      GDDtIFLSK, 2+ Figure 2.2B 
 
a2 145.0667 0.0059 
y1 147.1155 0.0027 
b2 173.0548 -0.0009 
y2 234.1452 0.0004 
b3 288.0808 0.0018 
y3 347.2307 0.0018 
b4-H3PO4 371.1197 <0.0001 
y7-H3PO4 
2+ 403.2272 0.0008 
b5-H3PO4 484.2046 0.0008 
M+2H-H3PO4
2+ 489.2523 0.0017 
y4 494.2996 0.0023 
M+2H2+ 538.2377 -0.0026 
y5 607.3747 0.0067 
b6-H3PO4 631.2717 -0.0005 
y6-H3PO4 690.4173 -0.0012 
b7-H3PO4 744.3632 0.0069 
y6 788.4078 0.0124 
y7-H3PO4 805.4371 -0.0083 
b8-H3PO4 831.4328 0.0445 
y7 903.4244 0.0021 
      GDDAIFLSK, 2+ Figure 2.2C 
 
a2 145.0622 0.0014 
y1 147.1139 0.0011 
b2 173.0571 0.0014 
y2 234.1470 0.0022 
b3 288.0856 0.0030 
y3 347.2322 0.0033 
b4 359.1227 0.0030 
M+2H2+ 483.2340 -0.0166 
y4 494.3006 0.0033 
y5 607.3846 0.0032 
b6 619.2752 0.0030 
y6 678.4231 0.0046 
b7 732.3587 0.0024 
y7-H2O 775.4364 0.0015 
y7 793.4499 0.0045 
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Figure 2.3: Overlaid chromatograms of six transitions specific to the doubly 
phosphorylated GraR peptide tLtWQDAVVDLSK from a tryptic digest of GraR after 
treatment with Stk1 and ATP.  Data from the entire analytical gradient is shown to 
illustrate the specificity of the transitions, which appeared simultaneously in a single 
peak.  All transitions shared the same precursor ion with m/z 545.9 Th, corresponding to 
the triply charged phosphopeptide ion. The identities of the product ions are shown in the 
inset which includes data from 20.5 to 22.5 minutes.  The product ion mass window was 
+0.025 Th for each transition. 
 
Figure 2.4: Sequence alignment of GraR and BceR, its homologue in B. Subtilis, in the 
region containing the Stk1 interaction site. The Stk1 phosphorylation sites on GraR and 
their equivalents on BceR are indicated by arrows. 
VraR phosphorylation by acetyl phosphate  
The region flanking VraR D55 has few Lys and Arg residues, resulting in a fully tryptic 
peptide 28 amino acids long (AHELKPDLILMDLLMEDMDGVEATTQIK), the C-
terminus of which is next to a Lys and therefore potentially forms ragged ends.  The fully 
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tryptic peptide eluted late in the LC gradient as a narrow, well resolved peak; however, it 
was highly retained on the chromatographic system and carried over in considerable 
amounts into successive runs following the sample. Glu-C digestion produced a group of 
shorter peptides containing D55 having equally well resolved but earlier chromatographic 
peaks than their tryptic counterpart. Glu-C gave the fully cleaved species LILMD (Figure 
2.5) as well as the partially cleaved LILMDLLME, LKPDLILMD and 
LKPDLILMDLLME (Figure 2.6).  
Exposure to NaBH4 did not alter the mass of D55 from purified VraR, however a 14 Da 
mass shift was observed after the protein was treated with acetyl phosphate then reduced 
(Figures 2.5 and 2.6).  The mass shift corresponded to the replacement of Asp with Hse, a 
structural isomer of threonine.  The masses of small neutral species commonly lost from 
peptide ions differ significantly from the change induced by Asp to Hse conversion.  
Water and ammonia loss alter the precursor ion mass by 18 and 17 Da, respectively, and 
therefore phospho-Asp reduction resulted in a distinctive mass shift, one discernable even 
on a relatively low resolution mass spectrometer such as a triple-quadrupole instrument.  
Product ion spectra of each Glu-C cleavage variant confirmed D55 to be the reduced 
residue, indicating that it was phosphorylated by acetyl phosphate (Figure 2.7). As 
evidenced by MS and MS/MS data from peptides having missed cleavage sites, neither 
D50 nor E59 was affected by NaBH4  (Figures 2.6, 2.7 and 2.8 and Table 2.2).  A 
representative product ion spectrum from LILM-Hse-LLME depicted in Figure 2.7 
includes the entire b-ion series and all but one y-ion with b5 to b8 and y5 to y7 having m/z 
values reflective of the loss of one oxygen along with the gain of two hydrogen atoms.  
The b2 to b4 and y1 to y4 ions in contrast had m/z values identical to those from the 
unmodified peptide ion.  The peptide LKPDLILM-Hse-LLME also dissociated 
extensively so that all but one of its y-ions and every b-ion save one were detected 
(Figure 2.8, Table 2.2).  From these findings it can be concluded that both the 
phosphorylation and the reduction were highly site-specific.  Since acetyl phosphate is a 
small molecule which can presumably access much of the protein sequence, it follows 
that VraR actively participates in its own phosphorylation at D55.  Reduced D55 
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remained a Glu-C cleavage site, though the prominence of peptides with missed 
cleavages suggested Glu-C efficiency may be compromised by removal of the aspartate 
carboxyl-group. 
LC elution profiles of the peptides and analogous reduced peptides were consistent and 
their similar chromatographic behaviour is reasonable since threonine and aspartic acid 
differ in their indices of hydropathy by 2.8 on a scale 9 units in magnitude (34).  
Coelution could be advantageous in the quantification of activated VraR since this assures 
uniformity of LC-MS matrix effects. 
Phosphorylated-reduced VraR peptide ions were consistently lower in abundance than the 
unmodified versions.  This finding was consistent with the observation that acetyl 
phosphate yields phospho-VraR hundreds of times more slowly than does phospho-VraS 
at the concentration used here (17). The fully cleaved peptides LILMD and LILM-Hse 
differed in abundance by three orders of magnitude but both fragmented extensively to 
give b- and y-ions which had consistent relative abundances between the reduced and 
unmodified species (Figure 2.5).  Despite their limited size and low basicity relative to 
tryptic peptides, these species formed mainly doubly charged ions.  
Both LILMDLLME and LKPDLILMDLLME formed doubly protonated ions yielding 
extensive sequence information upon CAD in their unmodified and reduced forms.  The 
peptide LKPDLILMDLLME at m/z 772.43 Th eluted less than a minute earlier than 
LILMDLLME at m/z 545.80 Th as did their respective reduced versions (Figure 2.6).  
MS signals of LILM-Hse-LLME and LKPDLILM-Hse-LLME prepared from the purified 
recombinant were approximately 10% those of unmodified forms remaining after 
treatment but reached 50 to 70% in E.coli lysate.  The chromatographic properties of the 
LILMDLLME and LKPDLILMDLLME ions were comparable in the presence and 
absence of soluble E.coli protein however their signals decreased by an order of 
magnitude in the lysate which may account for the apparent increase in phosphorylation 
efficiency.  While purified VraR samples contained single analytes with m/z values 
corresponding to those of the peptides of interest, many isobaric species were present in 
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cell lysates though with markedly dissimilar retention times and product ion spectra 
(Figure 2.6 C and D). 
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Figure 2.5: Chromatograms of MRM transitions corresponding to the fully cleaved Glu-C 
peptide LILMD in unmodified and reduced forms from purified recombinant VraR.  
Peaks from each transition are labelled according to their precursor/product ion m/z. 
Signals for (A) LILMD from NaBH4-treated protein, (B) LILM-Hse from NaBH4-treated 
protein, (C) LILMD from acetyl phosphate phosphorylated NaBH4-treated protein (D) 
LILM-Hse from acetyl phosphate phosphorylated NaBH4-treated protein.  In order to 
eliminate potential carryover, three blank runs were performed between each sample run, 
which reduced the transition signals to baseline intensity. A single acquisition method 
was used to run the blanks and samples. 
Sample complexity obscures VraR D55 phosphorylation state 
Hse55-containing peptides were detected in crude lysates of VraR-overexpressing E.coli 
subjected to acetyl phosphate/NaBH4 treatment (Figure 2.6D and 2.8), demonstrating that 
conditions under which VraR was modified were largely unaffected by the presence of 
other soluble proteins, however recombinant VraR represented a large fraction of total 
protein in this sample.  Lower limits of detection for both D55 and Hse55 were 
established by spiking S. aureus lysate with phospho-VraR.  Signals for both 
LKPDLILMD (529.3 Th, doubly charged) and LKPDLILM-Hse (522.3 Th, doubly 
charged) were observed only at the highest phospho-VraR concentration used, an amount 
of lysate equivalent to 2 µg of recombinant VraR in a total protein background of 1 mg.  
D55 alone was observed in the sample spiked with ten times less phospho-VraR, or 0.2 
µg in 1 mg of lysate protein.  Based on these finding, the limit of detection for Hse55 was 
estimated to be 1 µg per 1 mg lysate protein based on the assumption that half the total 
amount of VraR added was phosphorylated (17) (data not shown).  Only SDS-PAGE was 
used to purify the protein prior to digestion and the VraR band was not discernable by 
Coomassie blue staining against a background of other proteins.  Inclusion of matrix 
proteins, rather than VraR concentration, therefore increased the limit of detection beyond 
biologically relevant concentrations. 
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Hse55 was not observed in S.aureus MU50 cultured in the presence of oxacillin.  Low 
intracellular VraR concentration was confirmed by SDS-PAGE and resulted in low 
signals for the unmodified peptides of interest.  The apparent VraR concentration of the 
immunoprecipitate was low and the expected modification was not detected.  It is feasible 
that the antibiotic exposure period used was excessive since phospho-VraR is 
dephosphorylated in less than five minutes following phosphorylation by VraS (17).  It 
may be possible to follow the kinetics with a time-course study of MU50 oxacillin or 
vancomycin exposure.  
Figure 2.6: Qq-TOF-MRMhr spectra of Glu-C cleaved D55-containing peptides from 
purified recombinant VraR and E.coli lysates.  All samples were NaBH4 reduced, 
digested with Glu-C then collected by zip tip prior to LC-MS/MS.  The data was 
processed with the XIC Manager function of PeakView
TM
 using a mass width of 0.02 Da 
over the entire data acquisition period. (A) Untreated recombinant VraR, (B) acetyl 
phosphate treated VraR, (C) untreated lysate from E.coli overexpressing VraR, (D) acetyl 
phosphate treated lysate from E.coli overexpressing VraR. Inset of panel D is the region 
of the chromatogram between 23 and 24 minutes by which the reduced peptides can be 
distinguished from their co-eluting unmodified variants. 
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Figure 2.7: MS/MS spectrum of the doubly protonated peptide ion LILM-Hse-LLME 
(m/z  538.8 Th) from a Glu-C digest of acetyl phosphate-treated NaBH4-reduced purified 
recombinant VraR.  This spectrum was collected 23.512 minutes into the LC-MS run 
shown in Figure 2.6B. 
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Figure 2.8: MS/MS spectrum of the doubly protonated peptide ion LKPDLILM-Hse-
LLME (m/z 765.4 Th) from a Glu-C digest of lysate from E. coli expressing VraR after 
incubation with acetyl phosphate then NaBH4.  This spectrum was collected 23.338 
minutes into the LC-MS run shown in Figure 2.6D. 
 
 
Table 2.2: Mass accuracies of ions observed in MS/MS spectra of Glu-C VraR peptides 
enclosing reduced D55. 
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Ion
Observed monoisotopic 
m/z (Th)
Error (Th)
LILM-Hse-LLME, 2+
y1 148.0620 0.0016
b2 227.1778 0.0024
y2 279.1033 0.0024
b3 340.2620 0.0025
y3 392.1877 0.0027
b4 471.3025 0.0025
y4 505.2725 0.0035
M+2H2+ 538.8119 0.0036
b5 572.3512 0.0036
y5 606.3213 0.0046
b6 685.4363 0.0046
y6 737.3607 0.0035
b7 798.5158 0.0000
y7 850.4441 0.0028
b8 929.5632 0.0070
LKPDLILM-Hse-LLME, 2+
y1 148.0592 -0.0012
b2 242.1865 0.0002
y2 279.1015 0.0006
y3 392.1844 -0.0006
b4 454.2678 0.0018
y4 505.2675 -0.0015
b5 567.3532 0.0031
y5 606.3143 -0.0024
b6 680.4336 -0.0005
y6 737.3584 0.0012
M+2H2+ 765.4372 -0.0005
b7 793.5116 -0.0066
y7 850.4422 0.0009
b8 924.5501 -0.0086
y8 963.5248 -0.0005
b9 1025.6072 0.0008
y9 1076.6061 -0.0033
b10 1138.6905 0.0001
b11 1251.7744 -0.0001
y11 1288.6826 -0.0065
b12 1382.8101 -0.0049
y12 1416.7818 -0.0023
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Figure 2.9:  Proposed antibiotic response mechanisms involving VraSR, GraSR and 
Stk1/GraR.  The unique extracellular ligands of each cell surface receptor are represented 
by different shapes.  Each receptor is autophosphorylated upon binding its extracellular 
ligand then phosphorylates its cognate response regulator.  VraS and GraS phosphorylate 
residues D55 and D51 of VraR and GraR respectively.  Stk1 phosphorylates GraR T128, 
T130 and T149.  Modification of the response regulators enhances their affinity for their 
respective promoters, leading to DNA binding and subsequent transcription initiation.  
Dephosphorylation causes detachment of the response regulators from the chromosome.     
GraR and VraR aspartate dephosphorylation can occur in the absence of a separate 
phosphatase whereas an unknown phosphatase, possibly Stp1, may act on GraR 
phosphothreonine residues. 
2.4 Conclusion 
In the above study, LC-MS/MS allowed the determination of phosphorylation sites within 
two S. aureus RRs known to mediate antibiotic resistance, namely VraR and GraR.  A 
cell lysate-compatible method for the study of VraR activation showed that VraR D55 is a 
phosphate acceptor, in agreement with indirect evidence previously reported.  Isolation of 
the region containing D55 required compromise between a tryptic peptide with 
unfavourable RPLC retention and ineffective Glu-C digestion. Endogenous VraR 
concentration remains the most significant barrier to its characterization.  
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The Stk1 and GraS phosphorylation sites are notably at the C-terminal DNA-binding 
domain and N-terminal TCS regulatory domain of GraR respectively.  The two GraR 
phosphodonors therefore act on different regions of the protein, unlike VraR which has 
two possible in vivo phosphodonors for the same site.  This suggests differential 
regulation, wherein the two sensors induce alternate active forms of the RR.  Threonine 
residues 128, 130 and 149 are distributed throughout a sequence rich in potential 
phosphate acceptors so that site-directed mutagenesis was required to discern them as 
Stk1 targets. 
Novel therapeutics are needed for the treatment of infection by multidrug resistant 
pathogens.  Elucidation of the systems by which these organisms survive current 
treatments may inform the design of compounds exploiting or circumventing them.  The 
complete description of VraSR and GraSR signalling, which initiates much of the S. 
aureus adaptive response, represents a step toward the management of this clinical 
challenge. 
2.5 Contributors 
All cloning, recombinant protein expression, recombinant protein purification, SDS-
PAGE, in vitro protein phosphorylation and wall teichoic acid isolation was performed by 
Michael Fridman (M.Sc.).  The reduction protocol was optimized by this author in 
collaboration with Michael Fridman.  Howard Hunter (Ph.D.) performed 
1
H-NMR 
analysis and interpreted the NMR results.  This author performed all sample preparation 
beyond SDS-PAGE including NaBH4 reduction and proteolytic digestion in the work 
presented above, as well as the acquisition, processing and interpretation of all LC-MS 
data.  The VraR immunoprecipitation experiment was carried out entirely by this author. 
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Chapter 3 
Phosphorylation of Zea mays Starch branching enzyme IIb by 
multiple calcium-dependent kinases of the amyloplast 
 
3.1 Introduction 
Starch is a mixture of highly-branched, high molecular weight polysaccharides 
synthesized by green algae and plants as an energy store.  The notable hydrophobicity and 
density of this macromolecular assembly have stabilizing effects advantageous to their 
long-term intracellular sequestration.  Seed endosperms contain the starch used by 
developing plant embryos in early growth and are a key source of dietary carbohydrates 
for livestock and humans.  In addition to its use as a foodstuff, starch has myriad 
applications as an industrial feedstock. For these reasons it is a globally traded 
commodity. Corn, Zea mays, accounts for the majority of global cereal production and is 
therefore the most widely available source of starch. 
Amylopectin and amylose, which are both composed exclusively of glucose monomers, 
are the two polysaccharide components of starches.  Amylopectin, the more prevalent of 
the two, contains both α-(1→4)-O bonds and α-(1→6)-O bonds whereas amylose has 
only α-(1→4)-O-linkages.  Chains of α-(1→4)-O bound glucose make up amylopectin 
strands, with α-(1→6)-O-linkages forming branch points between them (1).  The length 
of the core chain as well as the length and number of branches vary, reflecting the 
behaviour of the enzyme complex responsible for their biosynthesis.  Physicochemical 
properties of amylopectin depend on its structure, with the pattern of branching 
contributing more than chain length (2). 
At the macroscopic level, starch is assembled into granules whose conformation and 
chemistry have ramifications for the survival of the plant as well as its utility to humans.  
These factors are affected by amylopectin structure, for example a wheat mutant lacking 
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the starch granule protein (SGP-1) involved in amylopectin synthesis makes deformed 
granules and rice mutants with similar defects produce starch of low digestibility (3, 4). 
Developing endosperms generate starch for long term storage in specialized organelles 
called amyloplasts.  Proteins make up around 1% of the mass of the starch granule, many 
of them mediating its formation (1).  The starch synthesis machinery includes multiple 
gene products which differ among tissues of the same plant, presumably due to their 
unique energy requirements.  In maize, four soluble starch synthases, (SSI to IV) are 
responsible for the production of amylopectin strands, each SS isoform producing α-
glucan (polyglucose) chains of different length.  The related granule-bound starch 
synthase I (GBSSI) is thought to produce amylose of varying chain length and is strongly 
associated with the granule (5). The Starch branching enzyme (SBE) family of proteins 
add glucose residues to the α-glucan via hydrolytic cleavage of internal α-(1→4) bonds 
and reaction of the freed reducing ends with the C6 hydroxyl group of glucose (6).  
Debranching enzymes, which are required for normal granule formation, are also present 
(7).  Two SBE classes are known in maize, termed SbeI and SbeII, and these differ in the 
lengths of the glucan chains they transfer, the size of substrate they modify and their sites 
of action. SbeI has been shown to possess high amylose affinity, while SbeII displays a 
preference for amylopectin to which it transfers shorter α-glucan chains (8).  The two 
maize SbeII subtypes are known as SbeIIa and SbeIIb and they differ in their tissue 
distribution and catalytic behaviour (9, 10).  As the most abundant protein in the maize 
amylopast stroma, SbeIIb is expressed in at concentrations many times higher than SbeIIa 
throughout the endosperm (11, 12). 
Amylopectin synthesising proteins work in multi-subunit complexes.  In corn SSI, SSIIa 
and SbeIIb have been shown to congregate (13, 14) .  The components of this trimeric 
network eventually become entangled within the starch granule through the glucan-
binding capacity of SSIIa (15). SbeIIb also appears to form a protein complex with SbeI 
and starch phosphorylase (SP) (16).  These complexes are dynamic in that the loss of one 
member through mutation can be compensated by other members so that while their final 
product is altered, the plant remains viable.  For example, SbeIIa associates with many 
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SbeIIb binding partners and some additional proteins in the absence of functional SbeIIb 
and similarly SbeI replaces its interaction with SbeIIb in the knockout mutant, instead 
binding SSI along with SSIIa, SbeIIa and SP (Table 3.1).  That such protein-protein 
associations can vary dramatically, arise from mutations of a single gene and are found in 
nature suggests a powerful mechanism of evolutionary adaptation. 
Protein-protein interaction within the starch-synthesis machinery is dependent on its 
phosphorylation but no phosphorylation sites within starch synthesis proteins have been 
characterized prior to the study reported here (17).  SbeIIb was chosen for phosphosite 
analysis since it is known to be phosphorylated and phenotypes arising from its mutation 
have been extensively characterized. 
 Genotype/Bait protein no treatment phosphatase ATP phosphatase+ATP
wild type
SSI SSI, SSIIa, SbeIIb NA NA NA
SSIIa SSI, SSIIa, SbeIIb SSIIa, SbeIIb SSI, SSIIa, SbeIIb SSI, SSIIa, SbeIIb
SbeI SbeI, SbeIIb NA NA NA
SbeIIb SSI, SSIIa  SbeI, SbeIIb SbeIIb SSI, SSIIa  SbeI, SbeIIb NA
ae-1.1
SSI SSI, SSIIa, SbeI, SbeIIa, SP NA NA NA
SSIIa SSI, SSIIa, SbeI, SbeIIa, SP SSI, SSIIa, SbeI SSI, SSIIa, SbeI NA
SbeI SSI, SSIIa  SbeI, SbeIIa, SP NA NA NA
 
Table 3.1: Co-immunoprecipitation of starch synthesizing proteins from functional 
endosperm amyloplast lysates of wild type and SbeIIb deficient maize.  Bait protein refers 
to the antigen of the antibody used.   Amyloplasts were untreated or incubated with 1 mM 
ATP or E. coli alkaline phosphatase for 30 minutes at 25
o
C prior to immobilization of the 
bait proteins indicated.  The presence of each interacting protein was probed by western 
blot.  Adapted from Liu et al, 2009 (16).  Data for SP were reported only where SSI, 
SSIIa and SbeI were used as bait. 
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Figure 3.1:  Two known starch biosynthesis protein complexes containing SbeIIb in 
maize. SP may also bind the SbeI/SbeIIb complex. 
Maize SbeIIb structure and function 
The full length maize SbeIIb transcript is translated into a 91 kDa, 799 amino acid 
preproprotein including a 61 residue N-terminal domain which mediates its migration to 
the amyloplasts and is then removed to form the mature protein (18).  The mature form 
contains 48 serine, 31 threonine and 41 tyrosine residues, each of them a potential 
phosphosite.  The N-terminal carbohydrate binding domain, C-terminal substrate 
specificity domain and central catalytic domain contains conserved among SBEs are all 
present in SbeIIb (9, 10).  
Maize SbeIIb is phosphorylated in the granule and its catalytic activity and affinity for 
various proteins of the starch biosynthesis complex have been shown to be modulated by 
its phosphorylation state (13, 16, 19).  A viable maize mutant lacking SbeIIb called 
amylose extender (ae
-
1.1) exists. A related catalytically inactive SbeIIb mutant with a 
deletion spanning Val272 to Pro299, called ae
-
1.2, is associated with starch that differs 
from both ae
-
1.1 and wild type maize.  Granules from wild type, ae
-
1.1 and ae
-
1.2 are 
successively smaller, lower in starch content and more irregular in texture.  The ae
-
1.1 
and ae
-
1.2 starches have fewer but longer glucan branches than wild type.  Table 3.1 
compares the protein networks of SbeIIb under conditions favourable to and inhibitory to 
protein phosphorylation and indicates that interactions between SbeIIb and SSI as well as 
SbeIIb and SbeI are dependent on phosphorylation but that attachment of SSIIa to SbeIIb 
is not.  Addition of alkaline phosphatase to wild type amyloplast lysates appeared to 
abrogate the association of SbeIIb with all other proteins as assessed by SbeIIb 
immunoprecipitation however SbeIIb was detected in SSIIa immunoprecipitates under the 
same conditions.  It is not clear which interactions of SbeIIb are direct.  In addition, free 
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SbeIIb was shown to be phosphorylated within the plastid stroma, suggesting a role for 
the modification beyond coordinating protein binding (17).  The sequence from Val272 to 
Pro299 (VFRHAQPKRPKSLRIYETHVGMSS) harbours three serine, one tyrosine and 
one threonine residue and could therefore accommodate multiple phosphates.  At least 
one phosphosite outside of this region was assumed to exist since ae
-
1.2 was 
phosphorylated in vitro (13). 
LC-MS/MS was used to investigate SbeIIb modification in two ways.  First, targeted 
analysis of proteolytic SbeIIb peptides shown to be phosphorylated by amyloplast 
extracts revealed their differential phosphorylation at three sites by two or more 
endogenous kinases.  The affected residues were S286, S297 and S649.  Secondly, 
shotgun sequencing of partially purified amyloplast stroma identified putative SbeIIb 
kinases.  The kinase activity acting upon S649 and S286 was termed K1 and that activity 
acting on S649 and S297 was termed K2.  Fractions K1 and K2 contained different 
protein kinases which was consistent with the observation that they had different substrate 
specificities.  The contributions of this author to the work described in this chapter 
include all sample preparation for LC-MS/MS after the excision of gel bands, the 
collection and interpretation of all mass spectra. 
3.2 Methods and Materials 
Corn culture and endosperm amyloplast recovery   
The CG102 line of maize was grown in a field in Guelph, Ontario, Canada.  Whole cobs 
were harvested 20-25 days after pollination and from them were collected endosperm 
amyloplasts.  Amyloplasts isolation and subsequent protein collection were performed 
according to previously described methods (20).  Plastid disruption was conducted with 
100 mM Tricine/KOH, pH 7.8, 1 mM Na2-EDTA, 1 mM dithiothreitol (DTT), 5 mM 
MgCl2 and 10 μl/ml of protease inhibitor cocktail (G-Biosciences, St. Louis, MO, USA).  
The isolated plastid preparations were stored at -80˚C.  A single maize cob gave 
approximately 5 ml of amyloplasts with a total protein concentration of 1-2 mg/ml. 
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Recominant and synthetic SbeIIb polypeptides 
Synthetic peptides spanning Serine-containing sequences of SbeIIb with tri-Arginine C-
termini were produced by CanPeptide Inc. (Pointe-Claire, QC, Canada). These served as 
substrates for the amyloplast lysate kinase assay.  The sequence corresponding to 
processed, or mature, SbeIIb (residues 62-799, GenBank Accession L08065) with a fused 
N-terminal S-tag contained in the plasmid vector pET 29 (Novagen, EMD Millipore) was 
a gift from Dr. Alan Myers of Iowa State University, USA.  Truncated SbeIIb variants 
were created by PCR amplification of various segments of the coding sequence from the 
plasmid described above with subsequent ligation of each amplicon into pET29 and 
expression in E. coli ArcticExpress (Stratagene, La Jolla, CA, USA) upon induction with 
1 mM isopropyl-beta-D-thiogalactopyranoside.  Turbo polymerase was from Stratagene 
and deoxyribonucleoside 5’triphosphates were from Invitrogen (Burlington, ON, 
Canada).  Recombinant proteins were purified using a Novagen
TM
 Protein Refolding Kit 
then with size-exclusion chromatography on a Superdex 200 10/300GL gel permeation 
column from which monomeric and inactive aggregates eluted separately.  Sequences of 
all constructs were verified by DNA sequencing. Segments making up the truncated 
proteins were residues 62-732 (∆C1), 62-646 (∆C2), 62-562 (∆C3), 128-799 (∆N1), 214-
799 (∆N2) and 291-799 (∆N3).  Monomeric truncated proteins were used to isolate the 
location of phosphosites within the full length enzyme by amyloplast lysate kinase assay. 
The QuikChange site-directed mutagenesis kit (Stratagene) was employed to separately 
replace S286, S297 and S649 of the recombinant SbeIIb with alanine residues.  The S649 
recombinant gene served as the template for the production of double and triple mutants. 
Reaction mixtures included 2.5U/reaction of PfuTurbo™ DNA polymerase II (Agilent, 
Santa Clara, CA, USA), 50 ng of vector and 125 ng of each forward and reverse primer.  
Point mutants were expressed and purified according to the same protocol used for the 
truncated mutants. 
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Measurement of amyloplast kinase kinetics and activity 
The properties of kinases present in amyloplasts were determined based on their ability to 
radiolabel synthetic peptides or recombinant SbeIIb.  The assay was performed with 200 
µM of substrate and 10 µl of kinase preparation at pH 7.0 in 50 mM Tris-HCl, 1 mM 
DTT, 5 mM MgCl2 and 200µM of [γ-32P]-ATP for 10 min at 25˚C.  After this reaction 
period, the mixture was blotted onto phosphor-cellulose paper, washed in 1% (v/v) 
phosphoric acid then acetone and 
32
P measured with a Beckman Coulter LS6500 Multi-
Purpose liquid scintillation counter.  Radioactivity was normalized to protein content 
assessed with Coomassie blue staining. 
In vitro phosphorylation of recombinant SbeIIb and amyloplast stromal proteins 
In vitro SbeIIb phosphorylation was performed by two methods, both of which included 
amyloplasts proteins as the source of kinase. In one method, 20 µg of SbeIIb was added 
to 100 µl of endosperm plastid lysate (1-1.5 mg protein/ml) or partially purified protein 
kinase in the presence of ATP or [γ-32P]-ATP  (Perkin-Elmer, Waltham, MA, USA) and 
10 µl/ml Plant ProteaseArrest protease inhibitor mixture (G-Biosciences) for 30 minutes.  
Following exposure to ATP and kinases, S-tagged recombinant SbeIIb was collected on 
S-agarose beads over one hour. In the second method, 20 µg of monomeric recombinant 
SbeIIb was immobilized on S-protein agarose in the presence of protease inhibitors,  
unbound proteins were washed away in 20 mM Tris-HCl (pH 7.8), 0.15 M NaCl, 0.1% 
(v/v) Triton-X100 with 1 mM DTT then protein kinase and ATP were added to the 
washed beads. Phosphorylation was arrested in both methods by addition of Na2-EDTA 
to a final concentration of 20 mM. Each phosphorylated SbeIIb sample was heated at 
95˚C in loading buffer for 5 minutes prior to SDS-PAGE or digested with trypsin directly. 
Crude amyloplasts lysates were phosphorylated in vitro by the addition of [γ-32P]-ATP 
(0.5 µCi). 
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Detection of radiolabelled-phosphopeptides in RP-HPLC eluates 
In order to isolate phosphosites, kinase/[γ-32P]-ATP–treated SbeIIb was digested with 
trypsin and the products separated by RP-HPLC using a Gemini-NX 3μ C18 110A 
column (Phenomenex, Torrance, CA, USA) on an Agilent 1100 Series HPLC pump with 
a 38 minute mobile phase gradient from  0.1% (v/v) formic acid and acetonitrile with 
formic acid, which was converted from 95% to 0% water over.  Fractions containing 
phosphorylated peptides were identified with a Geiger counter, stored until no longer 
radioactive and subsequently analyzed by LC-MS/MS. 
Partial Purification of SbeIIb kinases 
SbeIIb kinase was partially purified from amyloplasts with an AKTA Explorer FPLC 
pump (Amersham Biosciences) at 4˚C. Initially, 10 to 12 ml of plastid lysate (5-10 mg of 
protein) was separated on a 1 ml HiTrap DEAE Sepharose Fast Flow column (GE 
Healthcare, Little Chalfont, UK) at a flow rate of 0.5 ml/min over a KCl gradient from 0 
to 1 M in mobile phase containing 100 mM Tricine-NaOH (pH 7.5), 7.5 mM MgCl2, 1 
mM DTT.  Kinase-containing fractions of the anion-exchange eluate were determined 
based on their ability to phosphorylate recombinant SbeIIb or synthetic SbeIIb peptides 
then pooled, desalted on a PD-10 column (GE Healthcare) and further separated on a 1 ml 
HiTrap Blue HP column (GE Healthcare) over a KCl gradient from 0 to 1.5 M.  Proteins 
were separated by glycine SDS-PAGE on 10% acrylamide gels.  Western blotting 
conducted with primary polyclonal rabbit anti-SbeIIb and anti-S-tag antibodies (AbCam, 
Cambridge, UK) confirmed the presence of SbeIIb. 
LC-MS/MS of SbeIIb and its kinases 
Prior to LC-MS/MS analysis of SbeIIb phosphorylation sites, the protein was separated 
by SDS-PAGE and bands equal in molecular mass to SbeIIb excised then subjected to in-
gel digestion. Coomassie Blue stain was removed from the isolated bands with water 
containing 50% acetonitrile (v/v).  The samples were washed twice with 100 mM 
ammonium bicarbonate (NH4HCO3) and reduced with 10 mM dithiothreitol in 100 mM 
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NH4HCO3 for 30 minutes at 60˚C then cooled to 21˚C.  Cysteine alkylation was 
performed with 20 mM iodoacetamide in 100 mM NH4HCO3 in the dark for one hour.  
Excess iodoacetamide was removed with two washes of 100 mM NH4HCO3.  The 
proteins were digested at 37˚C using 0.4 μg of endoproteinase Glu-C (Glu-C, Sigma-
Aldrich) per gel band for 16 h, then with 0.4 μg of endoproteinase Lys-C (Lys-C, Sigma-
Aldrich) per sample for 16 h.  Alternately 0.1 to 0.4 μg of trypsin was used in place of   
Glu-C and Lys-C.  Gel bands were washed with 100 μl volumes of water then 50% 
acetonitrile (v/v) and the washes were pooled, dried in a centrifugal concentrator, 
dissolved in aqueous 0.1 % (v/v) formic acid then purified using C18 zip tips (EMD 
Millipore, Darmstadt, Germany). 
Purified Glu-C/Lys-C and tryptic SbeIIb digests as well as tryptic digests of kinase 
isolates were analyzed by online nanoflow HPLC-MS/MS using a NanoLC-Ultra 2D 
HPLC pump coupled to a Nanoflex cHiPLC system and a TripleTOF 5600 Qq-TOF mass 
spectrometer (AB Sciex, Concord ON, Canada).  Peptides were loaded and washed on a 
0.5 mm long, 200 μm diameter trap (AB Sciex) and resolved on a 150 mm long, 75 μm 
diameter chromatographic column (AB Sciex).  The trap and the analytical column 
packing material consisted of 3 μm diameter C18 particles with 120Å pores.  Peptide 
separation was performed using a binary mobile phase gradient. Mobile phases A and B 
contained 0.1% (v/v) formic acid in water and acetonitrile respectively.  The following 
mobile phase B compositions were used: 2% at 0 min, 35% at 45 min, 80% from 46 to 50 
min, 2% from 51 to 60 min.  Nanospray emitters used were uncoated fused silica with 10 
micrometer ID tips (New Objective, Woburn, MA, USA). The mass spectrometer was 
operated in positive ion mode with an electrospray voltage of 2300 V.  The MS data 
acquisition cycle consisted of a single MS scan with a range of 400 to 1250 Th followed 
by MS/MS scans from 100 to 1800 Th of the most abundant ions detected in the 
preceding MS scan.  The number of MS/MS scans per MS scan was limited to twenty. 
Peptides and phosphopeptides were identified from the tandem mass spectra using 
ProteinPilot
TM
 software with phosphorylation emphasis and amino acid substitutions 
specified in the search parameters.  Separate searches of the dataset were conducted using 
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the RefSeq Zea mays library which contained 22444 sequences representing 7089707 
residues for peptide identifications (downloaded November 14, 2012). Glu-C/Lys-C 
digestion and cysteine carbamidomethylation were specified in the search terms and the 
confidence threshold for protein detection was set to 95%. 
For the identification of amyloplast kinases, plastid lysates were separated into the K1 
and K2 fractions as described above before reduction, alkylation with iodoacetamide and 
trypsin digestion.  Digests were dried then dissolved in aqueous 0.1% (v/v) formic acid 
and the peptides resolved over an hour long analytical gradient on the nano-LC system 
described above coupled to an Orbitrap Elite mass spectrometer via a Flex
TM
 ion source 
(Thermo Scientific, Waltham, MA) connected to the same type of emitter used for the 
Qq-TOF.  The data acquisition cycle began with a 30,000 resolution Orbitrap MS scan 
followed by MS/MS scans of the 10 most abundant precursor ions on the LTQ linear ion 
trap section of the instrument at normalized collision energy of 35, activation Q of 0.250 
and a 10 millisecond activation time.  Dynamic precursor exclusion was used with a 
repeat count of 1, repeat duration and exclusion duration both set to 15 seconds and an 
exclusion mass width of 10 ppm.  Mass calibration was continually adjusted over the 
course of the analysis using the lock mass function set to 371.101240 Th, the m/z of a 
ubiquitous indoor air contaminant. 
MS/MS data were searched with SEQUEST navigated through ProteomeDiscoverer 
software using the same FASTA format Zea mays sequence library as for the Qq-TOF 
data.  Search settings were as follows: precursor mass range: 290-5000 Da; minimum 
peak count: 1; enzyme: trypsin; maximum missed cleavages: 2; product ion series 
considered: b and y; dynamic modifications: methionine oxidation (+15.995 Da), 
phosphorylation (S, T and Y at +79.966 Da) and glutamine deamidation (+0.984 Da); 
static modification:  carbamidomethyl cysteine (+57.021 Da). 
The predicted tertiary structure of SbeIIb 
Three-dimensional modelling of SbeIIb predicted the position and role of each 
phosphosite in its tertiary structure.  The sequence of the processed 738 residue protein 
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with the N-terminal sub-cellular localizing transit peptide region absent was used for in 
silico simulations. The initial structure was predicted using I-Tasser (21).  Interrogation of 
the Protein Data Bank structure library showed SbeI from Asian rice (Oryza sativa L.) to 
be the most homologous to maize SbeIIb so this was used in the initial structure 
prediction.  Due to low sequence homology between SbeIIb and rice SBEI, the 55 N-
terminal residues were not simulated.  SbeIIb molecular dynamics were modelled on the 
GROMACS version 4.5.5 software suite with the Gromos96 ffG53a6 force-field adapted 
for phosphorylated serine residues using an existing model obtained from the GROMACS 
user contribution forum, with partial charges and Van der Waals values for the atoms in 
the phosphate group (22).  Phosphates were added to serine residues with SYBYL-X 1.3 
molecular modeling software (Tripos Associates, St. Louis, MO, USA) with charge of -2 
applied to each group. Terminal residues were assigned net charges of zero as were 
histidine side chains. Eight different SbeIIb structures were modelled, including the 
unmodified protein,  the protein phosphorylated at S286, phosphorylated at S297, 
phosphorylated at S649, simultaneously phosphorylated at S286 and S297 or at S286 and 
S649 or at S297 and S649 and triply phosphorylated at S286, S297 and S649.  
Simulations were run on Compute Calcul Canada’s SHARCNET computer cluster, 
accessed via www.sharcnet.ca.  The hypothetical folding space enclosing each model was 
a cube allowing a minimum gap of 1 nm distance from the protein to the perimeter. The 
cube was populated with water molecules, sodium and chlorine ions to a salt 
concentration of 0.15 M. Folding was simulated for 100 ns. 
3.3 Results 
Three modified amino acids from amyloplast treated SbeIIb were observed by targeted 
MS/MS while data-dependent acquisition of kinase-active amyloplast anion exchange 
chromatography eluates showed them to contain multiple fraction-specific protein 
kinases. 
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SbeIIb phosphosite localization using truncated variants and synthetic peptides 
S649 was indicated as the main site of SbeIIb
 
phosphorylation using a kinase assay 
performed on a series of recombinant and synthetic polypeptide substrates. The same 
assay also showed S286 and S297 to be potential kinase substrates.  Recombinant SbeIIb 
was readily phosphorylated in the presence of amyloplast lysates and ATP, as the 
endogenous equivalent and the ae
-
1.2 mutant were shown to be in previous work (13).  
Recombinant maize SbeIIb mutants with portions of their N- or C-terminal sequences 
were produced in E. coli and tested for reactivity with amyloplasts lysates to establish 
through a process of elimination the regions of the protein affected by kinase activity.  
The truncations were designed to maximize sequence coverage of the mature sequence of 
SbeIIb while isolating potential phosphosites.  The sequence spanning residues 62-732 
underwent 
32
P-labelling to a degree equivalent to the full-length protein while 
radiolabelling of the 62-646 and 62-562 truncations was very low.  From this data it could 
be concluded that multiple residues between M62 and S732 were modified and that the 
region from 646-732 received the most labelling.  Putative phosphorylation sites within 
this region determined by NetPhos 2.0 at probability greater than 90% were incorporated 
into synthetic peptides which separately covered S649, S286 and S297 (23). A synthetic 
peptide containing the sequence surrounding S649 (PRGPQRLPSGKFIPGNRRR) was 
synthesized and shown to be phosphorylated by the same amyloplast preparation.  
Addition of the synthetic S649 peptide to either native or recombinant SbeIIb in 
micromolar concentrations inhibited their phosphorylation whereas other endogenous 
amyloplast proteins were readily 
32
P-labelled in its presence. 
Two endogenous kinase modalities with distinct specificities for three SbeIIb regions 
were resolved by anion exchange chromatography of amyloplast lysates and these were 
termed K1 and K2, reflecting the order of their elution (Figure 3.2).  That the SbeIIb 
kinases were present in the same sub-cellular compartment suggests a biological role for 
its modification.  Synthetic peptide S649 was readily modified by both fractions.  Peptide 
S286 was phosphorylated exclusively by K1 while peptide S297 was phosphorylated 
exclusively by K2.  Both S286 and S297 underwent much less modification than did 
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S649 with either fraction.  Amyloplast isolates typically contained less than 1% protein 
contamination from the remainder of the cell, suggesting the SbeIIb kinases were specific 
to the organelle (24). 
 
Figure 3.2:  Rates of synthetic peptide phosphorylation upon treatment with anion 
exchange chromatography fractions of amyloplast lysate.  Each curve shows the reaction 
of a different synthetic peptide.  K1 appeared most concentrated in fraction 4 whereas K2 
was apparently most concentrated in fraction 9.  A synthetic peptide equivalent to SbeIIb 
S147 and the region flanking it was used as a negative control. Adapted from 
Makhmoudova et al. 2014 (24). 
Wild type and S649A point mutants were both radiolabelled with [γ-32P]-ATP by K1 and 
K2, though the signals of S649A were much weaker.  S649A had equivalent enzymatic 
activity to the wild type protein based on in vitro phosphorylase stimulation, suggesting 
the site to be more important for protein-protein interaction than catalysis.  In contrast, 
mutation of S286 or S297 significantly lowered catalytic activity.  That S286 and S297 
are conserved in all known plant SBEs supports the conclusion that they are involved in 
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the starch branching reaction.  S286A/S649A and S297A/S649A double point mutants 
were used to verify the specificities of K1 and K2 since both fractions affected S649 
disproportionately.  The S286A/S649A mutation abrogated 
32
P-labelling by K1 and 
S297A/S649A was not labelled by K2. 
K1 and K2 had high specificities for their substrates as indicated by micromolar 
Michaelis constants (Km) using the synthetic peptides (24). Catalytic activities of both 
kinase fractions for each of the three peptides varied with Ca
2+
 concentration and even 1 
mM of Na2-EGTA reduced activities of both fractions on the S649 synthetic peptide by 
two orders of magnitude while Ca
2+
 at concentrations as low as 5 μM eliminated the 
inhibitory effect of EGTA.  Kinase activity was lowest in the case of K2 acting on the 
S297 peptide (Figure 3.2). 
Molecular dynamics simulation analysis of SbeIIb  
Though structural rearrangement was simulated for 100 ns, most took place in the first 10 
ns at which point a steady state was achieved, consistent with a highly favoured 
conformation.  S286, S297 and S649 all migrated to the protein surface at disordered 
loops where they were presumably kinase accessible.  S286 and S297 located to opposite 
sides of a central β-barrel.  Simulations of the phospho-SbeIIb variants showed minimal 
change in the overall structure took place.  Salt-bridging between phosphate groups and 
several Arg and Lys residues stabilized conformation, for instance phospho-S286 
interacted with K285 as well as R288 as did phospho-S297 and Arg665 (24).  These data 
indicate that each serine residue is a reasonable phosphosite and that the phosphorylation 
states of S286 and S297 control the structure of the catalytic domain. 
LC-MS/MS of SbeIIb phosphorylation sites 
The three putative SbeIIb residues were observed in their unmodified, alanine point 
mutated and singly phosphorylated states by LC-MS/MS.  It is apparent from the 
sequence of maize SbeIIb (Figure 3.3) that S286 and S649 are each separated from tryptic 
cleavage sites by no more than two amino acids at their N- and C-termini.  To produce 
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larger peptides encompassing these sites, double digestion with Glu-C and Lys-C was 
employed.  The larger peptides gave more MS/MS sequence information, had masses 
better suited to the instrument mass range and potentially had more favorable C18 
retention properties than shorter tryptic equivalents.  Signal intensities of the 
phosphopeptide precursor ions were low compared to the corresponding peptide ions 
however this was compensated by high resolution Qq-TOF spectra having low noise.  
Table 3.2 shows that product ions of SbeIIb phosphopeptides had m/z values differing 
from theory by less than 0.02 Th on average. 
(MAFRVSGAVLGGAVRAPRLTGGGEGSLVFRHTGLFLTRGARVGCSGTHGAMRAAAAARKAV)MVP
EGENDGLASGADSAQFQSDELEVPDISEETTCGAGVADAQALNRVRVVPPPSDGQKIFQIDPMLQGY
KYHLEYRYSLYRRIRSDIDEHEGGLEAFSRSYEKFGFNRSAEGITYREWAPGAFSAALVGDFNNWDP
NADRMSKNEFGVWEIFLPNNADGTSPIPHGSRVKVRMDTPSGIKDSIPAWIKYSVQAPGEIPYNGIYY
DPPEEVKYVFRHAQPKRPKSLRIYETHVGMSSPEPKINTYVNFRDEVLPRIKKLGYNAVQIMAIQEHSY
YGSFGYHVTNFFAPSSRFGTPEDLKSLIDRAHELGLLVLMDVVHSHASSNTLDGLNGFDGTDTHYFHS
GPRGHHWMWDSRLFNYGNWEVLRFLLSNARWWLEEYKFDGFRFDGVTSMMYTHHGLQVTFTGNF
NEYFGFATDVDAVVYLMLVNDLIHGLYPEAVTIGEDVSGMSTFALPVHDGGVGFDYRMHMAVADKWI
DLLKQSDETWKMGDIVHTLTNRRWLEKCVTYAESHDQALVGDKTIAFWLMDKDMYDFMALDRPSTP
TIDRGIALHKMIRLITMGLGGEGYLNFMGNEFGHPEWIDFPRGPQRLPSGKFIPGNNNSYDKCRRRFD
LGDADYLRYHGMQEFDQAMQHLEQKYEFMTSDHQYISRKHEEDKVIVFEKGDLVFVYNFHCNNSYF
DYRIGCRKPGVYKVVLDSDAGLFGGFSRIHHAAEHFTADCSHDNRPYSFSVYTPSRTCVVYAPVE
 
Figure 3.3:  The sequence of SbeIIb with S286, S297 and S649 indicated in bold and the 
nearest tryptic cleavage sites underlined.  The 61-amino acid transit peptide is shown in 
round brackets. 
Phosphorylation at S286 was detected in trace amounts following K2-treatment and in 
greater abundance in K1-treated samples by LC-MS/MS.  Serine and tyrosine in the Glu-
C/Lys-C peptide SLRIYE are both potential phosphosites; however product ion spectra 
showed serine to be the modified residue (Figure 3.4A).  A complete y-ion series matched 
that expected of the unmodified peptide, while all a-ions and b-ions present were 
phosphorylated.  A peak at m/z 136.1 was attributed to an iminium ion of unmodified 
tyrosine. 
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Figure 3.4: Tandem mass spectra of SbeIIb phosphopeptides with phosphates located at 
amino acid residues corresponding to S649, S286 and S297.  Top panel:  MS/MS of the 
doubly protonated Glu-C/Lys-C-generated phosphopeptide SLRIYE with the phosphate 
located at the S286 site from the K1-treated sample.  Middle panel:  MS/MS of the of the 
doubly protonated tryptic phosphopeptide IYETHVGMSSPEPK with the phosphate 
located at the S297 site, obtained from the fourth C18 RP-HPLC fraction of trypsin-
digested K2-treated triple mutant of SbeIIb S286A/S297A/S649A.  This spectrum was 
acquired from endogenous SbeIIb in the triple mutant sample, co-purifying with the 
protein kinase preparation.  The presence of SbeIIb in kinase preparations was confirmed 
by LC-MS/MS (data not shown).  Bottom panel:  MS/MS of the triply protonated Glu-
C/Lys-C-generated phosphopeptide WIDFPRGPQRLPSGK from the K1-treated sample 
with the phosphate located at the S649 site. 
The S297 phosphopeptide was observed exclusively in K2-treated SbeIIb, from which it 
was identified with 99% confidence by a ProteinPilot search against the whole Zea mays 
library.  The peptide THVGMSSPEPK, which contains the S297 site, was observed from 
Glu-C/Lys-C digests in both methionine-oxidized and unmodified forms with retention 
times between 12 and 13 min into the 60-min chromatographic run.  The Glu-C/Lys-C 
peptides containing S297 had consistently low LC-MS signals.  For instance, an 
untargeted MS/MS analysis of K2-treated wild-type SbeIIb resulted in relative signal 
intensities of 1 and 8 and 78 for the monoisotopic precursor ions of oxidized 
THVGMSSPEPK, phosphorylated WIDFPRGPQRLPSGK (S649) and non-
phosphorylated WIDFPRGPQRLPSGK respectively.  The concentrations of these species 
should be comparable since all originated from a single protein, however signals of the 
S649 containing peptide and phosphopeptide were orders of magnitude higher than those 
of the S297 containing peptide, suggesting the analytical platform had differential 
sensitivity for these analytes. Chromatograms of the oxidized and unmodified peptide 
THVGMSSPEPK were compared to those of other peptides observed in the same runs in 
order to determine if sensitivity was limited by low HPLC performance. Oxidized 
THVGMSSPEPK and unmodified THVGMSSPEPK had chromatographic qualities 
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comparable to other analytes. Despite considerable difference in their areas, the peaks of 
the oxidized S297-containing peptide and the unmodified S649-containing peptide were 
0.2 min and 0.22 minutes full width at half maximum (FWHM) respectively, suggesting 
that HPLC performance did not selectively reduce either signal. As evidenced by its early 
elution time, THVGMSSPEPK is a hydrophilic peptide and may not be effectively 
retained by the C18 trap.  The grand averages of hydropathy for the Glu-C/Lys-C peptide 
THVGMSSPEPK and the corresponding tryptic peptide IYETHVGMSSPEPK were -
0.945 and -0.764 respectively, indicating both were hydrophilic (25). The low signals of 
THVGMSSPEPK suggest observation of the corresponding phosphopeptide was 
unfavoured, since MS sensitivity for phosphopeptides is lower than for peptides. 
Phosphorylated S297 was not observed in Glu-C/Lys-C digests of SbeIIb, but was 
identified by LC-MS/MS of tryptic digests previously fractionated off-line by RP-HPLC.  
Consistent with its higher calculated hydrophobicity, IYETHVGMSSPEPK eluted later 
than the Glu-C/Lys-C equivalent digest, with a retention time of 21 min.  Phospho-
IYETHVGMSSPEPK had a retention time of 23 min.  The monoisotopic ion of the triply 
charged tryptic phosphopeptide had a maximum signal of 65,000 counts in the precursor 
ion scan.  While the signal may have increased due to C18 HPLC pre-fractionation, the 
sensitivity of the LC-MS system for this species was apparently much higher than for the 
Glu-C/Lys-C equivalent digest.   Modification of S297 was the slowest of all reactions 
studied here so the population of phospho-S297 and the corresponding MS signal were 
expected to be low.  Consistent with this expectation, MS/MS of the phospho-S297 
species had the lowest s/n of all three phosphopeptides studied.  The apparent absence of 
the Glu-C/lys-C phosphopeptide could therefore be due to the combination of low LC 
performance and low concentration. 
Potential kinase targets within the peptide IYETHVGMSSPEPK include two Ser, one Tyr 
and one Thr residue.   Product ion spectra showed the phosphate to be absent from all but 
the S297 site (Figure 3.4B).  Abundant a2, b2, and b3 ions indicated that tyrosine was not 
phosphorylated while b5, a6, b6 and b7 ions suggested both Tyr and Thr were unmodified.  
The Ser closest to the C-terminal of the peptide was observed in an unmodified state 
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within a y5 ion having a mass accuracy of 0.0037 Da and s/n between 5.5:1 and 11:1.  All 
product ions containing the S297 site also contained a phosphate.  Two series of 
phosphorylated ions, from y8 to y12 and b11 to b13, supported the assignment of the ninth 
residue within the peptide as the phosphorylation site. 
S649 is flanked by arginine and lysine so that trypsin digestion yielded the pentapeptide 
LPSGK with an m/z of 251.15 for the doubly protonated ion.  Glu-C/Lys-C digestion was 
used to extend the length of the S649-containing analyte to match the mass range of the 
mass spectrometer.  A S649 phosphopeptide was present in both K1- and K2-treated 
recombinant SbeIIb samples.  A missed Glu-C cleavage was consistently observed around 
the S649 site, resulting in a peptide with the sequence WIDFPRGPQRLPSGK, which was 
identified with 99% confidence in searches against the Zea mays protein library.  Low 
digestion efficiency at the third Asp of the S649 peptide may be due to the Pro located 
two residues C-terminal to it, since Pro at this position has been shown to inhibit protease 
activity (26).  A Ser residue is the only potential phosphorylation site within this sequence 
and MS/MS data acquired from phospho-WIDFPRGPQRLPSGK featured product ions 
consistent with serine phosphorylation (Figure 3.4C).   The fragments y12, y13 and y14, 
containing both the C-terminus and the phosphate, were detected with s/n values of 56:1, 
150:1 and 29:1 respectively.    Six prominent peaks corresponded to fragments having 
undergone phosphoric acid loss, an energetically favored fragmentation pathway of 
phosphopeptides. A series of N-terminal fragments which did not contain the Ser were 
without modifications.  Using the combined MS/MS evidence, the presence and location 
of the phosphate at S649 in both K1-treated and K2-treated SbeIIb were deduced. 
Untreated SbeIIb, as well as kinase-treated SbeIIb S649A and a SbeIIb 
S286A/S297A/S649A triple mutant were digested then analyzed by LC-MS/MS under 
conditions identical to those used for kinase-treated wild-type SbeIIb  to further assess the 
kinase-dependence of the phosphorylation.  While unmodified peptides containing S649, 
S286 and S297 were observed in the untreated controls, no phosphorylation of these sites 
was detected in these samples (data not shown). 
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Ion 
Observed 
monoisotopic 
m/z (Th) 
Theoretical 
monoisotopic 
m/z (Th) 
Error 
(Th) 
WIDFPRGPQRLPsGK, 3+, S649 
  
W 159.0923 159.0917 0.0006 
y2-NH3 187.0873 187.1077 -0.0204 
a2 272.1771 272.1757 0.0014 
b2 300.1719 300.1707 0.0012 
y4-H3PO4 370.2095 370.2085 0.0010 
b3 415.1980 415.1976 0.0004 
M+3H-H3PO43+ 579.3198 579.3179 0.0019 
y11-H3PO42+ 587.8452 587.8438 0.0014 
M+3H-NH33+ 606.3033 606.3013 0.0020 
M+3H3+ 611.9785 611.9768 0.0017 
y12-H3PO42+ 661.3788 661.3780 0.0008 
y122+ 710.3735 710.3665 0.0070 
y13-H3PO42+ 718.8930 718.8915 0.0015 
y132+ 767.8812 767.8799 0.0013 
y14-H3PO42+ 775.4346 775.4335 0.0011 
y142+ 824.4234 824.4220 0.0014 
y9-H3PO4 921.5237 921.5265 -0.0028 
sLRIYE, 2+, S286 
   
y1-H2O 130.0499 130.0499 0.0000 
Y 136.0760 136.0757 0.0003 
y1 148.0610 148.0604 0.0006 
a2-H3PO4 155.1181 155.1179 0.0002 
a5-H3PO4
2+ 294.1885 294.1868 0.0017 
y2 311.1244 311.1238 0.0006 
b3-H3PO4 339.2158 339.2139 0.0019 
M+2H-H3PO4
2+ 381.7122 381.7109 0.0013 
y3 424.2090 424.2078 0.0012 
M+2H2+ 430.7016 430.6993 0.0023 
b3 437.1910 437.1908 0.0002 
b4-H3PO4 452.2996 452.2980 0.0016 
a4 522.2810 522.2800 0.0010 
b4 550.2769 550.2749 0.0020 
y4-H2O 562.3009 562.2984 0.0025 
y4 580.3097 580.3089 0.0008 
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Table 3.2: Mass accuracy of each product ion attributed to the phosphopeptide spectra 
depicted in Figure 3.4. 
 
a5-H3PO4 587.3655 587.3664 -0.0009 
b5-H3PO4 615.3621 615.3613 0.0008 
a5 685.3398 685.3433 -0.0035 
y5 693.3952 693.3930 0.0022 
b5 713.3400 713.3382 0.0018 
IYETHVGMsSPEPK, 2+, S297 
  
H 110.0719 110.0713 0.0006 
Y 136.0755 136.0757 -0.0002 
y1 147.1114 147.1128 -0.0014 
y3-H2O
2+ 178.1372 178.1024 0.0348 
y4-H2O
2+ 226.1562 226.6288 -0.4726 
y2 244.1667 244.1656 0.0011 
a2 249.1617 249.1598 0.0019 
b2 277.1556 277.1547 0.0009 
b3 406.1993 406.1973 0.0020 
y4 470.2632 470.2609 0.0023 
z5 541.2242 541.2742 -0.0500 
y5 557.2967 557.2930 0.0037 
a5 616.3092 616.3089 0.0003 
y112+ 625.2445 625.2678 -0.0233 
b5 644.3119 644.3039 0.0080 
y122+ 689.7637 689.7891 -0.0254 
y6-NH3 707.3421 707.2648 0.0773 
a6 715.3755 715.3774 -0.0019 
b6 743.3716 743.3723 -0.0007 
b132+ 754.8792 754.8100 0.0692 
b13-H3O
2+ 763.8825 763.8153 0.0672 
b7 800.4016 800.3937 0.0079 
M+2H2+ 827.8365 827.8628 -0.0263 
y8 912.2966 912.3533 -0.0567 
y9 1011.3678 1011.4217 -0.0539 
y10 1148.4197 1148.4806 -0.0609 
b11+H 1283.5984 1283.5252 0.0732 
y12 1378.5131 1378.5709 -0.0578 
b12 1411.5067 1411.5600 -0.0533 
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LC-MS/MS identified protein kinases in amyloplasts extracts 
Information dependent acquisition of amyloplast anion exchange chromatography 
fractions revealed the presence of four kinases, two of which appeared to be unique to K1 
and two which appeared to be unique to K2.  K1 contained the uncharacterized putative 
protein kinase LOC100383602 (GI: 293336498) as well as its homolog Calcium-
dependent protein kinase 2 (CDPK2, GI: 162463011).  The two proteins share 69% 
sequence identity from V60 of LOC100383602 to their C-termini and were distinguished 
by six unique tryptic peptides.  Calcium-dependent protein kinase ZmCPK11 (GI: 
162460670) and abscisic acid (ABA) stimulation MAP kinase (GI: 226495415) were 
identified with high confidence by several peptides each in K2 samples.  Unlike the K1 
kinases, the two K2 kinases have less than 30% sequence identity overall, however 
ZmCPK11 shares around 60% of its sequence with both K1 kinases.  Though the 
functions of the aforementioned proteins within the endosperm remain unknown, 
ZmCPK11 is known to be transcribed at high concentrations in the maize seed (27). ABA 
stimulation MAPK is unique among the K1 and K2 kinases in its regulation of gene 
expression within the seed in response to abscisic acid (28). Starch synthase and SBE 
gene expression in the endosperm are regulated by ABA, therefore ABA stimulation 
MAPK likely has functions other than SbeIIb activation (29).  That three similar gene 
products, namely CDPK2, ZmCPK11 and LOC100383602, are expressed within one 
organelle suggests similar but distinct roles for each.  It is possible that two or more of 
these kinases respond to a single stimulus, namely calcium signalling, by separately 
functionalizing those SbeIIb residues controlling its productivity.  Such an activation 
mechanism could exert multiple levels of control on the starch biosynthesis complex by 
modulating the proximity of its members as well as the activity of SbeIIb.  It is striking 
that two serine residues affecting the behaviour of the catalytic domain are activated by 
separate kinases, so that a wide range in the starch branching rate is possible. 
Tandem mass spectra used in the assignment of protein identities to K1 and K2 are 
illustrated in Figures 3.5 and 3.6.  Peptides identified at 95% confidence spanned 11% of 
ABA stimulation MAPK, 11% of ZmCPK11, 8% of CDPK2, and 9% of LOC100383602 
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respectively.  Though overall sequence coverage was low, each protein was identified by 
multiple unique peptides sequenced with greater than 99% confidence.  Extensive product 
ion coverage was obtained from MS/MS data, for example each of the spectra in Figures 
3.5 and 3.6 contain overlapping b-series and y-series ions which together account for all 
residues.  Observed product ion mass accuracy was within the typical range of a linear ion 
trap, with most ions having absolute mass deviations within 0.1 Th.  Precursor masses 
measured on the orbitrap agreed with predicted values within 5 ppm.  The LTQ ion trap 
spectra consistently featured low intensity noise over a wide range of m/z values below 
1000 Th.  In general, smaller product ions had lower s/n than those above 800 Th, 
however their signals were adequate in differentiating them from noise and establishing 
their charge states. 
In addition to protein kinases, K1 was incidentally found to contain serine/threonine-
protein phosphatase 5 (GI: 226505390), a possible negative regulator of SbeIIb.  This 
phosphatase was recognized by four unique peptides identified with 99% confidence.  
MS/MS spectra from these species contained nearly complete b- and y-ion series with 
high s/n.  Though its role in maize has not been reported, the Arabidopsis thaliana 
homolog is known to mediate heat stress tolerance (30).  The amyloplast fractions 
contained other proteins not directly associated with starch synthesis such as actin, 
ribosomal proteins and enolase.  In total, 67 and 89 proteins were identified by two or 
more peptides at 95% confidence in the K1 and K2 respectively.  These contaminants 
reduced acquisition time available for sequencing the kinase peptides.  
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Figure 3.5:  Representative tandem mass spectra of tryptic kinase peptides obtained from 
amyloplast fractions K1.  A: doubly protonated EIISEVDTDNDGR from CDPK2 with a 
retention time of 31.58 minutes, a SEQUEST cross correlation score of 2.97 and a 
precursor ion mass accuracy of -0.00042 Da.  B: methionine oxidized 
 
 
111 
 
VVAENLSDEEIMGLK from LOC100383602 with a retention time of 38.38 minutes, a 
SEQUEST cross correlation score of 4.16 and a precursor ion mass accuracy of -0.00237 
Da. 
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Figure 3.6:  Representative tandem mass spectra of tryptic kinase peptides obtained from 
amyloplast fractions K2.  A: VIAESLSEEEIGGLK from ZmCPK11 with a retention time 
of 39.37 minutes, a SEQUEST cross correlation score of 4.96 and a precursor ion mass 
accuracy of -0.00083 Da.  B: GAYGIVCSALNSETAEQVAIK from ABA stimulation 
MAP kinase with a retention time of 53.75 minutes, a SEQUEST cross correlation score 
of 3.23 and a precursor ion mass accuracy of 0.00527 Da. 
3.4 Conclusion 
SBEIIb plays a central role in amylopectin production within maize endosperm, working 
in concert with several other enzymes.  The complex was suggested to be coordinated by 
phosphorylation though the phosphosites, kinase(s) and phosphatase(s) exerting such 
control remained to be discovered.  To explore activation of the starch synthesis complex, 
native SbeIIb, recombinant SbeIIb and several mutants were exposed to crude amyloplast 
isolates and found to undergo phosphorylation to different extents at three serine residues, 
namely S649, S286 and S297.  Two WAX fractions of amyloplast lysates differed in their 
ability to phosphorylate residues S286 and S297 and were therefore assumed to contain 
different kinases.  The two plastidial isolates phosphorylated each of three synthetic 
peptides harbouring S286 or S297 or S649 with the same differential specificity they 
showed for the full length enzyme.  Amyloplast isolates were partially sequenced by 
bottom-up LC-MS/MS and found to contain three distinct members of a calcium-
dependent serine/threonine kinase family.  Modification of the SbeIIb phosphosites by 
each isolate was found to depend on Ca
2+
 concentration, suggesting that the identified 
kinases were those acting on SbeIIb.  The discovery of calcium dependence establishes a 
novel upstream regulatory mechanism and will improve the efficiency of in vitro SbeIIb 
activation in ongoing research. 
Sites S286 and S297 were shown to modulate catalytic function and are conserved in all 
known plant SBEs, which suggests their role is maintained across plant species.  S649 
likely serves a more specialized role in protein-protein interaction as it occurs only in a 
subset of SBEs and its replacement with alanine does not affect SbeIIb catalysis.  
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Whatever the function of S649, it is clearly modified more readily than the other two sites 
as evidenced by biochemical characterization as well as LC-MS. 
Three dimensional molecular dynamic simulations indicated that S286, S297 and S649 all 
orient to the protein surface in disordered loops accessible to other proteins. S286 and 
S297 are located on either end of the central catalytic β-barrel where they could influence 
its structure or interact directly with the substrate.  Since replacement of S286 or S297 
with alanine decreased in vitro starch branching catalysis significantly, it could be 
concluded that these sites have important roles in vivo (24). 
Here are shown for the first time the locations of phosphosites on a protein which 
catalyzes a key reaction in starch biosynthesis and is known to recruit enzymes with 
related roles.  Though previously shown to undergo phosphorylation along with other 
amyloplasts proteins, SbeIIb is the first enzyme of the group to have its phosphosites 
identified.  That corn varieties featuring inactive SbeIIb yield distinct starches points to 
the potential of strains containing SbeIIb phosphosite mutants to produce novel variants 
of this important commodity.  The roles of the three phosphosites in the assembly of the 
starch synthesis complex and the behaviour of SbeIIb itself with respect to 
phosphorylation kinetics remain to be determined.  Since the phosphosites are modified to 
different degrees by at least two kinases, their functions in activity regulation are likely 
more sophisticated than switching the enzyme between completely inactive and 
completely active forms. 
3.5 Contributors 
Amina Makhmoudova (Ph.D.) performed all cloning and site-directed mutagenesis for 
this study, as well as maize seed processing, recombinant protein isolation and 
biochemical assays.  Jenelle Patterson (B.Sc.) performed chromatographic purifications of 
the kinases as well as the peptide kinase assay.  Kenrick A. Vassall (Ph.D.) performed the 
molecular dynamics simulations. 
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Chapter 4 
Identification of Beta-catenin interacting partners in a vascular 
smooth muscle cell model 
 
4.1 Introduction 
Cellular proliferation and differentiation are essential processes for development, growth 
and repair of animal tissues and organs coordinated through intercellular and intracellular 
signalling. The elucidation of pathway components and their interaction mechanisms 
holds important promise in regenerative medicine and oncology.  Novel therapies 
promoting dedifferentiation and growth may enable the replacement of damaged nerves 
and cardiac muscle, which normally lack regenerative capacities, while cancer treatments 
are intended to suppress these processes (1, 2).  Additionally, excessive proliferation of 
vascular smooth muscle cells (VSMC), the major component of blood vessels, has been 
implicated in cardiovascular diseases such as atherosclerosis and restenosis, leading 
causes of death in Western countries (3).  VSMC growth is therefore a potential target of 
pharmacological intervention in cardiovascular illness. 
The secreted signalling proteins wingless-type mouse mammary tumor virus integration 
site (Wnt) are key agonists of VSMC proliferation and muscle cell differentiation (3, 4, 
5).  Upon binding to the receptors Frizzled and low-density lipoprotein-related receptor 5 
and 6 (LRP5/6), Wnt causes them to form a heteromeric cell surface receptor complex, 
which promotes the transcription of numerous genes (6). 
In the basal state, a cytosolic protein complex including Axin, casein kinase 1 (CK1), 
glycogen synthase kinase 3 beta (GSK3B) and adenomatous polyposis coli (APC) inhibits 
Wnt target gene expression through its effect on the transcription mediator Beta-catenin.  
This degradation complex is inactivated following phosphorylation of the intracellular 
region of LRP5/6 and of the protein Dishevelled, which possibly promotes the interaction 
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of Axin and Dishevelled, upon stimulation by Wnt (7, 8, 9). Interestingly, membrane 
bound forms of GSK3 and CK1, the enzymes responsible for negative regulation of the 
Wnt signal cascade, are responsible for the activating phosphorylation of LRP (10, 11).  
When unconstrained by CK1/GSK3B/APC, Beta-catenin accumulates in the nucleus 
where it disrupts interaction between the transcription repressor transducin-like enhancer 
of split (TLE) and the transcription factors T cell factor/Lymphoid enhancer factor, 
displacing the former to allow DNA binding by the latter (12).  This assembly is known 
as the canonical Wnt signalling network since Wnt is known to bind other receptors with 
different downstream effectors. 
Beta-catenin is an 86 kDa protein with a sequence highly conserved in animals.  In the 
nucleus, Beta-catenin binds to and enhances the activity of a host of transcription factors 
including TCF/LEF, Nuclear Factor-Kappa Beta, Sex-determining region Y-related high-
mobility-group box (SOX) and Forkhead box-O (FOXO) but cannot itself bind DNA (9, 
12).  In the absence of Wnt, Beta-catenin distribution is restricted to the inner surface of 
the plasma membrane where it is bound to the intracellular region of the transmembrane 
protein cadherin.  Here Beta-catenin links cadherin to the actin cytoskeleton through 
alpha-catenin (13).  This interaction protects Beta-catenin from sequential 
polyphosphorylation at its amino terminal end by CK1 and GSK3, a modification which 
targets it for ubiquitylation and ultimately degradation (14).  In the cytoplasm Beta-
catenin is rapidly consumed by this process, however where the degradation complex is 
disrupted by LRP5/6 and Dishevelled, it accumulates in the cytoplasm, migrates to the 
nucleus and coordinates transcription. 
As might be inferred from the variety of transcription factors it influences, Beta-catenin 
activity is modulated by many proteins beyond the canonical Wnt signalling network.  
Other than CK1-dependent phosphorylation at S45 and GSK3-dependent phosphorylation 
at S33, S37 and T41, Beta-catenin is known to undergo 18 additional phosphorylations 
and two acetylations, and these modifications are associated with functions such as 
stabilization and relocalization of the protein (15).  For instance, epidermal growth factor 
receptor stimulation of the glioma cell line U87MG resulted in Beta-catenin Y333 
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phosphorylation by Src, which apparently lead to interaction between Beta-catenin and 
pyruvate kinase muscle 2 isoform, causing cyclin D1 transcription (16).  Protein kinase B 
(also called Akt) phosphorylates GSK3B at S9 as well as Beta-catenin at S552, 
inactivating the former and causing the latter to recruit the signalling protein 14-3-3-zeta 
(17, 18).  Furthermore, phosphorylation by CK1 and GSK3 is reversed by protein 
phosphatase 2A in the absence of APC, resulting in Wnt-independent protection of 
cytosolic Beta-catenin (19).  Acetylation of Beta-catenin at K49 by cyclic AMP response 
element binding protein binding protein (CBP) suppresses transcription of c-myc with no 
effect on cyclin D1 transcription, suggesting that these genes are controlled by Beta-
catenin in different PTM states (20).  Over 20 enzymes catalyze Beta-catenin PTMs.  This 
diversity of modification suggests the protein participates in a complex and incompletely 
described series of interactions. 
One protein of emerging significance in both Wnt-dependent and Wnt-independent Beta-
catenin signalling is p38 mitogen-activated protein kinase (p38).  Wnt signalling activates 
p38 and this effect depends upon Dishevelled as well as the Wnt-activated protein Gαq 
(21).  Subsequently, p38 protects Beta-catenin by phosphorylating GSK3B to render it 
inactive (21, 22).  The intracellular domain of LRP6 is activated through phosphorylation 
by p38, further controlling the CK1/GSK3B/APC degradation complex (23).  Platelet-
derived growth factor (PDGF) both activates p38 in VSMCs and disrupts the association 
of Beta-catenin and cadherin, causing Beta-catenin to migrate to the nucleus, a process 
associated with VSMC proliferation (24, 25).  Two kinases, MAPK kinase 3 (MKK3) and 
MKK6, directly activate p38 (26).  Phosphorylation of p38 by MKK6 is required for 
muscle differentiation (27).  Given the variety of modifications influencing Beta-catenin 
functionality and the involvement of p38 in Beta-catenin directed-gene expression, the 
interaction between the two was examined here. 
Two experiments employing LC-MS to describe the behaviour of p38 and Beta-catenin 
are described in this chapter.  Potential phosphorylation of Beta-catenin by p38 was 
explored, yielding strong evidence that such a PTM does not occur and implying that 
Beta-catenin regulation by p38 is indirect.  Secondly, novel Beta-catenin interacting 
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partners were revealed by sequencing of Beta-catenin immunoprecipitates from the A10 
cell line, an undifferentiated VSMC model (28).  Components of the transcription 
machinery were enriched along with Beta-catenin.  Eight mediators of gene expression 
with no previously established connection to Beta-catenin were identified.  WDR5 was 
subsequently shown to interact with Beta-catenin by western blot analysis. 
4.2 Methods and Materials 
Phosphosite prediction and in vitro protein phosphorylation 
The 781 residue full length Beta-catenin sequence was evaluated for potential 
phosphosites using the computer program NetPhosK (29).  Three serine residues were 
identified as p38 consensus sequences in this manner; S191, S246, and S605 and were 
targeted in subsequent LC-MS analysis. 
The plasmid vector 6xHis pet28a containing the full length Beta-catenin gene was 
inserted into E.coli BL21 to produce histidine-tagged Beta-catenin.  The bacterial culture 
was grown in LB broth at 37
o
C to an OD600 of 1 then vector expression was induced 
overnight in 500 nM IPTG at 16
o
C.  The recombinant protein was isolated from the crude 
cell lysate on a nickel column.  A truncated form of the known p38 substrate Activating 
transcription factor 2 (ATF2) purchased from Cell Signalling (Danvers MA, USA), 
spanning residues 19 to 96 of the full length protein, was used as a positive control (30).  
In vitro phosphorylation was carried out with 2-5 µg of purified substrate, 50-500 ng 
recombinant p38 (Millipore, Billerica, MA) and 200 µM ATP at 37
o
C in 50 mM Tris-HCl 
pH 7.5 with 10 mM MgCl2, 0.1 mM EDTA, 2 mM DTT and 0.01% Brij 35 for 30 
minutes.  Following treatment the proteins were separated by SDS-PAGE on 10 % 
acrylamide gels, Coomassie blue stained and bands matching the molecular weight of 
beta catenin and ATF2 were excised.  The molecular weight marker was from Pierce 
(Rockford IL, USA).  Each gel band was treated destained in 60% acetonitrile in water 
(v/v), washed in 100 mM NH4HCO3, reduced in 110 µl of 9 mM dithiothreitol at 60
o
C in 
100 mM NH4HCO3 for 15 minutes, brought to ambient temperature then alkylated with 
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iodoacetamide in the dark for 30 minutes.  Each band was then treated with 1 µg of 
trypsin at 37
o
C for 16 hours.  
Immunoprecipitation 
A10 cells (ATTC catalogue number CRL-1476) were grown at 37
o
C with an atmosphere 
of 5% CO2 on 10 cm diameter plates to 80% confluency in high glucose DMEM with 100 
U/ml penicillin, 100 µg/ml streptomycin, 1.5 g/l sodium bicarbonate and 10% (v/v) fetal 
bovine serum.  One hour after replacing the spent media, the cells were transfected with 
the vector pCDNA3 (Invitrogen, Burlington ON, Canada) or pCDNA3 containing full 
length genes of p38 and pCDNA3 the constitutively active MKK6 mutant MKK6-EE as 
well as DsRed-pCDNA3 using 25 µL of Lipofectamine 2000 (Life Technologies Inc., 
Burlington, ON) per plate.  The point mutations making MKK6-EE constitutively active 
are Ser207-Glu and Thr211-Glu.  A total of 0.5 µg of each plasmid was used for each 
plate.  Following 2 hours of incubation in plasmid-supplemented media, the plates were 
washed in phosphate buffered saline (PBS) then incubated in fresh media for 24 hours.  
Transfection efficiency was assessed based on DsRed fluorescence and was found to be 
approximately 70%.  The pCDNA-transfected and pCDNA3-MKK6-EE/p38C-
transfected A10 cells were cultured in triplicate.  Cells were harvested by scraping after 
two washes in PBS and immediately lysed in 5 volumes of 50 mM Tris-HCl, pH 7.6, 150 
mM NaCl, 100 mM NaF, 10 mM sodium pyrophosphate, 2 mM EDTA, 1 mM of the 
phosphatase inhibitor Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, 1 
µg/ml aprotinin, 1 µg/ml pepstatin A and 0.5% NP-40 (v/v).  Lysates were centrifuged at 
14,000 rpm at 4
o
C for 10 minutes and the supernatants collected. 
Anti-Beta-catenin IgG (Cell Signalling) was immobilized at a concentration of 5 µg per 
50 µL of ImmunoCruz IP/WB Optima F substrate (Santa Cruz Biotechnology, Dallas, 
Texas, USA) overnight at 4
o
C in 500 µL of phosphate buffered saline with 0.1% Tween 
20 (v/v). For negative controls, the substrate was incubated with rabbit serum (Sigma 
Aldrich, Oakville ON, Canada).  Unbound material was removed by two 500 µL PBS 
washes then the resin was suspended in 1 ml of cell lysate overnight at 4
o
C. 
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The immunoprecipitation washing procedure was optimized using SDS-PAGE to 
determine the degree of non-specific binding in the eluates.  In one case, the columns 
were treated with 1 ml of PBS following incubation with the sample. Alternately, two 500 
µl washes in lysis buffer followed by two 500 µl washes in lysis buffer without NP-40 
were used.  Bound proteins were eluted for LC-MS analysis in 500 µl of 0.5 M NH4OH 
whereas the washed beads were boiled in 34 mM Tris-HCl pH 6.8, 10% glycerol (v/v), 
1% SDS (w/v) with 2.5% 2-mercaptoethanol for SDS-PAGE.  Samples analyzed by LC-
MS were washed with lysis buffer as described above.  Separate immunoprecipitation 
columns were used for each sample so that a total of six anti-beta catenin eluates were 
generated.  Duplicate rabbit serum controls were generated from separate biological 
replicates of A10 cells transfected with either vector.  Eluates were dried by centrifugal 
concentration then dissolved in 100 mM NH4HCO3 and treated with dithiothreitol then 
iodoacetamide as in the p38 phosphorylation experiment.  The alkylated 
immunoprecipitates were incubated at 37
o
C overnight with 0.75 ug of trypsin. 
LC-MS/MS 
Trypsin digests were dried in a centrifugal concentrator then dissolved in aqueous 0.1% 
(v/v) formic acid and the peptides resolved by RP nanoflow-HPLC over a 60 minutes 300 
nl/minute acetonitrile gradient via a NanoLC-Ultra 2D HPLC pump coupled to a 
Nanoflex cHiPLC system.  The pump and columns were from AB Sciex (Concord ON, 
Canada).   Mobile phase A consisted of 0.1% formic acid in water (v/v) and mobile phase 
B was 0.1% formic acid in acetonitrile (v/v) (Honeywell, Morristown, NJ, USA).  Over 
the course of each LC-MS/MS analysis, the mobile phase B concentration went from 2% 
(v/v) at 0 minutes to 35% at 35 minutes, then to 80% from 35.5 to 38.5 minutes back to 
2% from 39 to 60 minutes.  Both the trap and analytical column were packed with 3 μm 
diameter C18 stationary phase with 120Å pores.  The trap was 0.5 mm long and 200 μm 
in diameter and the column was 150 mm long and 75 μm in diameter.  The column eluate 
was sampled by an Orbitrap Elite mass spectrometer though an uncoated fused silica 
capillary having a 10 µm internal diameter mounted into a Flex
TM
 ion source (Thermo 
Scientific, Waltham, MA). 
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For examination of Beta-catenin phosphorylation, the acquisition cycle included an 
Orbitrap MS scan at 60,000 resolution followed by MS/MS scans of the 10 most 
abundant precursor ions.  The orbitrap and the linear ion trap were used to acquire 
MS/MS data in alternate runs of the kinase-treated samples so two complimentary 
datasets were produced; one at high resolution and one at high sensitivity.  For 
immunoprecipitate analysis, precursor ion scans were collected on the Orbitrap at a 
resolution of 30,000 and the linear ion trap was used for MS/MS.  All tandem mass 
spectrometry was carried out at normalized collision energy of 35, activation Q of 0.250, 
isolation width of 2 Da and a 10 millisecond activation time.  Dynamic precursor ion 
exclusion with a repeat count of 1 and an exclusion mass width of 10 ppm was applied.  
A 5 second dynamic exclusion duration and 5 second repeat duration were used in data 
acquisition for the recombinant proteins while these values were 10 seconds and 20 
seconds respectively for the immunoprecipitate analyses.  The lock mass function was 
used at 371.101240 Th to maintain mass calibration. 
For phosphosite identification, an inclusion list consisting of m/z values for fully tryptic 
peptide and phosphopeptide ions having the tentative p38 phosphosites assigned by 
NetPhosK was generated.  The sequences SPQMVSAIVR, 
MLGSPVDSVLFYAITTLHNLLLHQEGAK and GLNTIPLFVQLLYSPIENIQR 
contained S191, S246, and S605 respectively.  Mass shifts from methionine oxidation and 
glutamine deamidation in conjunction with those due to phosphates were accounted for in 
the inclusion list.  During immunoprecipitate analysis, three blank runs were performed 
between each pair of samples in order to control carryover, which may otherwise have 
obscured the origins of those proteins identified.  Blank and sample data were acquired 
under identical instrumental parameters. 
MS/MS data were searched against the UniProt Rattus norvegicus sequence library 
(September 18, 2013 edition downloaded from the UniProt Knowledge Base on 
September 26, 2013) with the SEQUEST algorithm navigated through Proteome 
Discoverer
TM
 software version 1.3.  Search settings were as follows: precursor mass 
range: 350-5000 Da; minimum peak count: 1; enzyme: trypsin; maximum missed 
 
 
121 
 
cleavages: 1; precursor ion tolerance: 10 ppm, product ion tolerance: 0.4 Da, product ion 
series considered: b and y; dynamic modifications: methionine oxidation (+15.995 Da), 
phosphorylation (S, T and Y at +79.966 Da), glutamine deamidation (+0.984 Da) and 
tryptophan dioxidation (+31.990); static modification:  cysteine carbamidomethylation 
(+57.021 Da).  Monoisotopic ion masses were considered in the search. 
Identification of Beta-catenin associated proteins 
Proteins specific to the Beta-catenin immunoprecipitate were determined by processing 
the SEQUEST outputs.  Cutoff scores at the peptide level were determined by automated 
false discovery rate (FDR) estimation for each sample independently.  Lists of proteins 
identified in each sample at ≥95 and ≥99% peptide confidence were compared separately 
and those meeting the 95% cutoff were used in subsequent data processing stages.  
Proteins common to anti-Beta-catenin column eluates and rabbit serum controls were 
rejected as potential Beta-catenin binding partners. 
4.3 Results 
Using targeted LC-MS/MS as the detection system in an in vitro phosphorylation 
experiment, no direct effect of p38 on Beta-catenin could be discerned.  Known and novel 
interacting partners co-immunoprecipitated along with Beta-catenin from A10 cell 
lysates, though p38 activity could not be correlated to any particular interaction. 
Beta-catenin is indirectly activated by p38 
Only three sites within Beta-catenin match the highly specific p38 substrate consensus 
sequence serine-proline or threonine-proline, and these are isolated within separate 
peptides upon trypsin digestion (31).  The three candidate phosphosites were present in 
their unmodified states with high s/n by MS and MS/MS in samples treated with p38 as 
well as the untreated controls, however the corresponding phosphopeptides were not 
observed (Figure 4.1).  Ions of the S191, S246, and S605 peptides had maximum signals 
on the order of 200,000 to 300,000,000 counts (Figure 4.1) in the same chromatographic 
 
 
122 
 
run.  Given the magnitude of signals from the unmodified species, the absence of signals 
for the corresponding phosphopeptide precursor ions suggested the tentative phosphosites 
were unmodified by p38. SPQMVSAIVR and GLNTIPLFVQLLYSPIENIQR were 
reproducibly identified by SEQUEST at 99% confidence whereas 
MLGSPVDSVLFYAITTLHNLLLHQEGAK was assigned low confidence and 
confirmed by manual inspection.  Similarly, deamidated and oxidized forms of 
SPQMVSAIVR were present while the phosphorylated equivalents were not.  In contrast, 
the known ATF2 phosphosite was observed in its modified state in p38-treated samples 
but not in the absence of p38 (Figure 4.1G).  Tandem mass spectra from the expected 
ATF2 phosphopeptide NDSVIVADQTPTPTR, spanning residues 60 to 74 of the 
canonical sequence were identified by SEQUEST.  The peak height of this species was 
13% that of the unmodified version, consistent with active p38.  The observation that 
each candidate p38 phosphorylation site remained unmodified under conditions which 
readily phosphorylate ATF2 indicated that the previously reported activating effect of p38 
on Beta-catenin in VSMCs is indirect.  By inactivating GSK3B and activating LRP6, p38 
maintains elevated cytosolic Beta-catenin concentration, which could account for its 
increased nuclear function. 
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Figure 4.1:  Ion chromatograms of tryptic Beta-catenin peptides containing candidate p38 
phosphosites and a tryptic ATF2 peptide and phosphopeptide containing known p38 
phosphosites.  Phosphorylated residues are shown as lower case letters. Doubly 
protonated SPQMVSAIVR (A) from Beta-catenin gave a prominent chromatographic 
peak while the corresponding phosphopeptide (B) did not.  The quadruply protonated 
peptide MLGSPVDSVLFYAITTLHNLLLHQEGAK (C) was confirmed by MS/MS at 
43.25 minutes while the ion at 26.86 minutes was an isobaric species. No 
chromatographic peak from phosphorylated MLGSPVDSVLFYAITTLHNLLLHQEGAK 
was present (D).  Doubly protonated GLNTIPLFVQLLYSPIENIQR (E) was observed at 
43.21 minutes while the extracted ion chromatogram of the phosphorylated counterpart 
(F) had no signal.  The ATF2 peptide NDSVIVADQTPTPTR is shown in both its 
unmodified and phosphorylated state in panel G. 
The determination of Beta-catenin binding partners 
Eluates of immunoaffinity columns functionalized with Beta-catenin antibody and rabbit 
serum were compared by SDS-PAGE in order to assess their specificity as well as to 
optimize the stationary phase washing protocol.  Eluates from anti-Beta-catenin columns 
and those of rabbit serum columns were indistinguishable following washes with PBS 
alone (data not shown), whereas washes with lysis buffer reduced the complexity of the 
former (Figure 4.2).  Lysis buffer washing was therefore applied in preparation for LC-
MS.  Several prominent bands were common to eluates of both columns, indicating that 
some degree of contamination from the cell lysate remained in the experimental 
preparations as well as the rabbit serum controls.  For example, two resolved bands 
exceeding 130 kDa and another between 70 and 100 kDa were found in all samples. 
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Figure 4.2: SDS-PAGE of immunoprecipitates from A10 cells.  Lane 1: molecular weight 
marker.  Lanes 2 to 5 are eluates from anti-Beta-catenin IgG columns.  Lanes 6 to 9 are 
eluates from rabbit serum columns. Lanes 2, 4, 6 and 8 are eluates from A10 cell lysate 
transfected with the empty vector. Lanes 3, 5, 7 and 9 are eluates from A10 cells 
transfected with pCDNA3-MKK6-EE/p38. 
Proteins identified by MS/MS of rabbit serum column eluates were presumed to be non-
specifically bound.  Consistent with the SDS-PAGE results, the majority of proteins 
identified in the rabbit serum control were also found in Beta-catenin column eluates.  
Given the stochastic nature of ion sampling in shotgun proteomics and differences 
between the two immunoaffinity columns used, the numbers of peptides assigned to any 
one protein could be expected to differ among analyses.  To address sequence coverage 
bias introduced by such variation, the presence of a single unique peptide within a single 
rabbit serum immunoprecipitate was used as the criterion by which the corresponding 
protein was excluded as a potential Beta-catenin interacting partner.  This approach was 
justified by the absence of Beta-catenin in all rabbit serum column eluates and its 
appearance in anti-Beta-catenin column eluates from all biological replicates.  Protein 
identifications from anti-Beta-catenin column eluates were confirmed to be sample-
specific based on their absence in SEQUEST results from the preceding blank runs and 
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therefore did not result from HPLC column carryover.  Those proteins found only in anti-
Beta-catenin column eluates were similarly confirmed to be absent in the preceding 
blanks. 
A total of 528 proteins met the 99% peptide confidence threshold in all experimental 
samples, whereas 797 were identified at or above 95% confidence from the same data.  
Similarly 336 and 526 proteins were identified within the rabbit serum controls at 99% 
and 95% confidence respectively.  The dataset generated at 95% confidence contained 
more peptide identifications per protein and more proteins per sample relative to that 
obtained at 99% confidence.  The 95% confidence interval was used in later stages of data 
processing because it provided higher sensitivity in peptide detection and therefore 
superior selectivity.  For example, based on the 99% cutoff Nuclear cap binding protein 
subunit 1 appeared in Beta-catenin immunoprecipitates from both experimental states but 
not in control immunoprecipitates, however under relaxed tolerance the protein appeared 
in two of four control samples.  This protein was confirmed to be present in the controls 
by manual interpretation of tandem mass spectra of its peptides. Identical peptides were 
also observed in the experimental samples with 99% confidence at equivalent retention 
times, strengthening the credibility of sequence assignments from the controls.  Similar 
findings for the proteins AT rich interactive domain 1A, Fragile X mental retardation 
protein 1 homolog isoform 2 and La-related protein 4 (LARP4) indicated that the 99% 
confidence threshold yielded false positive interacting partners.  Of the 526 proteins 
identified at 95% peptide confidence from rabbit serum column eluates, 226 were found 
in a single sample, indicating they were retained randomly.  That more than half of the 
non-specifically bound fraction was found in multiple control samples could be attributed 
to their abundance in the lysate and this conclusion was supported by the presence of 
several isoforms of actin, histones and heterogeneous nuclear ribonucleoproteins in 
controls from all biological replicates. 
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Known and novel Beta-catenin binding partners present in immunoprecipitates  
Fourteen proteins were exclusively found in Beta-catenin immunoprecipitates, including 
Beta-catenin itself (Table 4.1).  Among these were alpha-catenin and CBP, both of which 
have been demonstrated to form heteromers with Beta-catenin at the plasma membrane 
(32).  The known Beta-catenin binding transcription activator brahma-related gene 1 
(BRG1), which also regulates Frizzled expression, was found in Beta-catenin 
immunoprecipitates as well as three of the four rabbit serum controls  indicating that it 
was not selectively enriched by the Beta-catenin antibody (33,34).  An additional 49 
proteins were found in at least two experimental samples as well as at least one control 
using the 99% peptide confidence threshold and like BRG1 some of these may have been 
false negative interacting partners; however this was considered acceptable given that the 
data handling strategy appeared to minimize false positives. 
The Contaminant Repository for Affinity Purification (CRAPome), a public database of 
non-specifically bound proteins in immunoprecipitation experiments, was queried for the 
gene products found exclusively in Beta-catenin immunoprecipitates (35).  Human 
homologues were referenced since Rattus norvegicus data was unavailable.  Of the 411 
experimental datasets making up the repository, BRG1 appeared in 59 (14%) while Beta-
catenin appeared in one (0.2%), suggesting that BRG1 is retained by immunoaffinity 
media and was therefore prone to false negative interacting partner assignment.  Nine of 
the putative binding partners had fewer entries in the database than BRG1 while 14-3-3 
epsilon was most frequently found (45.3%), suggesting its association with Beta-catenin 
was the most difficult to prove by immunoaffinity chromatography (Table 4.1). 
Interrogation of the CRAPome revealed 14-3-3 epsilon to be the most prevalent 
contaminant of all the species unique to the Beta-catenin immunoprecipitate.  Given its 
apparent tendency toward non-specific binding, the absence of 14-3-3 epsilon from the 
controls was conspicuous.  Nuclear Beta-catenin is shuttled to the cytoplasm by the 
protein Chibby in combination with 14-3-3 epsilon, which accounts for the observation of 
the latter (36).  Neither of the two Chibby isoforms were found by MS/MS. 
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Protein name Abbreviation
Uniprot 
ID
pCDNA3 
replicates
 pCDNA3-
MKK6/p38 
replicates
Subcellular 
localization
Function
Uniprot 
ID of 
Human 
isoform
CRAPome 
Occurance       
(n = 411) 
14-3-3 protein epsilon P62260 2 2
multiple       
(non-nuclear)
signalling P62258 186
alpha-catenin Q5U302 3 3 cytoskeleton
cytoskeletal 
anchoring
P35221 34
beta-catenin Q9WU82 3 3
cytoskeleton, 
cytoplasm, 
nucleus
cell adhesion, 
transcriptional 
regulation
Q9NSA3 1
Cyclic AMP response 
element binding protein
CBP Q6JHU9 3 2
cytoplasm, 
nucleus
transcriptional 
regulation
Q92793 1
Glutamate rich WD 
repeat containing protein 
1
GRWD1 Q5XI13 2 2 nucleus
transcriptional 
regulation
A0MNN5 42
Histone deacetylase 1 HDAC1 Q4QQW4 1 1 nucleus
transcriptional 
regulation
Q13547 108
KH domain-containing, 
RNA-binding, signal 
transduction-associated 
protein 1
Sam68 Q91V33 3 1 nucleus
transcriptional 
regulation
Q07666 138
La-related protein 1 LARP1 F1M062 3 3
cytoskeleton, 
cytoplasm
translational 
regulation
Q6PKG0 78
PDZ and LIM domain 
protein 7
LMP-1 Q9Z1Z9 2 1
cytoskeleton, 
cytoplasm
transcriptional 
regulation
Q9NR12 16
Poly(A) binding protein,   
nuclear 1
Pabpn1 G3V7Z8 1 2 nucleus
transcriptional 
regulation
Q86U42 50
Polymerase (RNA) II 
(DNA directed) 
polypeptide C
POLR2C Q5EB90 1 2 nucleus transcription Q6FGR6 24
purine-rich element 
binding protein alpha                       
PURA or 
ssCRE-BP
P86252 2 1 nucleus
transcriptional 
regulation
Q00577 27
purine-rich element 
binding protein beta
PURB Q68A21 2 1 nucleus
transcriptional 
regulation
Q96QR8 23
WD repeat containing 
protein 5
WDR5 Q498M4 2 3 nucleus
transcriptional 
regulation
P51532 59
 
Table 4.1: Proteins specific to anti-beta catenin immunoprecipitates of A10 lysates 
observed in two or more biological replicates at or exceeding the 95% peptide confidence 
limit.  Uniprot IDs associated with the sequence assignments are indicated in the third 
column.  The fourth and fifth columns show the number of biological replicates in which 
each protein was observed from pCDNA3-transfected and pCDNA3-MKK6-EE/p38C-
transfected cultures respectively.  Uniprot IDs of homologous proteins from Homo 
sapiens used to interrogate the CRAPome are displayed in the eighth column and the 
frequency of their occurrence is indicated in the ninth column. 
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The majority of co-purified gene products were previously reported to have nuclear 
functions, possibly because their association with Beta-catenin affects transcriptional 
regulation.  Consistent with the similarity in polypeptide distribution observed by SDS-
PAGE, all proteins which co-immunoprecipitated with Beta-catenin from p38 
hyperactivated cells were also found in at least one sample collected from cells with basal 
p38 activity (Figure 4.2 and Table 4.1).  This might imply that binding partners of Beta-
catenin were unaffected by p38 activation alone or that the immunoprecipitates contained 
a mixture of p38-dependent and p38-independent binding partners.  Several aspects of the 
experimental design could account for this trend.  The purity of p38 activated cells was 
limited by transfection efficiency while immunoprecipitation of whole cell extracts 
allowed the simultaneous capture of nuclear and cytoplasmic Beta-catenin.  The liberation 
of organellar contents during lysis potentially exposed free Beta-catenin to binding 
partners from which it had been isolated during cell culture.  These aspects of sample 
preparation could have increased the uniformity of immunoprecipitate components from 
the two biological conditions tested.  The isolation of basal state interacting partners from 
those directed by p38 could be expected to require subcellular fractionation since they 
recruit Beta-catenin simultaneously in vivo.  Alpha-catenin interacts with cadherin 
anchored-Beta-catenin at the plasma membrane and its presence in Beta-catenin pull-
downs from p38-stimulated cells could be attributed to a membrane bound Beta-catenin 
population remaining in the absence of a functional degradation complex (37).  This is 
reasonable given that some Beta-catenin remains bound to cell-cell adherence junctions 
during Wnt and PDGF signalling (38). 
The dataset from which the interacting partners were initially identified was processed for 
relative quantification in order to distinguish Beta-catenin interacting proteins in the two 
metabolic states.  Extracted ion chromatograms for peptides of alpha-catenin, Beta-
catenin and BRG1 were obtained, however the areas under the curves for each precursor 
ion were insufficiently reproducible among biological replicates to estimate their relative 
quantity.  Quantification by spectral counting was not feasible given the small number of 
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spectra assigned to each protein.  These findings were realistic given the stochastic nature 
of ESI sampling and the untargeted acquisition settings used (37,24,38). 
Biological roles of candidate Beta-catenin binding partners 
Data dependent acquisition yielded five unique WDR5 peptides with 99% confidence 
(Figure 4.3). Though it has not been previously shown to interact directly with Beta-
catenin, WDR5 is a known enhancer of canonical Wnt signalling which binds the 
promoter of the Wnt target gene c-myc as well as that of Wnt1 and whose expression 
affects nuclear Beta-catenin concentration in osteoblasts (39).  It is conceivable that 
WDR5 recruits Beta-catenin to the nucleus, enhancing WDR5-directed transcription.  A 
FLAG-tagged WDR5 construct was overexpressed in A10 and Beta-catenin 
immunoprecipitation was performed on the cell lysates.  Western blot analysis confirmed 
the interaction of WDR5 and Beta-catenin (Figure 4.4). 
Two unique LARP1 peptides were found with 99% confidence and an additional peptide 
exceeded 95% confidence (Figure 4.3).  LARP1 is an mRNA-binding protein controlling 
translation which has been found to bind cytoskeletal and cell-cell junction components  
(40,41).  It is therefore conceivable that LARP1 and Beta-catenin associate at the inner 
face of the cell membrane.  LARP1 has been shown to interact with a member or 
members of the polyadenylate binding protein family, so the presence of Pabpn1 in Beta-
catenin immunoprecipitates may be due to a Beta-catenin-LARP1-Pabpn1 complex 
(40,42,43).  RNA polymerase II polypeptide C (POLR2C), of which two unique peptides 
were sequenced, may also comprise part of this complex since Pabpn1 was shown to bind 
RNA polymerase II during transcription (44).  Pabpn1 has been implicated in myogenesis 
but little is known about its regulation during this process (45). 
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Figure 4.3:  Representative tandem mass spectra of WDR5 (A and B) and LARP1 (C and 
D) from Beta-catenin immunoprecipitates.  A:  Doubly protonated, singly 
carboxymethylated DGSLIVSSSYDGLCR with a m/z of 814.88202 Th (-0.00088 Th 
mass error) and a retention time of 39.32 minutes from p38 hyperactive A10 culture.  B:   
Doubly protonated WIVSGSEDNLVYIWNLQTK with a m/z of 1133.08777 Th 
(0.00659 Th mass error) and a retention time of 49.54 minutes from pCDNA3-transfected 
A10 culture. C: Triply protonated MDADGFLPITLIASFHR with a m/z of 635.33130 Th 
(0.00192 Th mass error) and a retention time of 51.60 minutes from pCDNA3-transfected 
A10 culture.  D:  Doubly protonated VINDGLFYYEQDLWTEK with a m/z of 
1067.01453 (0.0021 Th mass error) and a retention time of 47.29 minutes.  Sequence 
assignments for the spectra shown were given more than 99% confidence. 
 
Figure 4.4:  Western blot analysis of Beta-catenin immunoprecipitates from FLAG-
WDR5-overexpressing A10 lysates.  Blots with anti-FLAG (A) and anti-Beta-catenin (B) 
as the primary antibodies are shown.  Anti-beta catenin column eluates (eluate) appear in 
the left lanes, rabbit serum control column eluates (IgG) appear in the center lanes and 
crude cell lysates (lysate) appear in the right lanes of each blot.  The bands shown in 
panel A appeared at approximately 40 kDa while those shown in panel B appeared at 
approximately 90 kDa. 
An intricate relationship between histone deacetylase 1 (HDAC1), CBP and Beta-catenin 
emerging through the results of parallel studies could account for their simultaneous 
observation in Beta-catenin immunoprecipitates.  CBP modulates the Wnt pathway by 
acetylating Beta-catenin and it is conceivable that HDAC1 reverses this reaction since 
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histone deacetylase inhibition results in CBP-dependent Beta-catenin mediated 
transcription (20, 46).  Alternately, the opposing roles of CBP and HDAC1 in 
transcriptional control may be manifested in their reactions with other proteins while 
Beta-catenin serves to enhance the effect of each separately. HDAC1 is known to bind 
reptin, which itself complexes with Beta-catenin, and all three coordinate to negatively 
regulate expression of the tumor metastasis repressor p83 (47, 48).  A single unique reptin 
peptide was observed with more than 99% confidence in a single beta catenin 
immunoprecipitate from one biological replicate but not in any of the controls and its 
presence could account for the appearance of HDAC1 in the immunoprecipitates.  
Detection of KH domain-containing RNA-binding signal transduction-associated protein 
1 (Sam68) provided further evidence that Beta-catenin and CBP function in concert.  CBP 
and Sam68 colocalize in the nucleus and their interaction stimulates Sam68-regulated 
transcription (49). Beta-catenin and Sam68 have both been co-purified with protein 
tyrosine kinase 6, of which they are both substrates (50). 
In the nucleus, CBP is coupled to the DNA by its binding partner cyclic AMP response 
element binding protein (CREB) (51).  CREB was not found in the immunoprecipitates 
though two similar DNA binding proteins, PURA and PURB, were identified by two 
unique peptides above 99% confidence.  PURA, also known as single-stranded CRE 
binding protein (ssCRE-BP), has affinity for the same DNA element as CREB and both 
are activated by calmodulin so each may connect Beta-catenin-containing transcription 
machinery to their respective target genes in response to calcium or other stimuli (52, 53).  
PURA and PURB form a heterodimer, which could explain their simultaneous 
observation (54).  The target genes and primary structures of PURA/PURB and CREB 
differ.  Only seven amino acids in the region spanning residues 66 to 84 of PURA are also 
present in CREB and this is the region of highest sequence homology between the two.  
CREB residues 256-299 and PURB residues 103-141 have the highest homology at 36% 
sequence identity.  CREB residues 130 to 141 including the calmodulin-dependent 
phosphorylation site at Serine-133 were demonstrated to affect CBP binding and are 
absent in PURA and PURB (55).  Given the dissimilarity of their primary structures, it is 
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likely that PURA/PURB connects to the transcription machinery through an entirely 
different motif than that employed by CREB.  There is subtle evidence to suggest that 
Smad3 and PURA/PURB associate in myoblasts upon transforming growth factor beta 1 
stimulation while the same growth factor has been demonstrated to induce interaction 
between Beta-catenin and Smad3 necessary for epithelial-mesenchymal transition and 
myogenensis (56, 57, 58). It is therefore possible that Smad3 connects Beta-catenin to 
PURA/PURB in a multisubunit complex, though Smad3 was absent from the SEQUEST 
output. 
Little is known about the function of GRWD1, however there is indirect evidence for its 
involvement with Beta-catenin.  Initially shown to affect ribosome biosynthesis and 
differentiation, GRWD1 was also found in a protein complex with the cell cycle 
regulators Cdc10-dependent transcript 1 (Cdt1) and geminin (59, 60).  In embryonic stem 
cells and early embryos, geminin overexpression decreased cadherin expression and 
increased Wnt pathway activation through an unknown mechanism in which Beta-catenin 
may participate (61, 62).  BRG1, which itself enhances TCF target gene transcription, 
interacts directly with geminin, providing a link to Beta-catenin (63, 33).  It is therefore 
possible that GRWD1 contributes to a geminin-BRG1-Beta-catenin functionality.  
Neither Cdt1 nor geminin were sequenced by MS/MS of the A10 immunoprecipitates. 
PDZ and LIM domain protein 7 (LMP-1) expression is associated with bone formation in 
vivo and causes the C2C12 myoblast cell line to differentiate into osteoblasts (64).  No 
relationship between Wnt signalling and LMP-1 has been established however the 
differentiation of progenitor cells into osteoblasts and the maintenance of osteogenic 
lineage are dependent on Wnt signalling through Beta-catenin (65, 66).  In the context of 
the known role of LMP-1, the data presented here are consistent with Beta-catenin 
enhancing its function during osteogenic stimuli. 
Figure 4.5:  Model of Beta-catenin function including known roles of p38 in Wnt 
signalling.  Pointed arrows indicate activation and blunt ended arrows indicate 
inactivation.  Three hypothetical DNA-binding nuclear protein complexes containing 
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Beta-catenin are shown, two associating with cyclic AMP response elements (CRE) and 
one associating with a Tcf target gene.  Possible opposing roles of CBP and HDAC1 in 
controlling the CREB complex through Beta-catenin acetylation and deacetylation are 
shown.
 
4.4 Conclusion 
Both p38 and Beta-catenin are essential to muscle development, however the actions of 
each in facilitating differentiation and proliferation remain incompletely described.  
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Direct phosphorylation of Beta-catenin by p38 was investigated here.  The apparent 
failure of the active kinase to modify the only Beta-catenin residues matching its highly 
specific substrate sequence motif indicated that p38 affects Beta-catenin localization and 
Wnt signalling through other substrates such as LRP6 and GSK3B.  Though Beta-
catenin-associated proteins in a cellular model of high p38 activity persisted without p38 
stimulation, novel interacting partners were indicated.   
The co-purification of proteins known to bind other Beta-catenin-binding species by 
immunoprecipitation could be accounted for by multisubunit transcription complexes.  
HDAC1, PURA and PURB are each associated with Beta-catenin through an additional 
protein.  Nuclear proteins identified here could represent parts of at least two distinct 
complexes, one binding the DNA through CREB and another through PURA/PURB.  The 
implication of Beta-catenin in the regulation of PURA/PURB target genes is without 
precedent.  A possible novel contributor to the canonical Wnt signalling pathway, 
GRWD1 was also identified.  Consequences of the associations shown to the fate of 
muscle progenitors are unclear and require further in vitro and in vivo study to elucidate. 
4.5 Contributors 
This author contributed to the experimental design, silver staining of SDS-PAGE gels, 
LC-MS sample preparation, LC-MS analysis as well as data interpretation.  The 
remainder of the experimental work, including cloning, cell culture, in vitro protein 
phosphorylation, immunoprecipitation and Western blotting were performed by Saviz 
Ehyai (B.Sc.) as part of his ongoing Ph.D dissertation work.
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Chapter 5 
Identification of isobaric peptide ions and product ions from 
sequence information: Implications for selective reaction 
monitoring 
 
5.1 Introduction 
Selected reaction monitoring (SRM) is a sensitive technique allowing the quantification 
of multiple peptide analytes in complex biological matrices including tissue homogenates, 
serum and plasma (1-3).  SRM has drawbacks arising from two phenomena; transitions 
selected to represent an analyte are sometimes produced by other species and transition 
signal intensity is sometimes distorted by matrix effects.  Both problems are significant in 
proteomic samples containing thousands of polypeptides and other biomolecules as well 
as contaminants of sample preparation.  Around half of all transitions may be 
insufficiently reproducible in their signal abundance to permit accurate quantification, 
with some being more reproducible than others from the same peptide (4).  The limited 
resolution of quadrupoles contributes to ambiguity in quantification since signals from the 
analyte and contaminants cannot be isolated, however reducing transmission window 
width to increase specificity simultaneously decreases sensitivity. Practically all 
transitions are subject to isobaric interference.  It follows that SRM specificity increases 
with the number of transitions-per-peptide, though no method for establishing an 
acceptable minimum number has been established (5). 
Even isobaric species with no sequence homology to the analyte can cause interference in 
an SRM assay. One example of this occurred during optimization of an assay for 
chaperonin 10 in human serum.  Despite having no major product ions in common, the 
 
 
138 
 
non-tryptic albumin peptide LVAASQAALGL was associated with four peaks 
corresponding to transitions for the tryptic chaperonin 10 peptide GGEIQPVSVK and 
having the same relative abundance (Figure 5.1).  Though they had distinct retention 
times over a 90 minute separation, the difference would be reduced by compression of the 
chromatographic gradient, an important consideration in minimizing run time.   
Enhanced product ion scanning, an MS/MS mode in which fragments are accumulated in 
the ion trap, automatically triggered when the transitions exceeded a user defined 
intensity threshold allowed both the expected chaperonin 10 peptide and the albumin 
peptide to be identified by a Mascot search.  It should be noted that incorporating MS/MS 
scans into an SRM method for analyte identity verification reduces the number of data 
points in the SRM experiment so that peak integration suffers. MS/MS spectra of the two 
species were highly dissimilar.  The product ions of the albumin peptide isobaric to those 
of the chaperonin peptide transitions could only be attributed to low level noise.  This 
implies that peptide mass alone can cause isobaric interference in SRM as well as SIM.  
Being one of the most abundant plasma proteins, albumin could remain in concentrations 
equivalent to those of a low abundance analyte even in a purified blood sample.  
Transition selection may therefore be assisted by knowledge of isobaric peptides and their 
proteins of origin. 
Every proteomic sample contains a finite number of sequences determined by the 
biological material from which it was derived and how it was processed so that protein 
sequence databases can in theory be used to describe all polypeptides contributing to 
isobaric interference.  A variety of tools supporting the selection of specific transitions for 
SRM assay development are available.  One optimization approach is to find all unique 
hypothetical transitions within a whole proteome.  This entails calculating the precursor 
and product ion m/z values of all proteotypic peptides within a sequence library then 
comparing them within some tolerance and eliminating any matches (6).  The concept 
was extended to include retention time and spectral library information (7). With these 
approaches the majority of peptides within selected proteomes were associated with sets 
of two to three transitions which were unique identifiers; however the identities of 
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interfering peptides were not discussed in detail.  While these studies probed the 
proteome for transition sets devoid interference, we worked from the assumption that the 
end user of SRM has specific proteins of interest and must accept some degree of 
interference which can nevertheless be minimized by avoiding the effects of prominent 
endogenous matrix proteins as well as those transitions which are generally redundant.    
The determination of transition redundancy using a novel automated algorithm (SRMass), 
designed by this author and written by Olga Krakovska at York University, is described 
below.  The SRMass program is similar in function to SRMCollider in that the 
modifications considered, precursor and product ion mass tolerance and proteomic library 
are all user defined (7).  Relationships between redundancy, mass deviation and peptide 
sequence were examined using prostate-specific antigen (PSA), a current biomarker of 
prostate disease, as a model protein.  The focus on specific peptides revealed distinct 
trends in redundancy.  For example, the number of isobaric transitions increases at 
different rates with expanding precursor ion mass tolerance for different product ions.  
There was a linear relationship between precursor resolution setting and the number of 
potential interfering species for many product ions however no clear relationship between 
product ion size and transition specificity could be discerned.  These observations have 
implications for the transition selection process and practical mass transmission ranges of 
SRM assays. 
5.2 Methods 
Isobaric interference was evaluated by determining the number of peptides within a large 
sequence database which were isobaric to a given analyte which also produced fragment 
ions isobaric to those of the analyte.  This approach provides perspective on the extent 
and nature of SRM interference caused by the biological background for given a protein 
of interest.  Precursor/product ion m/z pairs corresponding to tryptic peptides of human 
PSA, a prostate health biomarker used in the diagnosis of prostate cancer were queried 
against a RefSeq non-redundant human proteome FASTA format library (downloaded 
September 20, 2010) representing 19,127,252 amino acids in 32208 distinct proteins. 
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Figure 5.2 depicts the SRMass user interface. The following search terms are used: Mass 
mode (calculates either monoisotopic or average precursor and product ion masses from 
the FASTA database), precursor ion m/z (in Th), precursor ion m/z tolerance (twice the 
absolute mass deviation limit for the precursor ion), product ion m/z (in Th), product ion 
m/z tolerance, possible modifications, and the maximum number of modifications on any 
one peptide (0-20).  Full tryptic cleavage is the only allowed proteolytic condition.  
Precursor ions with charges of 1 to 6 and product ions with charges of 1 to 2 are 
considered in the search.   
In order to test the effect of the precursor ion mass window on selectivity, otherwise 
identical searches were conducted at precursor mass tolerances between 0 and 2 Th, a 
range selected to span the practical resolution settings used in SRM acquisition.  The 
following constant parameters were used: product ion tolerance, 0.1 Da; mass mode, 
monoisotopic; modifications, cysteine carbamidomethylation and methionine oxidation; 
maximum number of modifications considered, 3. The input data set included  
precursor/product ion pairs from nine fully tryptic and one semi-tryptic peptide, 
representing 122 of the 261 amino acids from PSA isoform 1 preproprotein (GI 4502173).  
The semi-tryptic sequence WIKDTIVANP covers the protein C-terminus.  Transitions for 
the peptide LQCVDLHVISNDVCAQVHPQK carbamidomethylated at position 14 but 
unmodified at the third cysteine were searched as were transitions for the doubly 
carmidomethylated version.  All sequences were between 6 and 21 residues long.  The 
product ion masses used corresponded to all y-ions and in some cases b-ions from every 
peptide with those containing fewer than three amino acid residues excluded.  The query 
list totalled 132 precursor/product ion pairs. 
5.3 Results 
Trends in transition redundancy were inferred from results generated using the relatively 
small input set of precursor/product ion pairs.  The universality of isobaric interference 
was apparent in that virtually all precursor/product ion pairs tested had tens to hundreds 
of database matches at m/z widths typical of triple quadrupole instruments (Figures 5.3 
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and 5.4).  Even mass windows associated with decreased sensitivity resulted in tens to 
hundreds of matches for most transitions.  Transmission ranges below 1 Da are associated 
with signal attenuation, however at precursor and product ion mass windows of 0.1 Da all 
transitions tested matched non-sequence precursor/product ion pairs from the FASTA 
database (Figures 5.3 and 5.4 and Table 5.1).  Given this result, the mass accuracy 
required to identify analyte ions with certainty from a few transitions is beyond the 
capability of a triple quadrupole but possible with a contemporary Qq-TOF. 
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Figure 5.1:  Isobaric interference in an SRM assay.  Transitions designed to be specific 
for the unique, proteotypic chaperonin 10 peptide GGEIQPVSVK also resulted in signals 
from the non-tryptic albumin peptide LVAASQAALGL, a contaminant originating in the 
sample.  Top panel: Signals from the albumin peptide. Bottom panel: Signals from the 
chaperonin 10 peptide. The transition m/z 507.4/485.2 corresponds to a b5 ion from 
GGEIQPVSVK.  The data was acquired on a 4000QTRAP. 
 
Figure 5.2: The SRMass user interface. 
 
A complex relationship between product ion identity, allowable m/z deviation and 
transition specificity was evident in results for the PSA peptides.  At precursor ion and 
product ion tolerances of 0.01 and 0.1 Da respectively, the average number of matches to 
the database for the transitions tested was less than 5, with many returning no hits.  
Beyond a precursor tolerance of 1 Da, almost all transitions exceeded 100 matches with 
many having hundreds (Figures 5.3 and 5.4).  This showed that a set of peptide ions can 
produce many isobaric product ions and neither high precursor ion tolerance nor high 
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product ion tolerance alone can be expected to produce unique transitions.  Though 
SRMass does not report peptide ion matches lacking matching product ions, searches 
against y1 ions can provide similar data because a high proportion of isobaric peptides 
contain the same C-terminal residue as the query.  The y1 ions of SVILLGR and 
carbamidomethylated FMLCAGR returned 5220 and 4136 results respectively at 1.0 Da 
precursor and 0.1 Da product tolerances, values one to two orders of magnitude higher 
than for transitions including larger product ions.  This result is consistent with SRM 
being more selective than SIM but also indicates that a large percentage of all isobaric 
peptides share isobaric b-ions or y-ions. 
For some of the peptides tested, a small number of product ions had substantially higher 
m/z redundancy than others of the same ion series at all mass tolerances tested.  For 
example, b6 of doubly protonated SVILLGR had 407 matches at precursor and product 
ion tolerances of 0.1 Da each, while the average number of matches for y3 to y6 and b3 to 
b5 from the peptide was 64.4 under this condition (Figure 5.5).  This suggests that among 
transitions for a given peptide, some are significantly more prone to misinterpretation 
than others.  Even b2 and y2 from SVILLGR had fewer matches than b6
 
at the 
aforementioned tolerances, with 111 and 87 hits respectively.  It could be reasoned that a 
longer fragment ion would share its m/z value with fewer species than would a shorter 
one, since length tends to increase sequence uniqueness.  Large product ions may be 
favoured in transition design for this reason.  Findings for HSQPWQVLVASR and 
VTKFMLCAGR support this line of reasoning; with the slopes of the redundancy plots 
decreasing from y3 to y11 in the former and from y3 to y6 and remaining low for y7, y8 and 
y9 in the latter (Figure 5.3A and B). For doubly charged FLRPGDDSSHDLMLLR, y3 and 
y4 had the most matches, however these ions contain two leucine residues and were 
therefore given to interference from both leucine-containing and isoleucine-containing 
fragments (Figure 5.5).  In contrast, large fragments from certain peptides had more 
isobaric ions than did smaller fragments in the same series, suggesting the absence of a 
direct correlation between product ion mass and specificity.  Notably, doubly charged y20 
from doubly carbamidomethylated LQCVDLHVISNDVCAQVHPQK at m/z 1174.0677 
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had more than eight times as many matches as the average for the remaining 18 ions 
investigated from this peptide at low mass tolerances (Figure 5.5).  Doubly protonated y13 
at m/z 748.3697 was the next most redundant product ion from this peptide with 24 hits 
whereas y5 at m/z 608.3515 returned none.  The y8 ion of IVGGWECEK, the largest in 
the y-ion series, had 113 transition matches at precursor/product ion mass deviation limits 
of 0.1 Da whereas the series from y3 to y7 had 24.8 matches on average (Figure 5.3C). 
The SVILLGR b6 ion discussed above shows this also occurs with short sequences.  One 
interpretation of these results is that a few product ions from a given series are outliers 
with respect to the probability of interference.  As such, the product ion containing the 
most residues will not necessarily make the most accurate transition. 
For most precursor/product ion masses tested, the number of database matches increased 
linearly with the precursor mass window.  All queried transitions of HSQPWQVLVASR 
and the semi-tryptic VTKFMLCAGR obeyed this rule with redundancy increasing by as 
many as 466 and as few as 10 matches per Da in the case of y11 and y3 from the former 
peptide (Figure 5.3A and B).  Two alternate relationships between precursor tolerance 
and specificity were also observed.  Matches to the y5 and y8 transitions of IVGGWECEK 
as well as the y11 transition of LSEPAELTDAVK increased according to natural 
logarithmic functions due to large differences in the number of matches over short 
precursor tolerance ranges, especially around 0.01 and 0.1 Da (Figure 5.3 C and D). The 
y6 and b6 transitions of carbamidomethylated FMLCAGR showed similar trends.  In 
comparison to those with a simple linear relationship, transitions of this type are more 
susceptible to noise at narrow transmission window widths and are therefore likely to be 
the least reliable in quantification.  Findings at higher tolerances support this conclusion, 
since each logarithmic functions lay above most others from 0.5 Da and beyond.  
Interestingly, the FMLCAGR b6 ion was by far the most redundant at tolerances of 0.01 
and 0.1 Da while the y6 ion was most redundant from 0.5 to 1.5 Da, demonstrating the 
potential for inversions of transition specificity at higher sensitivity (Figure 5.4).  The 
slope of the redundancy curve for transition y3 from IVGGWECEK was linear from 0.01 
to 1.5 Da but increased with precursor tolerance beyond that point in a manner best 
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described by a polynomial.  Examples of each of the three function types were found 
among the six transitions from IVGGWECEK queried; with y5 and y8 following natural 
logarithmic patterns and the remaining three being linear (Figure 5.3C).  Collectively, 
these data suggest that trends among transitions from the same peptide are independent of 
one another.  For the SRM experiment this could translate to highly variable 
susceptibilities to noise among related transitions at increasing sensitivity.  Using a single 
precursor transmission window for all transitions would have different consequences for 
the reliability of each one.  Furthermore, those transitions with many matches at low m/z 
tolerance, such as y8 from IVGGWECEK y11 from LSEPAELTDAVK and b6 from 
FMLCAGR also have above average number of hits at m/z widths more realistic for SRM 
acquisition. 
The sequences discussed above all have tryptic cleavage sites at their termini and are 
without unusual modifications.  Two exceptional sequences were investigated with 
SRMass in order to evaluate the effect of m/z bias in the input.  WIKDTIVANP with an 
internal lysine residue and lacking a C-terminal residue and 
LQCVDLHVISNDVCAQVHPQK with incomplete carbamidomethylation, gave results 
similar to other peptides.  Searching the sequence library for fully tryptic peptides against 
the m/z values of a non-tryptic peptide might be expected to result in a low number of 
matches, especially to y-ions lacking lysine, but y3 to y7 of WIKDTIVANP had an 
average of 222 hits at 1 Da precursor and 0.1 Da product ion tolerances while y8 and y9 
had 388 and 46 respectively.  Similarly, introducing a mass shift of -57 Da to a cysteine 
residue in the query relative to those in the database might decrease the number of 
matches.  The number of matches per transition from doubly and singly modified 
LQCVDLHVISNDVCAQVHPQK differed, however the values were on the same order 
of magnitude.  For the 18 identical y-ions the two species have in common, the largest 
difference in redundancy at precursor and product ion tolerances of 0.1 Da was that of y9, 
for which the singly alkylated version received 18 matches where the doubly alkylated 
version had 9.  The average numbers of hits among the y-ions queried for both variants of 
LQCVDLHVISNDVCAQVHPQK were comparable at all tolerances tested.  From 
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searches of these unusual sequences it is apparent that any proteomic library of sufficient 
size contains corresponding transitions from tryptic peptides.  
 
 
147 
 
y = 252.32x + 6.1642  
R2 = 0.9998
y = 87.74x + 8.3041
R2 = 0.9825
y = 44.534Ln(x) + 224.74
R2 = 0.984
0
100
200
300
400
500
0.00 0.50 1.00 1.50 2.00 2.50
N
u
m
b
e
r 
o
f 
m
a
tc
h
in
g
 t
ra
n
s
it
io
n
s
Peptide ion mass tolerance (Da)
LSEPAELTDAVK (z=2) 
y3
y4
y5
y6
y7
y8
y9
y10
y11
y = 54.81x2 + 43.21x + 11.16
R² = 0.991
y = 48.26x + 0.296
R² = 0.996
0
50
100
150
200
250
300
350
0.00 0.50 1.00 1.50 2.00 2.50
N
u
m
b
e
r 
o
f 
m
a
tc
h
in
g
 t
ra
n
s
it
io
n
s
Peptide ion mass tolerance (Da)
IVGGWECEK (z=2)
y3
y4
y5
y6
y7
y8
y = 465.9x + 13.042
R² = 0.9973
y = 37.587x - 3.055 
R2 = 0.9622
0
100
200
300
400
500
600
700
800
900
1000
0.00 0.50 1.00 1.50 2.00 2.50
N
u
m
b
e
r 
o
f 
m
a
tc
h
in
g
 t
ra
n
s
it
io
n
s
Peptide ion mass tolerance (Da)
HSQPWQVLVASR (z=3)
y3
y4
y5
y6
y7
y8
y9
y10
y11
y = 419.71x - 7.7712
R² = 0.9985
y = 78.573x + 12.556
R2 = 0.9849
0
100
200
300
400
500
600
700
800
900
0.00 0.50 1.00 1.50 2.00 2.50
N
u
m
b
e
r 
o
f 
m
a
tc
h
in
g
 t
ra
n
s
it
io
n
s
Peptide ion mass tolerance (Da)
VTKFMLCAGR (z=2)
y3
y4
y5
y6
y7
y8
y9
A
B
D
C
N
u
m
b
e
r 
o
f 
m
a
tc
h
e
s
 
 
 
148 
 
Figure 5.3: The number of precursor/product ion pairs within a non-redundant human 
protein database matching transitions as a function of precursor ion mass tolerance.  The 
human FASTA sequence database was queried with transitions for PSA peptides at a 
constant product ion mass tolerance limit of 0.1 Da and precursor ion mass ranges from 0 
to 2 Da. A: Triply protonated HSQPWQVLVASR. B: Doubly protonated semi-tryptic 
VTKFMLCAGR.  C: Doubly protonated IVGGWECEK. D: Doubly protonated 
LSEPAELTDAVK.  All cysteine residue masses were adjusted for 
carbamidomethylation. 
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Figure 5.4:  Relationships between precursor ion tolerance and specificity among 
transitions of carbamidomethylated FMLCAGR. 
 
An analyte sharing single transitions with several unrelated peptides might lead to 
inconsistent quantification and necessitate a change in the set of product ions monitored.  
A peptide unrelated to the analyte but sharing multiple transitions with it presents a 
different problem, namely that the alternate ion chromatogram could be mistaken for that 
of the analyte and integrated in its place.  Recognition of such cases could improve the 
efficiency of method development, as problematic peptide analytes could then be avoided 
altogether. 
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Figure 5.5:  Transition redundancy for three tryptic PSA peptide ions.  The number of 
precursor/product ion pairs within the human proteome matching m/z values of each 
transition is plotted.  Matches to peptide sequences derived from PSA isoforms within the 
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database were excluded from the results shown.  Precursor ion mass tolerance and 
product ion mass tolerance were both 0.1 Da.  All cysteine residue masses were adjusted 
for carbamidomethylation. 
SRMass results for three PSA peptides were interrogated for matches having more than 
one isobaric product ion.  The maximum allowable m/z deviations were set to +0.05 Th to 
mimic instances in which the contaminant and the analyte could not be clearly 
discriminated by MS/MS scans at quadrupole resolution.  Under these conditions 
IVGGWECEK shared between two and three transitions with 11 tryptic peptides, 
LSEPAELTDAVK shared between two and four transitions with 29 peptides and 
HSQPWQVLVASR from two to four transitions with 15 peptides from other proteins.  
Conserved domains and homologous proteins were underrepresented in this group; rather 
the matches had few sequence elements in common with the queries and came from 
proteins of various functions.  Thus the basis of the phenomenon for these three peptides 
was not protein families but the distribution of amino acids throughout the human 
proteome.  The differences in mass between query and match were typically well within 
tolerances applied to both the precursor and product ion search space (Table 5.1).  Larger 
query sequences also returned multiple hits from single peptides with low mass 
deviations, for instance triply charged TGIAFIYAVFNLVLTTVMITVVHER from 
Ceramide cholinephosphotransferase 2 and the doubly charged PSA ion 
FLRPGDDSSHDLMLLR were within 0.05 Da of each other as were their y8 and y15
2+
 
ions.  The obvious difference in the masses of these two sequences might be overlooked 
during quantification since charge state is not assessed in the SRM assay.  Arginine and 
lysine differ in mass by 28 Da and therefore contribute different masses to y-ions, 
however, regardless of the C-terminal residue of the query sequences, matches to multiple 
y-ions from peptides with both C-terminal arginine and lysine were found (Table 5.1).  
Aside from showing the discrepancy between sequence and mass, these data indicate that 
SRM at low resolution is not sufficiently specific for certain peptides. 
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Query precursor 
and product ions
Matching 
fragment 
m/z (Th)
Matching sequence
Charge of 
matching 
fragment
Matching 
fragment 
type
Matching 
peptide 
location start
Matching 
peptide 
location end
Precursor 
m/z 
deviation 
(Th)
Product 
m/z 
deviation 
(Th)
HSQPWQVLVASR, 2+ EQPLPAQDPVSVK, 2+
y3 333.2132 SVK 1 y3 100 112 -0.0002 0.0232
y4 432.2817 VSVK 1 y4 100 112 -0.0002 0.0217
y6 644.3614 DPVSVK 1 y6 100 112 -0.0002 -0.0486
y7 772.4199 QDPVSVK 1 y7 100 112 -0.0002 -0.0501
IVGGWECEK, 2+ DPNEWAMAK, 2+
y3 436.2224 AMAK 1 y4 830 838 -0.0182 0.0364
y5 751.3443 EWAMAK 1 y6 830 838 -0.0182 0.0363
y7 865.3873 NEWAMAK 1 y7 830 838 -0.0182 0.0364
LSEPAELTDAVK, 2+ EALLAEMGVAIR, 2+
y6 646.3705 MGVAIR 1 y6 460 471 0.0147 -0.0095
y7 775.4131 EMGVAIR 1 y7 460 471 0.0147 -0.0069
y8 846.4502 AEMGVAIR 1 y8 460 471 0.0147 -0.0098
y10 1072.6183 LLAEMGVAIR 1 y10 460 471 0.0147 0.0683  
Table 5.1:  Pairs of peptides having low sequence homology and multiple isobaric 
transitions.  Matching peptide ions shown for each PSA sequence included 
EQPLPAQDPVSVK from homeobox protein DLX-3, DPNEWAMAK from prune 
homolog 2 protein, and EALLAEMGVAIR (m/z 636.8527) from kinesin-like protein 
KIF1B isoform alpha.  The positions of the first and last amino acids of each peptide 
within their respective full length proteins are shown in the sixth and seventh columns.  
5.4 Conclusion 
The selection of peptides on which to base protein quantification can be informed by 
variables such as response factor and chromatographic resolution.  Another consideration 
in this process is the fact that non-redundant tryptic sequences have m/z values of varying 
uniqueness and CAD products thereof similarly vary in their mass specificity.  SRMass 
allows the categorization of transitions on the basis of specificity at discrete instrument 
settings.  Furthermore the program can be used to predict those sample components most 
likely to interfere with the quantification of a given analyte. 
The suitability of a peptide as an SRM target may be measured as the total number of 
database matches for all its transitions at fixed precursor/product ion tolerances, an 
estimate of the overall likelihood of isobaric interference.  Based on this metric, 
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LSEPAELTDAVK would be a better target than FMLCAGR in an MRM-based PSA 
assay.  Those peptide ions for which all transitions have redundancy functions with low 
slopes, such as IVGGWECEK could be less prone to interference at increasing 
transmission window, and so may be preferred targets.  A set of product ions from a given 
precursor differ substantially in their specificity between mass accuracies of 0.01 and 2 
Th, suggesting that random isobaric interference affects some more than others.  Some 
m/z pairs are common in proteomic samples but no simple rule defines them.   This 
finding is in agreement with studies employing global approaches to the identification of 
accurate transitions.  Though rare, the mimicry of several analyte transition signals by a 
single contaminant is especially troublesome as this decreases confidence in the identity 
of the target compound.  Grouping matches by peptide revealed those matrix proteins 
most incompatible with the assay and could guide proactive method design. 
It should be noted that the restricted proteolytic digestion and PTM conditions simulated 
in searches reported here resulted in conservative estimates of redundancy.  Isotopic 
distribution of the elements is another important contributing factor to isobaric 
interference which was not explored.  The isotopic envelopes of analytes differing in 
mass by several Daltons overlap so ions several mass units lower than the query as 
reported by other groups is reasonable (6, 7).  This effect was approximated at precursor 
ion mass tolerances of 1 to 2 Th.  Even with the simple model used here, all transitions 
tested at mass windows typical of SRM experiments returned tens to hundreds of hits to 
the human protein database, showing the proteome to be a major contributor to chemical 
noise common in SRM assays. 
5.5 Contributors 
All programming of the algorithm used in this study was performed by Olga Krakovska 
(Ph.D.).  The concept and input variable design of the algorithm as well as its final testing 
and application were carried out by this author. 
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Afterword 
 
Studies described in the preceding chapters are ongoing and mass spectrometry continues 
to have a place in each of them.  Findings presented in this dissertation are summarized 
below as are lines of scientific inquiry arising from them. 
Chapter 2 details the assignment of phosphosites within two S. aureus transcription 
factors.  In the case of VraR, the location of the phosphosite was previously assumed to 
be D55 based on several lines of evidence.  While unmodified and phosphorylated D55 
were differentiated in crude cell lysates by the method developed here, the latter form 
could only be observed when phospho-VraR made up around 0.1% of the total protein 
content of the sample, a concentration apparently higher than that of the endogenous 
protein.  Initial attempts to detect endogenous phospho-VraR following its purification 
from antibiotic challenged S. aureus cultures were unsuccessful.  It is unclear whether the 
absence of signal was due to inefficient purification or to low phospho-VraR 
concentration, since VraR autodephosphorylation appears to occur rapidly.  Because 
VraR and phospho-VraR have similar affinity for the VraSR promoter region, VraR-
dependent transcription may be maintained when the intracellular concentration of the 
unmodified protein is elevated.  VraR notably regulates its own promoter, so antibiotic 
response may be activated by VraR phosphorylation then maintained by an excess of 
VraR.  To determine if long-term antibiotic stress response is decoupled from VraR 
phosphorylation in vivo, endogenous phospho-VraR could be isolated, reduced then 
measured following brief duration oxacillin exposure.  If VraR purification must be 
improved in order to detect endogenous phospho-VraR, a novel antibody may be required 
for this purpose.  Quantification of VraR at various periods of antibiotic exposure could 
reveal the relative contributions of phospho-VraR and VraR to survival over time.  This 
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could be accomplished with an MRM assay standardized with stable isotope-labelled 
synthetic VraR peptides. 
VraR is one of many bacterial proteins controlled through aspartate phosphorylation, 
though phosphoanhydride reduction remains an underutilized technique in the study of 
this type of PTM.  The methodology presented here could in principle be applied to many 
other proteins in S. aureus and other species.  There are seventeen recognized two-
component systems within S. aureus and the phosphorylation of each RR could be 
characterized by LC-MS. 
The third chapter of this dissertation details the identification of three phosphosites which 
presumably modulate Z. mays SbeIIb function.  Specific roles of each phosphosite in the 
interaction of SbeIIb with other proteins and in starch branching catalysis remain to be 
demonstrated.  SbeIIb phosphosite point mutants generated by site-directed mutagenesis 
could be used to construct protein-protein interaction models by testing their affinities for 
other members of the starch biosynthesis complex.  The kinases and phosphatases which 
modify SbeIIb are also unknown, though several candidates were recognized.  Each 
candidate kinase could be cloned and tested in purified form for activity on each SbeIIb 
phosphosite.  If the kinases responsible for K1 and K2 activity were established in this 
manner, recombinant kinases in combination with wild-type and point mutant SbeIIb 
could be used to find the effects of each PTM on starch affinity and starch branching. 
The ultimate objective of the study of amyloplast protein phosphorylation is the complete 
description of starch synthesis complex function from extracellular signalling to the 
completion of the mature granule.  GBSS, SSIIa, and SP undergo PTM at unknown 
residues and the discovery of additional modification sites within the complex is of 
importance to describing its workings.  As with SbeIIb, the definition of novel GBSS, 
SSIIa, and SP phosphosites could be followed by biochemical examinations of each, 
leading to a model of protein complex modulation. 
In chapter 4, the hypothesis that Beta-catenin is a substrate of p38 was tested with an in 
vitro phosphorylation assay.  No phosphorylation of Beta-catenin was observed, 
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supporting the conclusion that the activating effect of p38 was produced indirectly.  Co-
immunoprecipitation of a muscle cell lysate in which Beta-catenin was the antigen failed 
to differentiate a p38-hyperactivated state from a state of basal p38 activity.  Repetition of 
the immunoprecipitation experiment with subcellular fractionation preceding affinity 
purification is warranted as the division of compartment-specific Beta-catenin complexes 
may allow the effects of p38 on each to be revealed by LC-MS. 
Several proteins which co-immunoprecipitated with Beta-catenin are novel interaction 
partners, and in the case of WDR5 the interaction was confirmed by Western blot.  
Studies on the interplay of Beta-catenin and WDR5 could follow from this initial 
discovery.  Spatial and temporal components of WDR-Beta-catenin association could 
both be examined using LC-MS in conjunction with microscopic and biochemical 
techniques.  LARP1 is a putative Beta-catenin binding protein; however any continuing 
investigation of their interaction should begin with further biochemical confirmation of its 
occurrence. 
Results presented in chapter 5 showed that the m/z redundancy of a peptide and its 
product ions can be tested considering the biological matrix in which the peptide appears.  
Furthermore, the redundancy of a particular transition is not strictly dictated by precursor 
ion length or product ion length.  A comparison of mass tolerance and transition 
redundancy revealed that selectivity varies to different degrees for each precursor/product 
ion pair.  This implies that two or more isobaric peptides of highly dissimilar sequence 
may not be distinguishable based on an MS/MS spectrum containing a small number of 
product ions as well as the precursor ion mass, because such peptides may still have 
several product ion masses in common. 
The SRMass program was tested on a small set of transitions and extending this study to a 
larger set would permit statistical analysis of transition redundancy.  Predicted 
redundancy trends for specific transitions could also be related to actual mass 
spectrometry data, to show how quantification is affected by mass selection windows as 
well as transition selection. 
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